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Prologue
Part 1

CHAPTER1
General Introduction 
and
Outline of the Thesis
4 | Chapter 1
Derived from the ancient Greek words ‘tomos (τόμος)’ and ‘graphein (γράφειν), meaning ‘slice’ and 
‘to write’, tomography stands for “to write (or describe) in slices [1]. One of the earliest reports of 
computed tomography can be traced back to publications in the beginning of 1960s by Allan M. 
Cormack, who described a scan of an aluminium phantom ring filled with Lucite and two aluminium 
disks, representing two tumors [2,3]. At that time, little attention was paid to his work, because the 
technique was time-consuming and involved complicated calculations. In the same period, Godfrey 
N. Hounsfield came up with a concept that if multiple X-ray measurements are taken through a 
body from different directions it could be possible to reconstruct its internal structure. From here 
on, it took several years of dedicated work before he developed the first clinical CT scanner at the 
Atkinson-Morley Hospital in September 1971 (Figure 1) [4]. For their pioneer work in the field of 
computed tomography, both G. Hounsfield and A.M. Cormack received the Nobel Prize of Physiology 
or Medicine in 1979. 
Figure 1 | EMI Brain Scanner. Museum of Sci-
ence, London, UK. The EMI scanner produced 
detailed pictures of patients’  brains for the first 
time. Godfrey Hounsfield invented the tech-
nique, called computed tomography, which 
constructed a picture from a series of 28.800 
measurements made by a paired X-ray source 
and detector rotating around the patient. Previ-
ously, X-rays could only image the brain after 
hazardous injections of air or special liquids.
In his Nobel lecture Cormack referred to his early publications: “There was virtually no response. 
The most interesting request for a reprint came from the Swiss Center for Avalanche Research. The 
method would work for deposits of snow on mountains if one could get either the detector or the 
source into the mountain under the snow!”. 
 Nowadays medical care is impossible to imagine without the aid of computed tomography. 
In computed tomography, X-ray beams are transmitted by an X-ray source on one side through 
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a patient and registered on the opposite side by detectors. While passing through a patient, 
different tissues allow X-ray beams to pass in different degrees, also called attenuation. Tissue like 
bone or calcification inhibit the passage of X-rays beams and are called radiodense, while air allows 
for passage of all X-ray beams and is called radiolucent. The X-ray source and the detectors are 
situated on opposite sides of each other. As they rotate around the patient, attenuation profiles 
of the transversed tissues are acquired as X-ray beams fall through the patient on the detectors. 
By using attenuation profiles from multiple radial points, we can transform them into images of 
the organ that is being radiated using advanced computer reconstruction techniques (Figure 2). 
As the patient is moved axially through the rotating gantry, images are constructed in slices. First-
generation scanners took several minutes to perform one scan making them very susceptible for 
patient movement. In second generation scanners, multiple beam-detector matches instead of one 
were implemented to reduce scan times. Initial narrow X-ray beams were replaced by fan-beam 
technology in third generation scanners, reducing scan times even more. At that time, X-ray tube 
and detectors were connected by cables to the rest of the scanner and after a number of rotations 
they had to stop and reverse direction. These interscan delays were an important limitation for 
cardiac imaging, where a fast acquisition time is a prerequisite as the heart is a moving organ. 
Figure 2 | A rotating X-ray source emits X-ray beams which are, after being attenuated as they pass 
through a patient, detected on the opposite of side. The detectors transform the incoming attenuation 
profiles in electronic information which is used by a supercomputer to manufacture an image. 
Also, a long acquisition time made good contrast enhancement of the coronary arteries very 
hard. Two different types of scanners were developed in response, more suitable for cardiac 
imaging. The electron beam CT scanner, liberated from a mechanically rotating X-ray tube, used an 
electromagnetically guided electron beam over a tungsten target ring to acquire a slice (tomogram) 
within 100 milliseconds [5]. Although promising, cost issues and limitations in image quality 
prevented general acceptance of electron beam CT scanners. Focus was redirected to a different 
type of scanner, the helical multi-detector scanner with slip-ring technology, precursor of the current 
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multi-slice scanners, first released in 1992. Slip-ring technology allowed data between the rotating 
and stationary components in a scanner to be exchanged without fixed connections, eliminating 
interscan delays. A slip ring is a drum or annulus with grooves along which electrical contact brushes 
slide (similar to bumper cars). Helical scanners became immensely popular and they improved with 
increased volume coverage, improved spatial resolution and higher temporal resolution in the years 
that followed. 
 To obtain angiographic images, iodinated contrast medium, which is very radiodens, is injected 
into the vascular system of the patient to enhance the lumen of a blood vessel of interest, revealing 
the presence and degree of atherosclerosis. Scans without contrast enhancement scans do not 
allow to differentiate between vessel wall, lumen and atherosclerosis, but can be used to detect 
and quantitate calcium in coronary arteries, which signifies the presence of atherosclerosis [6]. To 
date, the coronary calcium score remains a valuable screening tool used next to contrast enhanced 
coronary computed tomography angiography [7]. In chapter 2 of this thesis, further technological 
aspects of cardiac CT imaging, acquisition protocols and their associated radiation exposure are 
discussed. We also touch upon studies assessing the diagnostic accuracy of coronary CT angiography 
and some potential clinical applications are discussed. 
 Soon after the introduction of coronary CT angiography in clinical practice it became evident 
that this modality was a good angiographic non-invasive alternative for the diagnosis of coronary 
artery disease, exceeding in the ability to exclude important coronary artery disease [8-10]. Having 
the ability to reliably exclude coronary artery disease might be of particular benefit to patients 
who present at the emergency department with suspected coronary artery disease. Although the 
majority of them have a benign cause for their complaints, missing an acute coronary syndrome 
can have grave consequences. We investigated the value of coronary CT angiography in patients 
presenting to the emergency department suspected of an acute coronary syndrome (part 2). First, 
Chapter 3 provides a systematic review on the diagnostic performance of the most used diagnostic 
modalities at that time (echocardiography, radionuclide myocardial perfusion imaging and 
coronary CT angiography) for patients presenting to the emergency department suspected of an 
acute coronary syndrome. In chapter 4, the results of our single-centre, blinded, observational study 
are presented, which was designed to examine the safety, feasibility and accuracy of coronary CT 
angiography in this clinical setting. In a sub study, described in chapter 5, coronary CT angiography 
is compared with copeptin, a novel biomarker, released very early in the case of hemodynamic 
stress. Finally, we designed and performed a multicentre, randomised controlled trial to compare 
a diagnostic strategy supplemented by early coronary CT angiography with standard optimal care, 
incorporating new high-sensitivity troponins. The results are presented in chapter 6. 
While it is becoming evident that coronary CT angiography is a reliable diagnostic modality, 
expanding to several clinical scenarios, it has been suggested that the presence and degree of 
coronary artery disease detected by coronary CT angiography also might provide information 
regarding adverse events in the future.
 In part 3, we examined the ability of coronary CT angiography to identify patients at higher risk 
of future adverse events. In chapter 8, we compared exercise electrocardiography and coronary 
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calcium scanning, both minimally invasive tests, as gatekeepers for additional testing. Chapter 9 
describes the prognostic value of coronary CT angiography and the coronary calcium score in high-
risk patients without symptoms of coronary artery disease. Chapter 10 covers the prognostic value 
of coronary CT angiography in patients with stable angina pectoris and how it compares to that of 
exercise electrocardiography. Finally, the prognostic implications of non-culprit lesions detected by 
coronary CT angiography in patients presenting with an acute coronary syndrome is described in 
chapter 11. 
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Summary
ECG-synchronised computed tomography with intravenously injected contrast medium allows 
visualisation of the coronary anatomy, detection of luminal obstruction and evaluation of 
atherosclerotic plaque in the vessel wall. The current state of technology allows routine use of CT 
angiography, either as the initial test or as an alternative to functional testing, to exclude obstructive 
coronary artery disease. The high negative predictive value of CT angiography permits reliably 
exclusion of coronary artery disease. CT angiography may reveal coronary stenoses, which is 
difficult to visualise with conventional angiography. Combined CT and radionuclide imaging can 
potentially ascertain the haemodynamic effect of visualised stenoses. Contrary to catheter coronary 
angiography, CT angiography also images atherosclerotic plaque. Imaging of coronary plaque could 
improve risk stratification and perhaps lead to optimised risk modification.
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Introduction
Despite the impressive quality and versatility of various invasive coronary imaging technologies 
described elsewhere in this book, there is both a clinical and scientific need for noninvasive imaging 
of coronary artery disease. The current availability of noninvasive coronary angiography by computed 
tomography (CT) is the result of an extraordinary technological development, which took place over 
the past 15 years. While initially electron-beam CT (EBCT) with its high temporal resolution seemed 
best suited to image the fast moving coronary arteries [1], eventually mechanical, multislice spiral 
CT emerged as the most widespread CT coronary imaging technique. The feasibility of mechanical 
(spiral) CT coronary angiography, though still challenging in its performance and interpretation, was 
demonstrated using 4-slice scanner technology [2,3]. At the present time, 64–320 slice CT scanners 
deliver reliable coronary imaging on a routine basis, allowing widespread clinical application of this 
exciting diagnostic modality. Further innovation in terms of scan speed, coverage and radiation 
dose saving is offered by the latest technology, with development of new applications, including 
stress imaging.
Principles of Cardiac CT
CT images are created by calculation of the spatial roentgen attenuation throughout a plane from 
a large number of radial roentgen attenuation projections acquired while the roentgen tube and 
opposed roentgen detectors rotate around the object. Roentgen attenuation is different for various 
tissues depending on the atomic mass and density of the material the photons pass through. The 
ability of CT to differentiate natural tissues is limited, and can be summarised as air containing 
tissues (lungs), fat tissue, soft tissues and bone.
 To create contrast (an attenuation difference) between blood and the surrounding tissues CT 
angiography requires injection of a (iodine containing) contrast medium. The minimum number 
of projections needed to reconstruct a cross-sectional image is acquired during an approximate 
180 degrees of scanner rotation. Displacement of the object during this half rotation will result in 
image degradation. To image a continuously moving organ it is crucial to perform this half rotation 
as fast as possible. The temporal resolution of the CT scanner is determined by the rotation speed 
of the scanner, but can be further improved by special reconstruction algorithms (multi-segmental 
reconstruction), or by equipping scanners with more than one tube and detector array (dual-source 
CT). Additionally, acquisition or reconstruction needs to be performed when cardiac motion is as 
minimal as possible, usually the mid-diastolic or end-systolic phase of cardiac contraction. Finally, 
cardiac motion may be reduced by administration of medication to slow the heart rate.
 Because the CT scanner does not correct for displacement of the entire heart during acquisition, 
patients are required to hold their breath during the scan and remain motionless.
 The use of spiral CT acquisition, i.e., continuous scanning and uninterrupted patient advancement, 
and multidetector technology allowed high-resolution CT angiography of the moving heart within 
the duration of a single breath hold.
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Current CT Technology
State-of-the-art CT technology is equipped to simultaneously acquire at least 64 slices and scan the 
entire heart in no more than a few seconds. Meanwhile, scanners with wider detector collimation have 
been introduced by most vendors, which further shortened the scan time. Recently 320-detector 
row CT technology has become available with the advantage of complete coverage of the heart 
without the need for table movement during imaging of the heart. Cardiac motion artifacts on 
CT images can be challenging, particularly for patients with a high heart rate. The rotation time 
of most scanners is around 300 ms, resulting in a temporal resolution of 150 ms. Despite their 
limitations in efficiency, multi-segmental reconstruction algorithms can improve the effective 
temporal resolution by combining data from different heart cycles. Alternatively, dual-source CT 
technology, i.e., scanners are equipped with two sets of roentgen tubes and detectors mounted 
at a 90 degree angle, allows simultaneous acquisition of two complementary sets of 90-degrees 
projection data instead of a single 180-degrees dataset. This cuts the acquisition time per slice in 
half, temporal resolution of 70 ms at a scanner rotation time of 280 ms, irrespective of the heart 
rate of the patient. Concerns regarding radiation exposure have resulted in hardware and software 
modifications that have reduced the radiation exposure significantly. While conventional spiral CT 
acquisition protocols exposed the patient throughout the heart cycle, despite the fact that generally 
only mid-diastolic images were used for reconstruction of the coronary images, prospectively ECG-
triggered tube modulation restricts full output to the cardiac phase of interest. Reintroduction of 
sequential or step-and-shoot CT imaging has reduced radiation doses to below 5 mSv [4,5,6], which 
can be further reduced by scanning at a lower tube voltage (80–100 kV) in smaller sized patients [7,8] 
(Table 1). Wide-detector, single-phase CT imaging is also associated with a lower radiation exposure 
compared to 64-slice spiral CT [9,10]. Finally, high-pitch, single-phase spiral imaging can bring the 
exposure below 1 mSv [11,12] (Figure 1).
Figure 1 | High-pitch, single-phase cardiac CT angiography. Prospectively ECG-triggered, high-pitch spiral 
CT angiogram, with 3D volume-rendered (A, B) and curved-plane reconstruction (C), demonstrating severely 
obstructive coronary artery disease in the right coronary artery (RCA). Left anterior descending coronary 
artery (LAD), intermediate branch (IMB) and left circumflex coronary artery (LCX).
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Table 1 | 
CT acquisition techique Range of average dose (mSv)
Conventional 64-slice spiral CT 12–18
ECG-triggered tube output modulation 8–12
Prospective (step-and-shoot) CT* 2.8–4.2 [4-6]
Lowed tube voltage* 1.5–3.8 [7,8]
320-detector CT 3.9–6.0 [9,10]
High-pitch spiral CT* 0.9 [11,12]
*Selected patients
Imaging Coronary Artery Obstruction
Initial studies comparing four-slice CT angiography and catheter angiography reported promising 
results, but also exposed the limitations of this technology in terms of temporal resolution, spatial 
resolution and scan duration [2,3]. In these comparative studies up to a third of the coronary branches 
needed to be excluded from evaluation as a result of insufficient image interpretability. Many of these 
excluded branches were affected by motion artifacts. Faster sixteen-slice CT scanners combined 
with routine use of betablockers to lower the heart rate clearly improved diagnostic performance, 
while 64-slice CT technology provided the level of image quality and examination convenience that 
paved the way to widespread clinical use of the noninvasive coronary angiography (Figure 2, Figure 
3 and Table 2). The diagnostic performance of (64-slice) CT has been the topic of various meta-
analyses, which reported per-patient sensitivities of around 98% and specificities of around 90% to 
detect “significant” >50% obstructive coronary artery disease [13]. The ability to exclude obstructive 
disease is very high, as reflected by the excellent per-segment negative predictive value of CT (range 
95–100%). On the other hand, overestimation of stenosis severity on CT is common, hence the 
moderate positive predictive value in most comparative studies, ranging from 44% to 93% on a per 
segment basis. This tendency for overestimation particularly occurs in the presence of calcifications, 
which appear enlarged as a result of blooming. Furthermore, the subjective stenosis severity is 
increased by visualisation of plaque and outward vessel remodelling, which combined with an 
often defensive diagnostic approach in order not to miss any disease, contributed to the relatively 
high number of false positive diagnoses. As scanners have become faster and scan duration shorter, 
diagnostic performance is better with more advanced CT technology. Because motion artifacts occur 
less in patients with lower heart rates, beta-blockers are routinely administered in patients with 
heart rates over 65/min to improve image quality. As mentioned, diagnostic performance is better 
for patients with a low calcium score. Due to limitations in spatial resolution, diagnostic accuracy is 
better for larger proximal vessels in comparison to smaller branches. In obese patients, image quality 
is affected by increased levels of image noise, which can affect image quality dramatically. Because 
most scanners require several heart cycles to collect images, arrhythmia that results in a variable 
heart cycle duration causes misalignment and potentially missing data between the consecutive 
stacks of images, which negatively affects image interpretation.
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Figure 2 | CT angiography and second-
ary reconstruction techniques. Obstruc-
tive lesion (arrow) in the left anterior de-
scending coronary artery (LAD) imaged 
by CT angiography and demonstrated 
using various secondary reconstruction 
techniques: double-oblique multi-planar 
imaging along the short (A, B) and long 
axis (C), maximum-intensity projection 
(MIP, D), curved multiplanar reformation 
(E) and maximum intensity projection 
(F) along the course of the entire LAD, 
three-dimensional volume-rendered 
reconstruction (G, H).
Table 2 | 
N CAD Sensitivity Specificity PPV NPV
Miller, et al. [17] 291 56% 85% 90% 91% 83%
Budoff, et al. [18] 230 24% 95% 83% 64% 99%
Meijboom, et al. [19] 360 68% 99% 64% 86% 97%
Since the introduction of 64-slice cardiac CT, technical development has diverged between different 
CT manufacturers. Dual-source CT technology, which improves the temporal resolution and reduces 
motion artifacts, has demonstrated improved image quality even without routine use of heart rate 
modifying mediation [14-16]. All CT manufacturers continue to expand the number of detector 
rows on CT scanners to shorten the scan time, ranging from 128–320 detector rows. Studies using 
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320-detector CT, which allows complete coverage of the heart without the need for table movement, 
demonstrated good diagnostic performance [9,10].
Figure 3 | CT angiography revealing RCA obstruction. Volume rendering and planar curve reconstruction of 
a severely obstructed right coronary artery (RCA).
Quantitative CT angiography tools are widely available and potentially improve diagnostic accuracy, 
reproducibility and diagnostic confidence. Despite good correlation, variability between individual 
quantitative CTA and catheter angiography measurements remains considerable. Given the limited 
spatial resolution of CT (0.4 mm at best) and the vulnerability of quantitative software to motion, 
calcium and other artifacts, automatic stenosis severity quantification may be misleading without 
consideration of the image quality.
 Thus far, tools for automatic quantitative stenosis severity assessment, as compared to visual 
estimation, have not convincingly improved the diagnostic performance of coronary CT [10]. The use 
of categories of visual obstruction severity, normal, minimal obstructive (<25%), mildly obstructive 
(<50%), moderately obstructive (50–70%), severely obstructive (>70%) and occluded (100%), are 
currently recommended.
 While CT angiography (CTA) and invasive angiography generally show good correlation, both 
angiographic techniques show only modest comparability with various invasive and noninvasive 
functional tests (Figure 4). Several comparisons between CTA and various noninvasive stress tests 
have been published, which demonstrated that an abnormal CTA does not necessarily imply 
(detectable) myocardial ischaemia. Myocardial ischaemia in the absence of obstructive disease on 
CTA is much less likely, although it does occur in clinical practice [21,22,23,24,25].
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Figure 4 | CTA versus fractional coronary flow 
reserve. Correlation between CT angiography 
stenosis severity and intracoronary flow mea-
surements, adapted form Meijboom et al. [20].
Clinical Applications
From the comparative studies between CTA and catheter angiography as well as functional tests we 
can conclude that CTA has a low detection threshold to coronary artery disease with a tendency to 
overestimate obstructive severity.
 On the other hand CTA rarely misses significant disease as represented by the high sensitivity 
and negative predictive value in comparison to other techniques. The accuracy to confirm normal 
or minimally affected coronary arteries is much better than the accuracy to establish the extent 
of obstructive disease when atherosclerotic, and particularly calcified disease is abundant. In 
that perspective CTA appears to be particularly useful for exclusion of coronary artery disease in 
patients without a high pre-test probability of significant coronary artery disease. Although CTA 
is effective in excluding obstructive coronary artery disease in very low risk patients, the fact that 
these individuals have an excellent prognosis and may be managed without extensive testing 
needs consideration. Published consensus documents state that CTA is an acceptable diagnostic 
option in patients with symptoms, a low to intermediate probability of CAD (15–50%), provided 
that sufficient expertise is available and the patients lacks characteristics that make the CT exam 
unreliable (arrhythmia, obesity, contrast allergies, renal dysfunction) [26,27,75,76]. CTA is considered 
appropriate, particularly when a stress test is not feasible (abnormal resting ECG, inability to exercise), 
not diagnostic (insufficient exercise performance) or non-conclusive (moderately abnormalities or 
suboptimal test results). Considering the less than perfect diagnostic performance of stress tests, 
and particularly exercise electrocardiography with a sensitivity of merely 50–70%, there is a debate 
whether CTA is preferable as the initial test, reserving stress testing for patients with non-conclusive 
CTA results. While the recent multicentre PROMISE trial could not demonstrate superiority in terms 
of hard cardiovascular outcomes, CTA appears to perform equivalently in comparison to established 
functional test strategy [77].
 While CTA is mostly used in patients with stable chest pain complaints, the use of noninvasive 
coronary angiography to exclude obstructive coronary artery disease also shows promise prior to 
non-coronary cardiac surgery, (assumed) non-ischaemic heart failure and in the setting of (low-risk) 
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acute chest pain. Many patients presenting with or after sudden chest pain symptoms and negative 
initial test (ECG and blood markers) will be admitted for observation, while only a minority will 
eventually be diagnosed with an acute myocardial infarction or obstructive coronary artery disease. 
Immediate exclusion of obstructive coronary artery disease makes an acute coronary syndrome 
unlikely, although observational studies observed a number of events in patients without significant 
obstructive disease. In the absence of any detectable atherosclerotic disease the odds of an acute 
coronary syndrome are extremely low; however, this lower threshold will decrease the specificity of 
the test considerably [28,78]. Randomised controlled trial between CTA and myocardial perfusion 
imaging in low-risk patients showed that CTA was safe and potentially cost-effective [29,79,80]. Of 
added value is the ability of CT to exclude other life threatening conditions such as aortic dissection 
and pulmonary embolism.
 An important recommendation, which was explicitly expressed in the ESC consensus document, 
is that CTA should only be performed when interpretable image quality can be achieved [75]. 
Conditions that reduce the likelihood of a conclusive examination include arrhythmia, tachycardia, 
high calcium score, coronary stents, obesity, uncooperativeness.
 Registry data from our own institution showed that when the coronary calcium score was more 
than 400 all but a few CTAs turned out positive, whether true of false, for obstructive coronary 
artery disease (Figure 5). Considering the limited quantitative correlation between CTA and catheter 
angiography, and the limited value of anatomical stenosis severity and myocardial ischaemia, 
clinical use of repeated CTA for monitoring obstructive coronary artery disease progression seems 
inappropriate.
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Figure 5 | Calcium score versus CT 
angiography. Number and percentage 
of positive CTAs (dark bars, any >50% 
lumen obstruction) versus the number 
of negative CTAs (bright bars), stratified 
by calcium score categories. Obstructive 
CAD on CT angiography is an infrequent 
finding when the calcium score is nega-
tive. On the other hand, obstructive 
disease is unlikely to be excluded by 
CTA in patients with a very high calcium 
score. Data from Nieman et al. [30].
CTA after Myocardial Revascularisation
As metal attenuates roentgen more than any natural tissue stents are generally well visible as bright 
structures on conventional greyscale CT images. This strong roentgen attenuation is also the cause 
of artifacts, which can complicate the assessment of the in-stent lumen. Blooming artifacts, referring 
to the apparent expansion of the stent strut dimensions on CT, is caused by partial volume effects 
(related to the spatial resolution of CT) and convolution filters used during reconstruction [31]. These 
stent artifacts become more severe combined with cardiac motion artifacts. Depending on the stent 
alloy, the stent design, its diameter size, the scanner and the reconstruction algorithm up to half of 
the in-stent lumen is affected by these artifacts [32].
 Comparative studies between CTA and invasive angiography for the assessment of in-stent 
restenosis have demonstrated variable results [33,34,35,36,37,38,39] (Figure 6). For instance, the 
exclusion rate varied between none and 42%, while the sensitivity and specificity varied between 
33–100% and 74–98%, respectively (Table 3). A meta-analysis calculated the pooled exclusion rate, 
sensitivity and specificity of 64-slice CT for the detection of restenosis per stent as, 11%, 82% and 
91% [40]. While differences in patients selection and the number of completely occluded stents 
will be partially responsible for the differences in diagnostic performance between studies, the 
accuracy of CT is also associated with the earlier mentioned stent diameter size and alloy, and the 
use of sharp kernels for image reconstruction. Stainless steel is one of the more permissive metal 
alloys that produce relatively limited artifacts, while cobalt, tantalum and gold cause much more 
severe artifacts. At the current stage, use of CTA after PCI is restricted to patients with large stents, 
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in who excellent image quality can be expected [27]. Bioresorbable scaffolds with non-metal 
backbones interfere much less with interpretation by CTA. In several studies on the performance of a 
bioresorbable scaffold made of polylactic acid cardiac CT was applied for noninvasive angiographic 
follow-up [41,81]. 
Figure 6 | CT angiography after three-vessel stent-
ing. CT coronary angiography of a patient with 
stents in all three coronary arteries. The stent in the 
left circumflex coronary artery (LCX) is occluded 
(A), the two stents in the left anterior descending 
coronary artery (LAD) are completely patent, and 
the stents in the right coronary artery (RCA) show 
various degrees of narrowing (C), as confirmed by 
conventional catheter angiography.
Table 3 | 
N Stents ISR Excl. Sens Spec PPV NPV
Van Mieghem et al. [33] 64 162 6% 21% 100% 91% 67% 100%
Cademartiri et al. [34] 182 192 11% 7% 95% 93% 63% 99%
Rixe et al. [35] 64 102 12% 42% 89% 98% 86% 98%
Pugliese et al. [36] 100 178 39% 5% 94% 92% 77% 98%
Ehara et al. [37] 81 125 20% 12% 91% 93% 77% 98%
Hecht et al. [38] 67 132 13% – 94% 74% 39% 99%
Wykrzykowska et al. [39] 52 75 0 36% 33% 92% 57% 81%
CTA after Bypass Graft Surgery
Because bypass grafts have a large diameter with modest displacement during cardiac contraction 
they can be imaged well by cardiac CT (Table 4, Figure 7). Compared to venous bypass grafts, arterial 
grafts are smaller in diameter size with more metal clips, which potentially complicate evaluation of 
the CTA images. Assessment of graft occlusion does not require advanced CT technology and could 
be performed reliably even with more dated equipment [42,43], although complete coverage 
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Figure 7 | Occluded LIMA and vein graft disease. Severe obstruction (arrows) of a venous graft to the right 
coronary artery by CT angiography (A and B) and conventional angiography (C). The animated 3D volume 
rendered angiogram also shows a string of high-density vascular clips along the anterior surface of the heart, 
which indicate the trajectory of an occluded left internal mammary grafts to the left anterior descending 
coronary artery. The metal indicator (arrow heads) near the proximal graft anastomosis causes severe beam 
hardening artefacts on CTA.
Table 4 | 
Total occlusion Stenos (50–99%)
Study N Excl Sens spec Excl Sens Spec
Pache et al.a [44] 31 6% 98% 89%
Malagutti et al. [45] 52 0% 96% 100% 0% 100% 94%
Ropers et al. [46] 50 0% 100% 100% 0% 100% 94%
Meyer et al.b [47] 138 2% 97% 97%
Onuma et al.b [48] 53 1–10% 100% 91–98%
of the proximal left anterior mammary artery grafts would require a 40 to 50 seconds breath-hold. 
Imaging of graft stenosis, particularly close to the more motion sensitive coronary anastomoses, has 
benefited from more advanced CT technology [44,45,46,47,48]. The challenge of imaging patients 
after coronary artery bypass graft surgery (CABG), however, are not the grafts, but the native 
coronary branches and the clinical interpretation of detected obstructions. Postsurgical patients 
often have advanced atherosclerotic disease with extensive deposition of calcium. For this reason, 
diagnostic performance of CTA of the coronary branches after CABG is inferior to patients without 
prior surgery [43,45,46,48]. In the presence of diffuse coronary artery disease, developed collateral 
vasculature and potentially long-standing (subclinical) graft thrombosis, it may be difficult to assess 
which (if any) stenoses are responsible for the patients complaints, without performing some sort 
of stress test. In certain situations, CT imaging of the grafts can avoid, simplify or shorten invasive 
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procedures. CTA can also provide important anatomical information in post-CABG patients (again) 
undergoing thoracic surgery.
CT Guided Percutaneous Coronary Interventions
Although in the near future CT angiography is unlikely to replace invasive catheter angiography as 
the roadmap for coronary interventions, there may be complementary use to CT imaging in specific 
situations. While CTA is inferior to catheter angiography in terms of spatial and temporal resolution, 
it has practical advantages and outperforms projectional lumenography where three-dimensional 
orientation and visualisation of the vessel wall are concerned.
 Without the requirement of selective ostial engagement, CTA effectively images obstructive 
disease in proximal coronary branches, as well as anomalous coronary arteries and occluded 
grafts (Figure 8). Because CT is not a projectional technique the exact angle between branches 
can be determined, which can be helpful prior to revascularisation of bifurcation stenoses 
(Figure 9). Recanalisation of chronic total occlusions remains a challenge. CTA can provide additional 
information with regard to the length of the occlusion, calcifications within the occluded vessel 
segment, which predicts and potentially positively affects success of the revascularisation procedure 
[49,50] (Figure 10). Finally, the CT angiogram may be integrated as a roadmap for advanced 
revascularisation techniques, such as magnet navigated revascularisation procedures [51].
Figure 8 | Anomalous origin of the left circumflex 
coronary artery. 3D CT angiogram with a posterior 
view of the heart after removal of the left atrium, 
shows the anomalous origin of the left circumflex 
coronary artery from the right sinus of Valsalva, and 
its trajectory behind the aortic root towards the left 
interventricular groove.
Figure 9 | Left main coronary artery bifurcation 
stenosis. Severe stenosis of the left main bifurcation 
caused by plaque of mixed composition on opposite 
sides of the distal left main coronary artery.
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Figure 10 | Chronic LAD occlusion. CT angiography (A, B and C) prior to recanalisation of a chronically oc-
cluded left anterior descending coronary artery. Contrary to the catheter angiogram (D), CT visualises the 
length of the occlusion, its content in terms of calcium or non-calcified tissue, and the presence and location 
of side branches. Panels B are consecutive cross-sections of the middle segment of the LAD.
Functional Assessment of Coronary Artery Disease
At the current time, cardiac CT is predominantly used for assessment of coronary lumen stenosis. 
Similar to invasive angiography, cardiac CT is not easily able to differentiate haemodynamically 
significant from non-significant luminal narrowing. There are various means to overcome this 
limitation. The diagnostic performance of CT allows confident exclusion of (haemodynamically) 
significant coronary artery disease in the majority of patients. In case of coronary lumen narrowing, 
CT may be followed by a (noninvasive) stress test, for instance myocardial perfusion imaging or 
merely an exercise ECG, to assess whether myocardial ischaemia can be induced. Alternatively, 
multidetector CT can be physically combined with a myocardial perfusion imaging modality, for 
instance single-photon-emission computed tomography or positron emission tomography, to 
correlate coronary obstruction and inducible myocardial ischaemia in a single examination.
 As a third alternative stress myocardial perfusion imaging may be performed using CT itself. 
Dynamic perfusion imaging has been performed in the past using electron-beam computed 
tomography [52]. Recently, as a result of wider longitudinal coverage and low-dose scan techniques, 
adenosine stress perfusion imaging using mechanical cardiac CT has been revisited. The least 
demanding stress perfusion methodology involves the acquisition of a single CT dataset during 
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myocardial enhancement during hyperemia by intravenous infusion of adenosine or another 
vasodilator. Feasibility of the technique and the potential for incremental diagnostic accuracy, has 
been demonstrated in several single and multicentre studies [53,54,82,83]. Alternatively, repeated 
scans can be performed during injection of contrast medium to acquire time-attenuation curves 
of the myocardium and calculate the myocardial blood flow. The latter technique, known as 
dynamic perfusion imaging, requires more advanced CT technology with extended coverage and is 
associated with a higher radiation dose. Advantages include the ability of absolute flow calculation 
and the apparent lower susceptibility to beam hardening artifacts (Figure 11). 
Figure 11 | CT myocardial perfusion imaging. 
Dynamic myocardial perfusion imaging after adenos-
ine vasodilation using a third generation dual-source 
CT system. The calculated myocardial blood flow is 
lower, displayed as blue (arrows), in the lateral wall 
(A), corresponding to a stenosis (arrow) in the mar-
ginal branch of the left circumflex coronary artery (B). 
Figure 12 | CTA derived fractional flow reserve. 
Three-dimensional display of the coronary anatomy, 
and superimposed in colour the spatially distributed 
fractional flow values as calculated from the CT an-
giogram using computational fluid dynamics (A). 
CT angiography follow-up after implantation of a 
bioresorbable coronary scaffold in the left anterior 
descending coronary artery (LAD), as indicated by 
the two platinum indicator, which shows moderate 
angiographic obstruction. CTA based fractional flow 
reserve shows that the FFR decreases to 0.86 distal to 
the scaffolded segment, but not reach 0.80 until very 
distally.
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Smaller studies have demonstrate the feasibility and incremental diagnostic value of the technique 
over CTA, although large multicentre trials have not yet been performed [84,85].
 An new method to assess the hemodynamic severity of coronary artery disease is the calculation 
of fractional flow reserve from CT images using computational fluid dynamics (Figure 12). Similar 
to applications used in the aviation industry, the modelling of flow in interaction with form can 
be simulated for the coronary arteries. Using these models flow and pressure can be calculated 
throughout the coronary arteries, including the calculation of the fractional flow reserve, but 
without the need for injection of vasodilator [86]. In controlled studies CTA based fractional flow 
reserve performs well and provides incremental diagnostic value over CTA alone [87]. In addition to 
remote services for CTA-FFR calculation, also locally performed interpretations of functional severity 
based on CT anatomy are currently developed [88]. Both myocardial perfusion imaging and CTA 
based fractional flow reserve represent promising new techniques that add valuable functional 
information for therapeutic decision. 
Infarct Imaging 
The permanent consequences of coronary artery disease to the myocardium can also be visualised 
using cardiac CT. Without adenosine stress perfusion defects may be observed in patients with 
severe myocardial ischaemia and more frequently after suffering myocardial infarction (Figure 13). 
On CT chronic myocardial infarction is associated wall thinning, dilatation and quite frequently fatty 
infiltration (with very low CT attenuation values) [55]. Similar to magnetic resonance imaging (MRI), 
infarcted myocardium displays increased contrast enhancement approximately 10 minutes after 
contrast administration, as a result of delayed wash-in and wash-out of contrast medium within the 
necrotic or fibrotic myocardium, of acute or chronic myocardial infarction, respectively [56,57,58,59]. 
Although the quality of CT delayed enhancement imaging is still regarded inferior to MRI, there are 
clinical situations (pacemakers, claustrophobia) where CT could be a useful alternative. If during a CT 
scan data are acquired continuously throughout the cardiac cycle, which is no longer routinely done, 
reconstruction of sequential cardiac phases allows evaluation of the left ventricular function. Global 
parameters of LV function: end-diastolic and end-systolic LV volumes, stroke volume and ejection 
fraction, by CT correlate well with other imaging techniques. In addition, regional wall motion can 
be displayed by viewing consecutive CT reconstructions in motion (Figure 14).
Coronary Plaque Imaging 
Visualisation and quantification of calcified plaque perhaps was the first coronary applications 
of computed tomography. Because of the inherent high attenuation of calcium it can be imaged 
without the need for injection of contrast medium. Coronary calcium is almost exclusively the result 
of coronary atherosclerosis, but not necessarily in association with luminal obstruction. Neither does 
the absence of detectable calcium exclude the presence of atherosclerotic plaque, although the 
probability of severely obstructive coronary disease will very low in most populations [30]. On the 
other hand, a high calcium score does increase the probability of obstructive disease, particularly in 
symptomatic populations [60]. Quantification of the coronary calcium burden correlates with the 
overall extent of atherosclerosis, and is associated with adverse cardiovascular events [60,62]. 
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Figure 13 | Myocardial ischaemia by cardiac CT. CT angiography (panels A, D and E) and invasive angiogra-
phy (panel F) showing severe obstruction of the left anterior descending coronary artery (arrow). In addition, 
the anterior wall shows decreased enhancement (arrow heads) of the subendocardial myocardium on the CT 
angiogram (B and C).
Figure 14 | Assessment of left ventricular 
function with CT. Assessment of left ven-
tricular function and regional wall motion 
can be performed with using consecutive CT 
reconstructions.
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For this reason, calcium scanning can be used for (further) risk stratification of asymptomatic 
individuals, particularly those at intermediate risk by traditional risk factors [63].
 Contrary to invasive catheter angiography, contrast-enhanced CT angiography can visualise the 
atherosclerotic coronary wall and distinguish calcified and non-calcified plaque material (Figure 15 
and Figure 16). While on average lipid-rich plaques have lower measured attenuation values (CT 
number in Hounsfield units) compared to fibrous plaque [64,65,66], differentiation of individual 
plaques remains difficult as the measured values are affected by the limited spatial resolution, 
residual coronary motion, reconstruction filtering and the contrast intensity of the adjacent coronary 
lumen [67].
Figure 15 | Non-calcified coronary plaque. Symptomatic male with moderately obstructive coronary artery 
disease. The left anterior descending coronary artery shows (A) noncalcified plaque at several locations, with 
evident outward vessel remodelling in the proximal LAD (cross-sections B and C). Better visualisation of 
noncalcified plaque requires optimisation of the display settings (window level and width, D, E).
Quantification of coronary plaque on CT correlates fairly well with invasive coronary imaging 
techniques [68,69]. Limited reproducibility of total plaque quantification [68,69], predominantly 
the result of poor delineation of the outer vessel border, may be overcome by more standardised 
acquisition techniques and automatic quantification tools. In one study the average annual 
progression of overall plaque on CT in a selected population was reported as 22% (95% confidence 
interval 15–30%) [70]. In addition to the presence of low-density plaque, CT studies in patients 
who suffered an acute coronary syndrome have revealed various other parameters associated with 
plaque instability, including large plaque size, outward vessel remodelling (Figure 15), and spotty 
calcifications [71,72,73]. Finally, preliminary data suggests that low-density plaque and outward 
vessel remodelling on coronary CTA predict adverse cardiovascular events [74].
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Figure 16 | Coronary plaque by CT angiography. Examples of noncalcified, severely obstructive, coronary 
plaque in the left anterior descending coronary artery (A), plaque of mixed composition also in the left 
anterior descending coronary artery (B), and predominantly calcified plaque in the right coronary artery (C).
Conclusions
 • Contemporary CT technology allows for diagnostic noninvasive coronary angiography in the 
majority of patients with symptoms of coronary artery disease.
 • High image quality requires patient cooperation and often heart rate modulation.
 • Interpretability of the CT images is negatively affected by arrhythmia, obesity, extensive 
calcification, and previous revascularisation procedures.
 • CT angiography is effective for exclusion of obstructive coronary artery disease in patients with 
a low-intermediate probability, or when functional testing cannot be performed or rendered 
inconclusive results.
 • Evaluation of haemodynamic significance and the need for revascularisation of (moderately) 
obstructive coronary disease by CTA often requires further invasive or noninvasive functional 
testing.
 • New CT applications for evaluation of the functional severity of coronary artery disease include 
stress myocardial perfusion imaging and CTA based computation of fractional flow reserve.
 • •While invasive angiography remains superior in many ways, CT angiography has practical 
advantages and can provide complementary information concerning the three-dimensional 
coronary anatomy, ostial and bifurcation disease, chronic total occlusion of coronary arteries 
and bypass grafts, as well as plaque imaging.
 • Although the CT plaque imaging is limited by spatial and contrast resolution, this non-invasive 
modality does allow for differentiation of calcified and non-calcified plaque and assessment of 
outward vessel remodelling, which has prognostic value.
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Objective
Echocardiography, radionuclide myocardial perfusion imaging (MPI), and coronary CT angiography 
(CTA) are the three main imaging techniques used in the emergency department for the diagnosis 
of acute coronary syndrome (ACS). The purpose of this article is to quantitatively examine existing 
evidence about the diagnostic performance of these imaging tests in this setting.
Conclusion
Our systematic search of the medical literature showed no significant difference between the 
modalities for the detection of ACS in the emergency department. There was a slight, positive trend 
favoring coronary CTA. Given the absence of large differences in diagnostic performance, practical 
aspects such as local practice, expertise, medical facilities, and individual patient characteristics may 
be more important.
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The entity acute coronary syndrome (ACS) encompasses the conditions unstable angina pectoris 
and myocardial infarction (MI) with or without ST-segment elevation. MI is a diagnosis based on 
patient symptoms, ECG changes, and markers of myocardial necrosis in the blood [1]. Unstable 
angina pectoris, on the other hand, indicates myocardial ischemia without biochemical evidence of 
cardiac myocyte death [2].
 Patients with ACS frequently present with atypical chest pain complaints, unremarkable 
findings on physical examination, and an ECG that either is difficult to interpret or has normalized 
at presentation [3]. Cardiac biomarkers are often normal during the initial phase and patients 
with unstable angina may not show a rise of these markers at all. In these patients, ACS cannot be 
ruled out on the basis of an initial assessment alone, which generally requires clinical observation 
and sequential testing. Optimal triage re-quires a quick noninvasive test that is cost-effective and 
is readily available to identify all patients with ACS. Moreover, a triage test should also be able to 
accurately identify patients in whom significant coronary artery disease (CAD) can be excluded and 
who can thus safely be discharged. This article quantitatively examines the existing evidence about 
the diagnostic performance of imaging tests in this setting.
Background and Importance
Acute chest pain is a common diagnostic dilemma in the emergency department and its impact on 
the health care system is substantial, with an estimated annual cost of sever-al billions of dollars in 
the United States [4]. Emergency department physicians and cardiologists are commonly required 
to make a decision whether to admit a patient with chest pain based on little more than clinical 
judgment and a rough estimation of risk but without conclusive evidence whether ACS is developing. 
Most patients presenting to the emergency department with sudden chest pain do not suffer from 
ACS and many are, in fact, free of CAD [5]. In the majority of cases, chest pain can be explained by 
other causes such as gastroesophageal diseases and chest wall syndromes [6]. Nevertheless, the 
risk of overlooking an underlying ACS has major consequences, which is why most patients are 
hospitalized to undergo additional stress testing and even invasive coronary angiography (CAG) 
to rule out ischemic heart disease. The results of a large multicenter study showed that although 
most patients with suspected ACS were hospitalized for further evaluation, only 17% was ultimately 
diagnosed with ACS [7]. Despite this defensive approach, the literature suggests that an estimated 
2–6% of the patients discharged from the emergency department were found to have ACS [8-12]. 
Patients with ACS who are mistakenly discharged from the emergency department generally have a 
worse prognosis than appropriately managed patients, partly because of their risk for sudden cardiac 
death but also because of the delay in implementing treatments that are known to be beneficial 
for ACS [8,11]. In the United States, an estimated 25% of the lawsuits concerning emergency care 
involves errors in the diagnosis of MI [13].
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Synopsis and Synthesis of Evidence
Echocardiography, radionuclide myocardial perfusion imaging (MPI), and coronary CT angiography 
(CTA) are the three main imaging techniques used in clinical practice for the diagnosis of ACS. 
Echocardiography and MPI are functional imaging modalities used to assess wall motion 
abnormalities (WMAs) and myocardial perfusion. Performed while the patient is resting, these 
modalities are used to identify ACS. They can also be performed during or after stress to detect 
inducible ischemia. Coronary CTA is an anatomic technique that can depict atherosclerotic plaque 
in the coronary tree and provide information about its composition and the degree of stenosis. A 
discussion of each technique follows, with a summary of these imaging techniques shown in Table 1.
Table 1 | Major Advantages and Disadvantages of Imaging Techniques for the Detection of Acute Coro-
nary Syndrome
Echocardiography
Echocardiography is a noninvasive, portable, and relatively inexpensive bedside imaging technique 
that is available in most hospitals. It can assess both left ventricular systolic function and regional 
WMAs and therefore provides valuable diagnostic as well as prognostic information. Because of the 
close relationship between wall motion and myocardial blood flow (MBF), echocardiography is a 
very useful tool in patients with suspected ACS. Development of WMAs is preceded by considerable 
reductions in MBF. Echocardiography is also useful in the assessment of many nonischemic causes 
of acute chest pain such as perimyocarditis, valvular heart disease, cardiomyopathy, pulmonary 
embolism, or aortic dissection. It is the preferred imaging method for detecting complications of 
acute infarction including myocardial free wall rupture, acute ventricular septal defect, and mitral 
regurgitation secondary to papillary muscle rupture or ischemia.
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Rest Echocardiography
When echocardiography is performed soon after a patient arrives at the emergency department or 
during a chest pain episode, WMAs are detected in up to 90% of the cases [14]. However, chest pain 
has subsided in most patients at the time of evaluation and the resting echocardiogram may be 
completely normal. Investigators of a large study reported rest echocardiographic findings of 901 
patients with acute chest pain but no clinical manifestations of acute myocardial infarction (AMI) 
as part of protocol-driven care along with serial myocardial bound creatine kinase measurements 
and continuous ECG monitoring. Rest echocardiography was associated with high specificity (99%, 
873/882) but unsatisfactory sensitivity (47%, 9/19) for adverse events within 30 days, including 
MI, revascularization, or unstable angina [15]. Smaller studies have shown similar results [16,17]. 
Di Pasquale et al. performed rest echo-cardiography in 280 patients presenting with chest pain of 
suspected cardiac origin but normal initial CK-MB levels and no evidence of ST-elevation or new left 
bundle branch block on ECG. The presence of WMAs was used to predict significant stenosis (>50% 
left main coronary stenosis or >70% stenosis in other branches) on invasive CAG. In this high-risk 
population, with significant CAD present in 50% of patients, the authors found, once again, not only 
a high specificity of 91% (84/92) but also a high sensitivity of 93% (170/182).
Contrast-enhanced Echocardiography
Microbubble contrast agents enhance delineation of endocardial borders, which facilitates wall 
motion assessment (Figure 1). Imaging using these agents also provides important information 
about myocardial perfusion and viability [19]. In a prospective analysis of 114 patients with cardiac 
chest pain and no clinical manifestations of AMI, Kang et al. found that the addition of contrast 
material improved the sensitivity of echocardiography from 49% (43/87) to 77% (67/87), whereas 
specificity was similar, 78% (74/95) versus 73% (69/95), for the detection of ACS at the index visit. 
In a large observational study, 1017 patients underwent contrast-enhanced echocardiography in 
addition to routine clinical evaluation. For the detection of a composite endpoint of CAD within 
48 hours of presentation, the authors reported a high sensitivity of 89% (148/166) and a modest 
specificity of 57% (485/851) [20].
Stress Echocardiography
Generally excluding only MI will not be sufficient to safely discharge patients. Patients may have 
myocardial ischemia with unstable angina pectoris, putting them at risk of adverse events. As soon as 
serial cardiac markers and rest imaging have excluded the presence of AMI, stress echocardiography, 
which is performed during pharmacologic stress or exercise, may be used to visualize inducible 
ischemia. Trippi and colleagues investigated the diagnostic performance of stress echocardiography 
in 163 patients with normal initial markers and normal findings on resting echocardiography. They 
reported a sensitivity of 89% (17/19) and specificity of 89% (128/144) for the detection of AMI or 
significant CAD (>50% stenosis) on invasive angiography [21]. In another study, investigators 
compared stress echocardiography with stress MPI in 503 patients without evidence of AMI after 
6 hours of observation and initial workup [22]. The authors used a composite endpoint consisting 
of ≥50% coronary stenosis on invasive CAG or cardiac events during a follow-up of 6 months. 
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Echocardiography had sensitivity and specificity of 85% (80/94) and 95% (390/409), respectively, 
and MPI had a sensitivity and specificity of 86% (81/94) and 90% (369/409).
Figure 1 | A 67-year-old man suspected to have myocardial ischemia who was referred for echocardiography. 
(A) Microbubble contrast agents were used to enhance delineation of endocardial borders. Arrowheads in 
A indicate endocardial borders on unenhanced echocardiography, and arrowheads in B indicate improved 
delineation of endocardial borders by using contrast agents. (B) Microbubble contrast agents were used to 
enhance delineation of endocardial borders. Arrowheads in A indicate endocardial borders on unenhanced 
echocardiography, and arrowheads in B indicate improved delineation of endocardial borders by using 
contrast agents.
Limitations
There are some key concerns regarding the use of echocardiography in the ED. Evaluation of 
remains a subjective and difficult skill to master. Interpreters should there-fore be experienced 
readers. Second, a considerable number of patients have a poor thoracic imaging window resulting 
in indeterminate findings in at least 10% [23]. Discriminating between existing WMAs and newly 
developed WMAs is difficult, and both conditions may even coexist in the same patient. AMI should 
be excluded before performing stress echocardiography by measuring serial cardiac markers or 
performing rest imaging. This step results in a longer diagnostic workup.
Myocardial Perfusion Imaging
Radionuclide MPI provides a direct assessment of MBF and is used for identification of ischemia or 
infarction. The injected radionuclide agents are transported through the coronary vasculature and 
eventually accumulate in the myocardium. At the moment of MBF impairment, MPI shows perfusion 
defects that allow early detection of obstructive CAD. Pioneer work from four decades ago showed 
that impaired myocardial uptake of 201Tl could be visualized on planar images in patients with MI 
[24]. By now, 201Tl has largely been replaced by 99mTc-based agents, which are associated with 
less scatter and blurring. Images could be acquired over a longer time because of slow myocardial 
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clearance, overcoming some logistic barriers [25]. Replacements of planar imaging by SPECT have 
resulted in improved visualization of the location as well as extent of disease [26]. Last, introduction 
of gated reconstructions permits assessments of regional and global ventricular function [27].
Rest myocardial Perfusion Imaging
The value of rest MPI in the patient with acute chest pain has been studied extensively. Numerous 
studies have reported sensitivities of more than 90% for the detection of MI ac-companied by 
specificities of 50–80% [28-30]. One study conducted at the Medical College of Virginia in 620 
patients with suspected ACS reported a sensitivity of 92% (54/59) and a specificity of 67% (376/561) 
for the detection of AMI. Among the 59 patients with AMI, five patients with an enzymatic small 
infarction had normal findings on rest MPI. The diagnostic performance to predict the need for 
revascularization was some-what lower: a sensitivity of 81% (47/58) and a specificity of 74% 
(416/562). In a randomized trial, Udelson et al. re-ported that the addition of rest MPI to standard 
care decreased the number of unnecessary ad-missions without an increase in inadvertent discharge 
of patients with acute cardiac ischemia.
Stress Myocardial Perfusion Imaging
Conti and colleagues evaluated the implementation of exercise MPI in the early triage of 306 
patients with suspected ACS and nor-mal findings on an initial workup (Figure 2). The sensitivity 
and specificity to predict significant CAD or adverse events within 6 months were 94% (45/48) and 
77% (198/258), respectively. A large observational study of 805 patients with low to intermediate 
risk of CAD compared the diagnostic performance of rest MPI with stress MPI. In that study, 
investigators evaluated the sensitivity and specificity for diagnosing the following events within 30 
days of MPI: AMI, revascularization, stenosis of more than 70% on invasive CAG not amenable to 
revascularization, life-threatening complication, or cardiac death. The sensitivity and specificity of 
rest MPI, 71% (109/153) and 73% (476/652), respectively, were significantly lower than the sensitivity 
and specificity of stress MPI, 97% (148/153) and 88% (574/652) [33]. In 2007, investigators com-pared 
stress MPI with CTA in a randomized trial of low-risk patients without evidence of AMI [34]. They 
found that the diagnostic performance of MPI and CTA was comparable, but there were reductions 
in the time-to-diagnosis and cost in the CTA group.
Limitations
The limited availability of nu-clear facilities in some hospitals and transportation of patients to the 
nuclear medicine department may form a barrier to the use of MPI. Physicians should be aware 
of possible false-negative results of rest images in patients with subsided chest pain or balanced 
ischemia caused by three-vessel disease [35]. AMI should be excluded before performing stress MPI 
by measuring serial cardiac markers or performing rest imaging. The need to exclude AMI results in 
a longer diagnostic workup. Finally, there is concern about the increasing radiation exposure from 
diagnostic imaging procedures and the potential risk of cancer [36].
44 | Chapter 3
Figure 2 | 51-year-old woman who 
presented with acute chest pain in 
emergency department. Short-axis and 
long-axis stress and rest nuclear perfu-
sion scans show ischemia of inferior left 
ventricular wall. Arrowheads indicate 
diminished perfusion of inferior wall dur-
ing stress acquisition.
Coronary CT Angiography
Coronary CTA can provide high-quality images of the heart and coronary vasculature and requires 
minimal patient cooperation (Figure 3). Coronary CTA provides accurate information about the 
degree of stenosis as well as certain characteristics of plaque, such as spotty calcification and low 
attenuation, that are associated with a higher risk of future ACS [37,38].
 Image acquisition with coronary CTA can be performed in minutes. Widely available dedicated 
software for automated post-processing makes interpretation quick and undemanding. In the past 
years, numerous articles about the diagnostic performance of coronary CTA have been published. 
In recent reviews, investigators reported sensitivities of greater than 95% and specificities of 90% 
or greater [39,40]. In a large observational study in an emergency department setting, Hoffmann 
et al. reported that the sensitivity of CTA for the detection of ACS was high and that the absence 
of atherosclerosis was associated with an excel-lent 6-month outcome. The results of that 
study confirmed the results of some earlier, smaller studies [42-44]. Recently, a large multicenter 
randomized trial (CT-STAT) focused on the cost-effectiveness of CTA versus nuclear imaging. Low-
risk patients were randomly allocated to undergo CTA (n=361) instead of rest and stress MPI (n=338) 
[45]. The CTA strategy reduced time-to-diagnosis by 54% and costs of care by 38%. The occurrence 
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of major ad-verse cardiac events (MACEs) was similar for CTA and nuclear imaging. However, that 
study was powered to detect a difference in the primary endpoint – that is, the time-to-diagnosis – 
and it may be underpowered to detect a difference in MACEs.
Figure 3 | 59-year-old man who presented with acute chest pain. Coronary CT angiography (CTA) was 
performed in emergency department. (A) CTA images show obstructive disease of left anterior descending 
artery (arrow, A) and occlusion of left circumflex artery (arrowhead, B). First marginal branch (asterisk, B) is 
shown. (B) CTA images show obstructive disease of left anterior descending artery (arrow, A) and occlusion 
of left circumflex artery (arrowhead, B). First marginal branch (asterisk, B) is shown. (C) Catheter angiogram 
shows lesions in left anterior descending (arrow) and left circumflex arteries (arrowhead). Occlusion of left 
circumflex artery (asterisk) is denoted by abrupt filling of contrast material after bifurcation of first marginal 
branch. (D)Three-dimensional volume-rendered image shows lesions in lieft anterior descending (arrow) and 
left circumflex (arrowhead) arteries.
Additionally, coronary CTA allows evaluation of important non-coronary cardiac findings. Depending 
on the scanning protocol, conditions such as acute aortic syndromes, pulmonary embolism, or 
esophageal abnormalities may be detected. Incidental findings may increase down-stream testing 
46 | Chapter 3
(e.g., CT for the workup and follow-up of pulmonary nodules). Studies that account for the costs of 
this additional testing are needed to evaluate the implications for the cost-effectiveness of coronary 
CTA.
 High-attenuation structures such as calcified plaques or stents appear enlarged (or “bloomed”) 
as a result of partial volume and beam-hardening effects. These artifacts obscure the adjacent lumen 
and may result in false-positive results. In response to the concern about the potential risk related 
to radiation exposure, several radiation dose reduction protocols have recently been developed and 
validated, including ECG-dependent tube modulation, prospective ECG gating, adaptive iterative 
reconstruction, and high-pitch helical acquisition [46-48]. When these techniques are applied, 
bearing in mind that prospective ECG gating may not be applicable for imaging patients with high 
heart rates, the radiation dose of coronary CTA compares favorably with current rest and stress MPI 
protocols [40,49] (Figure 4).
Figure 4 | Bar graph shows estimated 
effective doses for invasive coronary 
angiography. (CAG), percutaneous 
coronary intervention (PCI), coronary CT 
angiography (CTA), and myocardial perfu-
sion imaging (MPI). Both helical and axial 
image acquisitions are with tube current 
modulation. MPI was performed with 
99mTc using rest and stress protocols or 
stress-only protocol [49,60].
Systematic Review
To summarize the available literature on this topic, we formulated the following question: In patients 
with acute chest pain suggestive of ACS, what is the diagnostic performance of echocardiography, 
radionuclide MPI, and coronary CTA? A systematic search of the English-language literature in 
PubMed was performed to identify studies that addressed this clinical question leading to 219 
citations; search details are provided in Appendix 1. Subsequently, all systematic reviews and meta-
analyses that were found with the original search were reviewed to identify additional articles (Figure 
5). One reviewer extracted all relevant data from each included study. A second reviewer checked 
the results obtained for accuracy and completeness. Discrepancies were resolved by consensus. 
Summaries of the relevant articles categorized by imaging modality are included in Tables 2 and 3.
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Figure 5 | Flow diagram illustrates review process. ACS = acute coronary syndrome, MI = myocardial infarc-
tion, CAD = coronary artery disease, MPI = myocardial perfusion imaging, CTA = CT angiography.
Table 2 | Relevant Articles Evaluating Diagnostic Performance of Rest Echocardiography. Rest Myocardial 
Perfusion Imaging (MPI), and Coronary CT Angiography (CTA) for the Detection of Acute Coronary Syndrome 
(ACS) or Myocardial Infarction (MI) During Index Visita
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Table 3 | Relevant Articles Evaluating Diagnostic Performance of Rest and Stress Echocardiography. Rest 
and Stress Myocardial Perfusion Imaging (MPI), and Coronary CT Angiography (CTA) for the Detection of 
Coronary Artery Disease With or Without Follow-Up.
Statistical Analysis
To obtain summary estimates of sensitivity and specificity and account for a possible correlation 
between sensitivities and specificities, we used a bivariate random-effects model to perform the 
meta-analysis [50]. In the bivariate random-effects model, it is assumed that the logit-transformed 
true sensitivity and specificity in each study follow a bivariate normal distribution across studies, 
allowing a possible correlation between sensitivities and specificities. The random-effects model 
produces estimates of the mean logit-transformed sensitivity, logit-transformed specificity, log-
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transformed positive predictive value (PPV), and log-transformed negative predictive value (NPV) 
with their standard errors. Sensitivity, specificity, PPV, and NPV estimates with their 95% CIs were 
reported. All analyses were performed using statistics software (SAS version 9.2, SAS Institute).
 All studies were divided over two diagnosis groups according to the endpoint used as the 
reference standard for calculating diagnostic performance. Studies appointed to diagnosis group 
1 used MI or ACS during the index visit based on clinical presentation, serial cardiac marker 
results, or ECG results as the reference standard. Studies appointed to diagnosis group 2 used the 
composite endpoint “CAD” (a combination of proven ACS, angiographic evidence of obstructive 
CAD, obstructive CAD proven by noninvasive tests, and information from follow-up) as the reference 
standard. For diagnosis group 1, we compared coronary CTA, rest echocardiography, and rest MPI. 
For diagnosis group 2, we compared coronary CTA, rest and stress echocardiography, and rest and 
stress MPI (Figure 5).
Results (Diagnostic Performance)
For the detection of MI or ACS during the index visit (diagnosis group 1), the pooled sensitivities 
of coronary CTA, rest echocardiography, and rest MPI were as follows: 0.94 (95% CI, 0.74–0.99), 
0.86 (0.72–0.93), and 0.91 (0.85–0.95), respectively. The pooled specificity was 0.73 (0.46–0.90), 
0.82 (0.65–0.91), and 0.76 (0.64–0.85), respectively. The summary receiver operating characteristic 
(SROC) curves for group 1 are displayed in Figure 6. For the detection of CAD (diagnosis group 
2), rest echocardiography and rest MPI had a pooled sensitivity of 0.76 (0.58–0.89) and 0.80 
(0.64–0.90), respectively. The pooled specificity was 0.89 (0.78–0.95) and 0.83 (0.70– 0.91). Stress 
echocardiography and stress MPI had a pooled sensitivity of 0.78 (0.57–0.90) and 0.92 (0.84–0.97). 
Their corresponding pooled specificity was 0.92 (0.83–0.96) and 0.88 (0.78–0.94), respectively. 
Coronary CTA showed a pooled sensitivity of 0.93 (0.84–0.97) and a pooled specificity of 0.90 
(0.83– 0.95), which are comparable to its diagnostic performance for the detection of MI or ACS 
(diagnosis group 1). The SROC curves for group 2 are displayed in Figure 7.
Evidence-Based Guidelines
The current guidelines from the 2011 American College of Radiology Appropriateness Criteria 
consider combined rest and stress MPI as the preferred test in patients with intermediate to high risk 
of ACS. A reasonable alternative is rest and stress echocardiography, especially because it does not 
require radiation exposure. Combined rest-stress protocols are considered more appropriate than 
single protocols. Coronary CTA is regarded as an appropriate alternative in low- to intermediate-risk 
patients [51]. Patients with a high likelihood of CAD would benefit most from invasive angiography. 
The current analysis incorporated several recently published articles with coronary CTA in which 
diagnostic performance was reported to be excellent. Compared with the guidelines, our findings 
are more in favor of using coronary CTA than in using MPI or echocardiography.
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Figure 6 | Summary receiver operating 
characteristic curves for diagnosis 
group 1. Rest myocardial perfusion 
imaging (MPI) and CT angiography (CTA) 
are encircled by 95% CIs. No 95% CI 
could be calculated for CTA because of 
small number of studies.
Figure 7 | Summary receiver operating 
characteristic curves for diagnosis 
group 2. Rest echocardiography, stress 
echocardiography, rest myocardial per-
fusion imaging (MPI), stress MPI, and CT 
angiography (CTA) are encircled by their 
95% CIs.
Outstanding Issues That Warrant Research
Heterogeneity
The diagnostic performance of the three modalities showed large variation across studies. This 
variation is, in part, because of differences in patient populations but is mainly because different 
clinical endpoints were used as the reference standard to calculate diagnostic performance. These 
endpoints ranged from cardiac markers to angiographic results or adverse events during follow-
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up. Some studies used combined endpoints, which may be misleading because they may not truly 
reflect the ability to correctly risk-stratify patients with suspected ACS.
Technical Advancements
Three-dimensional volumetric imaging is a promising application of echocardiography that 
shortens acquisition time, reduces operator dependency, and provides more accurate assessment 
of ventricular volumes. However, for assessment of WMAs, this technique seems less applicable 
than conventional 2D echocardiography and its use is further held back because of lower spatial 
and temporal resolutions compared with conventional 2D echocardiography and multiple-beat 
acquisition artifacts [52,53]. The use of 3D echocardiography does not preclude convention-al 2D 
imaging and these techniques can be used side by side to reinforce each other.
 In nuclear perfusion imaging, reduced imaging time and better diagnostic information will 
be possible because of improved camera designs, iterative reconstruction methods, and new 
acquisition protocols (stress-only acquisitions, dynamic imaging, and so on) [54]. Also, radionuclide 
agents with “ischemic memory” could help identify patients with acute chest pain and subsided 
ischemia in the future [55].
 In search of the functional significance of plaques seen on coronary CTA, new techniques such 
as CT myocardial perfusion and computational fluid dynamics are being investigated and show very 
promising results [56,57].
Summary
Recommendations for Best Practice
Our systematic search of the medical literature showed no significant differences among the three 
modalities for the detection of both ACS and CAD with or without follow-up. There was a slight, 
nonsignificant positive trend favoring coronary CTA in both analyses.
 It is important to keep in mind that the optimal imaging strategy is determined not only by the 
diagnostic performance of a modality but also by local practice, expertise with imaging techniques, 
medical facilities, and individual patient characteristics. Given the absence of large differences in 
diagnostic performance, these practical aspects may be even more important.
 Because the diagnostic performance of CTA is excellent and the test can be performed quickly, 
we advocate performing coronary CTA of low- to intermediate-risk patients pro-vided the test and 
expertise to interpret the results are readily available in emergency situations. For institutions with 
nuclear imaging expertise and rapid access to nuclear facilities, MPI will generally be the first choice 
for imaging low- to intermediate-risk patients, despite the fact that recent trials suggest it is more 
costly and time-consuming than CTA. Rapid screening with echocardiography for the presence 
of many nonischemic conditions as well as for the assessment of hemodynamic status remains a 
vital part of the standard workup of all patients with acute chest pain. However, extensive imaging 
seems less suitable for diagnosing ACS or CAD than for diagnosing other cardiac abnormalities. In 
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concordance with the current guidelines, we believe high-risk patients would benefit most from an 
invasive strategy [58,59].
Recommendations for Future Research
The lack of robust evidence to identify the optimal test is partially caused by substantial heterogeneity 
across studies. The studies identified by our systematic search used various clinical endpoints to 
calculate diagnostic performance. To date, there seems to be no general agreement about which 
clinical endpoint – cardiac markers, angiographic results, or these combined with follow-up data 
– should be used for validation. In addition, there is still a limited number of comparative studies 
between imaging strategies. For a better understanding of the optimal imaging strategy for patients 
with acute chest pain, large randomized trials with generally accepted clinical endpoints are needed.
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Appendix 1 | Criteria for Study Selection
Search Details
Studies were included if they met all of the following criteria:
1. The study population was composed of patients with acute chest pain suggestive of acute 
coronary syndrome (ACS);
2. The study reported operating characteristics of echocardiography, nuclear myocardial perfusion 
imaging (MPI), or coronary CT angiography (CTA); and
3. The reference standard was the presence of ACS based on cardiac markers or ECG; clinical 
consensus based on invasive angiography or proven obstructive coronary artery disease on 
additional tests (not consisting of the index test); or cardiac events during follow-up.
Studies were excluded if they met one of the following criteria:
1. Article was a review, guideline, or cost-effectiveness analysis;
2. Study population consisted of patients with stable angina, asymptomatic patients, or patients 
with proven myocardial infarction (MI) at baseline;
3. Study population consisted of patients with ST-segment elevation MI; or
4. Study population overlapped with previous publications.
Articles not accessible or not written in English were excluded from the analysis.
Search Strategy
(“myocardial infarction” [MeSH] OR “myocardial ischemia” [MeSH] OR “angina, unstable” [MeSH] OR 
“acute coronary syndrome” [MeSH terms] OR “coronary disease” [MeSH] OR “coronary artery disease” 
[MeSH] OR “chest pain” [MeSH])
AND
(“acute disease” [MeSH] OR “emergency service, hospital” [MeSH] OR “emergency medical services” 
[MeSH] OR “emergency treatment” [MeSH] OR “emergencies” [MeSH] OR “emergency medicine” 
[MeSH])
AND
(“echocardiography” [MeSH] OR “radionuclide imaging” [MeSH] OR “technetium Tc 99m sestamibi” 
[MeSH] OR “tomography, X-ray computed” [MeSH])
AND
(“coronary angiography” [MeSH] OR “consensus” [MeSH] OR “acute coronary syndrome” [MeSH] OR 
“angina, unstable” [MeSH] OR “myocardial infarction” [MeSH] OR “myocardial ischemia” [MeSH])
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AND
(“sensitivity and specificity” [MeSH] OR sensitivity [tw] OR specificity [tw] OR “predictive value of 
tests” [MeSH] OR “ROC curve” [MeSH] OR (“positive predictive” [tw] AND value* [tw]) OR (“negative 
predictive” [tw] AND value* [tw]) OR (false [tw] AND nega-tive* [tw]) OR (false [tw] AND positive* 
[tw]) OR (true [tw] AND negative* [tw]) OR (true [tw] AND positive* [tw]) OR misdiagnosis [tw] OR 
misdiagnoses OR “diagnostic errors” [MeSH] OR (diagnost* [tw] AND (accuracy [tw] OR error* [tw] OR 
efficacy [tw])
AND
(English [lang] NOT (animals [MeSH] NOT humans [MeSH]) OR Editorial [Publication type] OR 
Comment [Publication type] OR Letter [Publication type] OR Case Reports [Publication type])
Note: MeSH refers to “Medical Subject Headings,” which is the National Library of Medicine’s controlled 
vocabulary thesaurus. tw = text word, * = MeSH concept that is the main point of the article.
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Abstract
Background: In this prospective study we determine the diagnostic value of coronary CT angiography 
(CTA) and calcium imaging in low to intermediate risk acute chest pain patients.
Methods: One hundred and eleven consecutive patients (57±11 years, 71 males) presenting to the 
emergency department with chest pain suggestive of acute coronary syndrome (ACS), but without 
indication for immediate catheter angiography, underwent both coronary CTA and calcium imaging 
without disclosure of the ﬁndings to the treating physicians.
Results: ACS was diagnosed in 19 patients (17%). Coronary calcium was present in 71 patients 
(64%). Coronary CTA identiﬁed 74 (67%) patients with coronary plaque and 36 (32%) patients with 
obstructive (≥50%) plaque. The sensitivity and speciﬁcity of the calcium scan were: 89% and 41%. 
The sensitivity and speciﬁcity of coronary CTA were: 100% and 40% based on the presence of any 
plaque and 89% and 79% based on the presence of >50% stenosis. C-statistics of the GRACE risk score 
(0.77 [95% CI 0.66–0.89]) improved after addition of coronary CTA (0.93 [0.88–0.98], pb0.01), though 
not after addition of calcium scores (0.81 [0.71–0.91], p=0.52). Follow-up at 3 months revealed four 
late revascularizations (no deaths or myocardial infarctions), all of whom had obstructive CAD with 
calcium on CT at presentation.
Conclusions: Coronary CTA outperforms calcium imaging in the triage of patients suspected 
of developing ACS. Absence of plaque on coronary CTA allows safe discharge. Coronary CTA has 
incremental value to clinical risk scores and has the potential to reduce unnecessary hospital 
admissions.
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Introduction
Acute chest pain (ACP) represents a major diagnostic challenge in emergency care [1]. The differential 
diagnosis is broad varying from benign causes to life-threatening conditions. Observational studies 
report that an estimated 2–8% of myocardial infarctions (MI) are missed [2,3]. Patients mistakenly 
discharged from the emergency department have a worse prognosis than properly managed 
patients, partly because of the risk for sudden death but also because of the delay in implementing 
treatment known to be effective for acute coronary syndrome (ACS) [2,4]. In fear of missing life-
threatening conditions, a large proportion of patients with ACP is admitted for clinical observation 
and serial testing to rule out ACS, of whom only a fraction turn out to have a MI, resulting in 
substantial resource utilization.
 Coronary CT angiography (CTA) readily provides high quality non-invasive images of the heart, 
great vessels, and coronary vasculature [5,6]. While registry data is available, only a few blinded 
prospective studies have evaluated the feasibility of coronary CTA in the emergency room so far, 
and none of these studies included a direct comparison of coronary CTA and calcium imaging. In 
this prospective study we determine and compare the diagnostic value of coronary CTA and calcium 
imaging in low to intermediate risk ACP patients.
Methods
Patient Population
A consecutive cohort of patients without a history of coronary artery disease (myocardial infarction 
or coronary revascularization) presenting to the emergency department with chest pain during the 
past 24 h, suggestive of ACS, were planned to undergo both coronary CTA and calcium imaging 
without disclosure of ﬁndings to the treating physicians. Patients older than 40 years, without ST-
segment elevation, hemodynamic instability or highly elevated cardiac troponin (>0.15 μg/l) were 
eligible for participation. Exclusion criteria included severe arrhythmia, impaired renal function and 
contrast allergies. Enrolment was conducted during weekdays between 7:00 h and 19:00 h.
 Patient demographics, presence of risk factors and type of medical treatment were prospectively 
collected and used to calculate traditional risk estimators (TIMI risk score and the GRACE risk score) 
for the occurrence of in-hospital mortality or myocardial infarction [7,8].
 Treating physicians were blinded to the results of cardiac CT imaging. The decision to admit 
patients for observation, including serial ECGs and cardiac biomarkers was clinically driven. 
Subsequent cardiac testing, i.e. exercise testing, stress perfusion imaging or cardiac catheterization 
was performed at the clinician’s discretion. The study complies with the Declaration of Helsinki, the 
local ethics committee approved the research protocol and all patients provided written informed 
consent.
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Coronary Computed Tomography
A standard prospectively ECG-triggered axial coronary calcium scan was per-formed with the 
following parameters: 120 kV tube voltage, 70 mAs tube current-time product and 3-mm slice 
thickness. Quantiﬁcation was performed using the Agatston method with a standard 130-HU 
attenuation threshold [9].
 Coronary CTA was performed on a dual-source 128-slice (Siemens Deﬁnition Flash, Forchheim, 
Germany) or a single-source 128-slice (Siemens Deﬁnition AS+, Forchheim, Germany), depending 
on availability, using the spiral mode with ECG gating and ECG-modulated tube output modulation 
in 20, and prospectively ECG-triggered axial imaging in 91 patients. Further scan parameters: 
100–120 kV tube volt-age, 320–370 or 160–188 mAs tube current-time product depending on 
patient size, detector row width 0.6 mm, rotation times 280 and 300 ms, temporal resolutions 75 
and 150 ms, respectively. Iopromide 90 to 100 ml (Ultravist 370 mgI/ml, Bayer Schering Pharma, 
Berlin, Germany), followed by a 45 ml saline bolus chaser, was peripherally injected at 5.0 to 5.5 ml/s. 
A bolus tracking technique was used to synchronize data acquisition with contrast delivery. Patients 
with high heart rates received intravenous beta-blockade (n=36, metoprolol up to 10 mg), while 
sublingual nitroglycerin was administered routinely. Median effective radiation dose for coronary 
CTA was 4.9 mSv (IQR 3.1–8.1) and for calcium scan 0.69 mSv (0.41–1.16).
 Coronary branches were evaluated on axial images, multiplanar reformations, and maximum 
intensity projections. The presence of coronary atherosclerotic plaque and the degree of stenosis 
was determined using a 16-segment AHA classiﬁcation by two experienced readers (AM, MO), who 
were blinded with regard to the patients’ clinical information, in a joint reading [10]. If consensus 
could not be reached, a third reader was consulted.
 Coronary atherosclerotic plaque was classiﬁed either as noncalciﬁed, partially cal-ciﬁed or 
calciﬁed. Stenosis grade was quantiﬁed either as no stenosis, less than 20%, 20–50%, 50–70%, >70% 
stenosis or occluded.
 Diagnostic accuracy for the calcium scan was calculated on a per-patient level using the following 
threshold: absence vs. presence of any calcium. Diagnostic accuracy for coronary CTA was calculated 
on a per-patient level using the following thresholds: presence vs. absence of any plaque; presence 
of minimal plaque (b20% stenosis) vs. substantial plaque (>20% stenosis) and the presence of non-
obstructive plaque (≤50% stenosis) vs. obstructive plaque (>50% stenosis). By intention to diagnose 
non-evaluable segments on CT were classiﬁed positive for plaque and obstructive CAD.
Follow-up
Follow-up was performed at 3 months using a standardized telephone interview or questionnaire 
for the occurrence of myocardial infarction and coronary revascularization (percutaneous coronary 
intervention or coronary artery bypass graft surgery), after consulting the national death registry 
(CBS). All events were conﬁrmed with death records and medical records.
Clinical Endpoints
Two cardiologists (KN, TG), blinded for the cardiac CT scan, independently reviewed patient data and 
hospital records to establish clinical outcome. In case of disagreement, consensus was reached by a 
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joint reading. ACS was deﬁned as either a myocardial infarction: myocardial ischemia resulting in a 
rise and fall of cardiac bio-markers (>99th percentile of the upper limit of normal); or unstable angina: 
chest pain with altered frequency or character, suspicious for ACS with documented ischemia on the 
ECG, stress testing or invasive angiography (ICA) [11,12]. At follow-up major adverse cardiovascular 
events were deﬁned as cardiac death, non-fatal myocardial infarction or revascularization.
Statistical Analysis
Categorical variables are presented as proportions; continuous variables are expressed as mean 
(±SD) or median (±IQR), as appropriate. Differences between independent groups were compared 
using the 2-sided unpaired t test, chi-square test or Wilcoxon rank-sum test, as appropriate. 
Differences between dependent groups were compared using the paired t test,Wilcoxon rank-
sumtest or McNemar’s test, as appropriate. Conventional parameters of diagnostic accuracy, i.e. 
sensitivity, speciﬁcity, positive predictive value and negative predictive value, were calculated with 
their corresponding 95% conﬁdence intervals. To account for the skewed distribution, calcium 
scores were transformed by taking the natural logarithm of the calcium score +1.
 Receiver operating characteristics (ROC)-curves with their corresponding areas under the curve 
(i.e. c-statistic) were constructed to assess the discriminative performance of the GRACE risk score 
alone and in combination with calcium scores or the degree of stenosis on coronary CTA (0, <20%, 
20–50%, 50–70% and >70%) on a per-patient level.
 To assess the potential impact of coronary CTA on clinical management in terms of hospital 
admission and additional testing the following assumptions were made: 1) no or minimal plaque 
(<20%) on a per-patient level allows for immediate discharge from the emergency department, 2) an 
observation period with serial enzyme measurements and ECG monitoring is needed in the presence 
of a 20–50% stenosis, 3) the presence of a 50–70% stenosis on CT requires stress testing, of whom 
eventually 50% will ultimately require ICA, 3) ICA is required in the presence of a >70% stenosis. 
The number of admissions and investigations was compared to actual clinical management. All 
probability values refer to 2-tailed tests of signiﬁcance; a value <0.05 was considered signiﬁcant. 
Statistical analyses were performed using SPSS software (version 17.0, SPSS Inc, Chicago, Ill).
Results
Of the 191 patients who met the inclusion criteria; 39 patients had a contraindication for CTA (20%), 
25 were unwilling to participate (13%), and in 10 patients (5%) the CT scan could not be performed 
because of claustrophobia (1), language problems (3) or unavailability of the scanner (6). Scan failure 
occurred in 6 patients (5%), because of severe patient movement (4), incorrect scan timing (1) and 
extravasation of contrast media (1). Consequently, our study population consisted of 111 patients 
(mean age 57±11 and 64% male; Table 1).
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Table 1 | Baseline characteristics. 
All (n=111) ACS+ (n=19) ACS– (n=92) p value
Age (years) 57±11 61±11 56±10 0.06
Male gender 71 (64) 13 (68) 58 (63) 0.80
Smoking 47 (42) 8 (42) 39 (42) 1.00
Hypertension 68 (61) 11 (58) 57 (62) 0.80
Diabetes mellitus 23 (21) 7 (37) 16 (17) 0.07
Statin use 36 (32) 12 (63) 24 (26) 0.003
Family history 34 (31) 7 (37) 27 (29) 0.59
TIMI score * 5 (5–8) 13 (8–13) 5 (5–8) <0.001
GRACE score †
Low
Intermediate
High
5 (4–7)
96 (87)
10 (9)
5 (5)
8 (6–14)
11 (58)
5 (26)
3 (16)
4 (3–7)
85 (93)
5 (5)
2 (2)
<0.001
ICA performed 31 (28) 18 (95) 13 (14) <0.001
Calcium imaging
Calcium score
No detectable calcium
19 (0–195)
40 (36)
256 (63–721)
2 (11)
2 (0–123)
38 (41)
<0.001
0.02
Coronary CT angiography
Plaque absent
Plaque present
Non-calcified 
Partially calcified 
Calcified 
Non-evaluable segment
37 (33)
74 (67)
6 (8)
43 (58)
23 (31)
2 (3)
0
19 (100)
3 (16)
14 (74)
2 (10)
0 (0)
37 (40)
55 (60)
3 (5)
29 (53)
21 (38)
2 (4)
0.001
≤20% stenosis 
20–50% stenosis
50–70% stenosis
>70% stenosis
50 
25
20
16
0 
2 (10)
7 (37)
10 (53)
50 (54)
23 (25)
13 (14)
6 (7) <0.001
Unless otherwise specified, the data are presented as numbers of patients (percentage) or mean ± standard deviation. * Risk of 
in hospital death, myocardial infarction or urgent revascularisation, median (inter-quartile range) [6].† Risk of in hospital death or 
myocardial infarction, median (inter-quartile range) [7]. ICA = invasive catheter angiography.
Early Clinical Outcome
The diagnosis of ACS was established in 19 patients (17%): 13 had myocardial infarction and 6 had 
unstable angina pectoris (Figures 1 and 2). According to the GRACE risk score, 11 (58%) of these 
patients were low risk, 5 (26%) intermediate risk and 3 (16%) high risk. Seventy-nine patients 
were admitted for observation and 62 underwent stress testing. Based on the initial evaluation 31 
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(28%) patients underwent ICA, followed by coronary artery bypass graft surgery in two (2%), and 
percutaneous coronary intervention in 18 (16%) patients.
Figure 1 | Clinical outcome in the study 
population.
Figure 2 | Acute coronary syndrome in the absence of detectable calcium in a 46 year-old man presenting 
with acute chest pain in the emergency department. (A) Coronary CTA shows high grade stenosis of the 
proximal LAD with post-stenotoic dilatation. (B-D) Cross sections proximal, local and distal to the stenosis. 
(E) This lesion was confirmed on ICA (black arrowhead) and subsequent percutaneuos coronary intervention 
was performed.
Diagnostic Performance of the Calcium Scan
Coronary calcium was detected in 71 patients (64%), with a median Agatston score of 19 (IQR 0–195). 
ACS (1 MI; 1 UAP) was established in 2/40 patients (5%) with a negative calcium scan: sensitivity 89%, 
speciﬁcity 41% (Table 2).
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Table 2 | Diagnostic accuracies on a per-patient level of calcium imaging (no vs. any calcium) and coronary 
CTA with different thresholds: no plaque vs. any detectable plaque; minimal (<20% stenosis) vs. substantial 
plaque (>20%) and non-obstructive (<50% stenosis) vs. obstructive plaque (≥50% stenosis).
Test Sensitivity Specificity NPV PPV 
Calcium 89 (65–98) 41 (31–52) 95 (82–99) 24 (15–36)
Any plaque 100 (79–100) 40 (30–51) 100 (88–100) 26 (17–37)
Minimal plaque (>20%) 100 (79–100) 54 (44–65) 100 (91–100) 31 (20–44)
Stenosis (>50%) 89 (65–98) 79 (69–87) 97 (90–100) 47 (31–64)
Data presented as percentages with 95% confidence intervals in parentheses. NPV = Negative predictive value, PPV = positive 
predictive value. 
Diagnostic Performance of Coronary CTA
Coronary plaque was present in 74 patients (67%, Table 1). None of the 37 (33%) patients without 
plaque had ACS: sensitivity and negative predictive value of 100%. Speciﬁcity and positive predictive 
values were lower: 40% and 26%, respectively. For the patients with an ACS, the culprit lesion 
consisted of non-calciﬁed plaque in 3 (16%) patients, partially calciﬁed plaque in 14 (74%) patients 
and calciﬁed plaque in 2 (10%) patients. Five patients (5%) had one or more non-evaluable segments 
and were classiﬁed as positive for obstructive CAD, of whom none experienced an ACS or a late 
adverse event.
 Obstructive CAD (>50% diameter reduction) was present in 31 (28%) patients of whom 17 were 
diagnosed with ACS. The sensitivity for this threshold was 89% and speciﬁcity 79%. Two patients 
with a ≤50% stenosis had a non-ST elevation myocardial infarction. The characteristics of patients 
with ACS and no calcium or non-obstructive plaque (<50%) are summarized in Table 3.
 No or minimal plaque (<20% stenosis on a per-patient level) was present in 50 patients (45%). 
Using absent or minimal plaque as the discriminator, ACS could be diagnosed with a sensitivity of 
100% and speciﬁcity of 54%.
 Receiver operating characteristics showed that combining the GRACE risk score with coronary 
CTA improved the diagnostic accuracy (c-statistic of 0.93 [95% CI 0.88–0.98], p<0.01) compared to 
the GRACE score alone (0.77 [0.66–0.89]; Figure 3). In the case of calcium scores, the additional value 
to the GRACE score was modest (0.81 [0.71–0.91], p=0.52).
 Two patients had signiﬁcant non-cardiac disease twice (lung malignancy and pulmonary 
embolism), which were disclosed to the treating physician.
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Figure 3 | ROC-curve of the GRACE risk 
score (c-statistic 0.77 [95% CI 0.66–0.89]). 
Additional value of calcium scores (c-statistic 
0.81 [0.71-0.91], p=0.52) and the degree of 
stenosis on coronary CTA (0, <20%, 20–50%, 
50–70% and >70%) for identification of ACS 
(c-statistic 0.93 [95% CI 0.88–0.98], p>0.01).
Late Adverse Events
After 3 months no deaths occurred in the entire group. Further follow-up was complete for 109 
patients (98%), of whom four (all without an initial diagnosis of ACS) had undergone coronary 
revascularization. The CT scan had shown obstructive disease at presentation, as well as a positive 
calcium scan in all four cases. One patient with earlier diagnosed ACS had a recurrent myocardial 
infarction and another was hospitalized because of unstable angina pectoris.
Anticipated Clinical Impact of Coronary CTA
Assuming that all patients with no or minimal plaque (<20% stenosis on a per-patient level) can be 
discharged from the emergency department, only 61 (55%) patients would have needed admission 
(versus 78 (70%) in actuality, p<0.01). Stress testing in case of moderately obstructive disease on CTA 
would be required in 20 (18%) patients (versus 62, p<0.01), while ICA was estimated to be performed 
in 26 (23%) patients (versus 31, p=0.06), in case of >70% stenosis on CTA or an abnormal stress test 
following an abnormal CT scan.
Discussion
The main ﬁndings of the this study are that 1) in patients at low to intermediate risk the absence of 
coronary plaque on CTA excludes ACS and seems to guarantee an event-free short-term outcome; 
2) because coronary CTA visualizes all plaques as well as the severity of stenosis, it outperforms 
calcium imaging in terms of diagnostic ac-curacy; 3) coronary CTA has incremental predictive value 
to traditional risk estimators; 4) coronary CTA has the potential to reduce the number of unnecessary 
hospital admissions and stress tests; 5) the use of contemporary scan techniques in this study 
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resulted in a lower radiation exposure in comparison to previous reports, without compromise to 
image quality.
Coronary CTA in the Emergency Department
Proof of concept studies, using 64-slice scanners, showed very acceptable diagnostic accuracies for 
the detection of ACS [13]. Studies that also included patients with a known history of CAD conﬁrmed 
these results; however the positive predictive value was hampered by blooming artifacts caused 
by stents, metal clips or highly calciﬁed lesions [14]. In a comparison with stress nuclear imaging, 
CTA was at least as effective in detecting or excluding ACS in low risk emergency department 
patients [15]. However, for most of the earlier observations, CTA was performed as part of the clinical 
management, introducing an unavoidable selection bias. In 2009, Hoffmann et al. published the 
ROMICAT study, which was performed in a low-risk group of consecutive patients presenting with 
acute chest pain [16]. The authors demonstrated in a blinded manner excellent diagnostic accuracy 
of coronary CTA, conﬁrming some early modestly sized studies (Table 4). In our study, which also 
did not disclose CT results, we could conﬁrm the good performance of coronary CTA in a Europe-an 
clinical setting, in a population at higher risk. As in ROMICAT, the absence of stenosis did not entirely 
exclude ACS in our population. The absence of plaque did exclude ACS and was found in a third of 
this high risk population. Our data show that ACS is also rare in patients with minimal plaque. Using 
this criterion, the speciﬁcity of CTA can be improved without sacriﬁcing sensitivity. 
Table 4 | Earlier studies assessing the feasibility of coronary CTA in the emergency department, performed 
in a blinded manner. 
Author N Outcome Age
(mean)
Male
(%)
Prevalence 
ACS (%)
CTA 
threshold
Sensitivity
(%)
Specificity
(%)
Soon, 
et al. (2007) [31]
34 ICA / 
Stress test
54 76 23 >=50% 100 80
Ueno, 
et al. (2009) [32]
36 ICA / S
tress test
66 53 31 >=50% 92 83
Hoffmann, 
et al. (2009) [15]
368 Clinical 
consensus
53 61 8 Any plaque 100 54
>=50% 77 87
Chow, 
et al. (2010) [33]
55 ICA / 
Stress test
53 58 25 >=50% 86 93
Dedic, 
et al. (2012)
111 Clinical 
consensus
57 64 17 Any plaque 100 40
>=50% 89 79
Data is presented as number of patients. ICA = invasive catheter angiography. Clinical consensus = Consensus between two inde-
pendent physcians after assessment of all available clinical information and tests.
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Risk stratiﬁcation (GRACE or TIMI) is important to allow for those at high risk to undergo early 
invasive therapy [17]. However, in our population more than half of the patients (58%) ultimately 
diagnosed with ACS, would be classiﬁed as low risk using the GRACE score. Our study demonstrates 
that coronary CTA, which showed plaque or stenosis in all patients with ACS, has incremental value 
to traditional risk stratiﬁcation, particularly in the low risk patients.
 Because the absence of obstructive (epicardial) CAD despite elevated cardiac markers is quite 
frequently encountered [18], and is likely to increase in frequency with the introduction of high-
sensitive troponin essays [19], we allowed (stabilized) patients with minor elevations of serum 
troponin T to undergo CT. While most of these showed obstructive CAD (67%), or non-obstructive 
plaque (22%), there was also one patient with left ventricular hypertrophy, who presented with chest 
pain and slightly elevated troponins after exercise, but had completely normal coronary arteries by 
angiography (Figure 4).
Figure 4 | A 41 year-old woman presented with acute chest pain after exercise. Initial work-up at the 
emergency department revealed abnormal troponins (0.10). (A,B) Coronary CTA showed no coronary 
artery disease. (C,E) This was confirmed on ICA. (D) Further diagnostic work-up with cardiac MRI showed left 
ventricular hypertrophy with myocardial fibrosis.
Coronary Calcium Imaging
Coronary artery calciﬁcation is considered to be a marker of atherosclerotic plaque [20,21]. Calcium 
imaging is a widely used diagnostic modality and it has been studied extensively for improvement 
of risk stratiﬁcation [22,23]. It is associated with minimal radiation exposure and therefore often 
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incorporated in scan protocols. However, whether calcium imaging can reliably be used to exclude 
ACS in the emergency department remains a subject of debate [24,25]. Several studies suggest that 
noncalciﬁed plaques play an important role in ACS [26,27] but at the same time there is evidence 
that a negative calcium scan in low risk ED patients has excellent negative predictive value [28]. In 
our study, we added a calcium scan to the CT protocol for direct comparison with contrast-enhanced 
angiography. The absence of calcium did not exclude ACS and its overall diagnostic performance 
was comparable to the commonly used GRACE risk score (Figure 3).
Clinical Implications
In clinical practice, patients with no or minimal CAD (no more than 20% stenosis plaque in one or 
more vessels) and resolved symptoms, which was nearly half of our population, could be safely dis-
charged from the emergency department. In case of mild disease (20–50% stenosis) safe discharge 
is still possible after a short period of observation and negative serial markers, without the logistic 
and economic consequences of in-hospital stress testing and/or ICA. Using contemporary high-
sensitivity troponins this observation period could be as short as three hours [19]. Less than half 
of patients with moderate CAD (50–70% stenosis) on CT angiography had ACS and/or required a 
revascularization procedure. In these patients, an observation period and a stress test should point 
out the need for ICA in our opinion. Given the heterogeneous pathophysiology of acute coronary 
disease, including spasm, emboli, resolved thrombus and micro-vascular disease, it should be 
emphasized that clinical management should not be dictated by a single test result [29].
Future Directions
The presented data are promising and conﬁrm previous studies. Expectations of coronary CTA in the 
emergency room are high [30], but largely based on registry data. However, before cardiac CT can 
be recommended in general clinical guidelines its performance needs to be compared to existing 
and emerging strategies for triage of acute chest pain, including clinical decision algorithms, novel 
biomarkers and other stress/imaging tests and should consider economic consequences. Recently, 
Raff and colleagues published the results of the multicenter CT-STAT trial, which compared the 
performance of cardiac CT and nuclear imaging in very low risk patients, and demonstrated that 
both tests safely rule out coronary artery disease with a 38% reduction in costs at the emergency 
room for cardiac CT as a result of shorter length of stay [31]. Future research is needed to conﬁrm 
whether these ﬁndings can be extrapolated to patients at higher risk, in varying clinical settings and 
different standards of care.
Strengths and Limitations
Strengths of our study are the blinded fashion in which the CT scans were performed and reviewed 
and the absence of a veriﬁcation bias. Radiation exposure remains an important limitation of cardiac 
CT. The use of contemporary scan techniques in this study resulted in a lower radiation exposure in 
comparison to previous reports, without compromise to image quality.
 It should be recognized that coronary CTA is useful for a selected group of patients with ACP. In 
this study 25% of all eligible patients could not participate because of CTA related exclusion criteria. 
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In addition, in 6 (5%) patients imaging acquisition failed, while 5 (5%) patients had scan that was 
not reliably interpretable. While certain contra-indications inherent to contrast-enhanced CT will 
remain, growing experience with coronary CTA and ongoing scanner development is expected to 
meet some of the present day challenges of imaging patients in the emergency department.
 Potential other limitations are the fact that the total population size was relatively small, and 
enrolled at a single university medical center. Clinical management was left to the discretion of 
the treating clinicians, while ICA and intracoronary imaging was not available for the majority of 
patients. The projected effect on clinical management should be regarded as hypothesis generating, 
and further investigated in a formal randomized controlled clinical trial. New applications, such as 
perfusion imaging and computational ﬂuid dynamics, are developing rapidly, which may further 
contribute to the triage of patients with acute chest pain [32,33].
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Abstract
Objective: To determine the diagnostic accuracy of copeptin in patients with suspected acute 
coronary syndrome (ACS) and its correlation with obstructive coronary artery disease (CAD) on 
coronary CT angiography (CTA).
Methods: Copeptin was measured at arrival in 65 consecutive patients (56±10 years, 45 men) 
suspected of ACS and no indication for immediate invasive angiography. All patients underwent 
coronary CTA without disclosure of the results to the treating physician, and outcomes were 
classiﬁed as obstructive CAD (>50% stenosis) or no obstructive CAD (≤50%) in one or more vessel.
Results: The ﬁnal diagnosis of ACS was established in 10 (15%) patients, 6 myocardial infarctions and 
4 unstable angina pectoris. Coronary CTA detected obstructive CAD in all patients with ACS and in 
10 (15%) patients with no ACS. Copeptin concentrations were higher in patients with ACS (median 
7.42 pmol/l (IQR 3.71–18.72)) vs patients with no ACS (3.40 pmol/l (1.13–6.27), p=0.02). Copeptin was 
not higher in patients with obstructive CAD on coronary CTA (4.87 pmol/l (2.90–8.51) vs 3.60 pmol/l 
(1.21–6.23), p=0.20) compared with patients with no obstructive CAD. 
Conclusions: Copeptin seems to be elevated in patients with ACS while there is no strong correlation 
with obstructive coronary disease on CTA.
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Introduction
Management of patients suspected of acute coronary syndrome (ACS) is a daily challenge for the 
clinician in the emergency department (ED) [1]. The majority presents with subsided chest pain, and 
the ECG is often normal or displays unspeciﬁc changes [2,3]. Current cardiac markers take several 
hours to convert, or do not rise at all in the case of unstable angina [4]. The arginine-vasopressin 
(AVP) hormone plays an important role in the retention of body ﬂuids and regulation of vascular 
resistance, and is rapidly released in conditions with haemodynamic stress [5,6]. The peptide 
copeptin is secreted alongside AVP by the neurohypophysis, and its concentrations adequately 
represent AVP levels.
 Copeptin can be measured more easily, making it suitable as a clinical marker [7,8]. Haemodynamic 
stress arising from myocardial infarction results in an increase in copeptin levels, detectable within 
3 h after onset [9].
 Recently, coronary CT angiography (CTA) has been introduced as a novel diagnostic modality 
in the ED. Several studies have demonstrated that coronary CTA has high negative predictive value. 
On the other hand, not all patients with acute chest pain and obstructive lesions on CTA turn out 
to have myocardial infarction. Their complaints might, however, be explained by the presence of 
ischaemia without onset of myocardial necrosis. In patients with obstructive coronary artery disease 
(CAD) on their CTA, copeptin might help to discriminate between those with and without ischaemia.
 In this study, we determine the diagnostic accuracy of copeptin in suspected ACS patients, and 
examine the association between CAD on CTA and copeptin levels.
Methods
Study Population
Patients with chest pain in the last 24 h were enrolled consecutively at the ED of Erasmus University 
Medical Centre from November 2009 to February 2011 [10]. Eligible for participation were patients 
older than 40 years, without ST segment elevation, haemodynamic instability or highly elevated 
cardiac troponin T (>0.15 μg/l). Exclusion criteria included severe arrhythmia, impaired renal 
function and contrast allergies. Information on patient demographics, presence of risk factors, and 
type of medical treatment were prospectively collected and used to determine the Thrombolysis 
In Myocardial Infarction risk score (TIMI) risk assessment score [11]. The study complied with the 
Declaration of Helsinki; the local ethics committee approved the research protocol, and all patients 
provided written informed consent.
Biochemical Analysis
A specimen of venous blood was drawn at arrival in the ED from a catheter inserted into the 
antecubital vein. The sample was taken at a median of 3 h after the complaints had started. The 
samples were collected in plastic tubes containing EDTA. They were placed on ice and centrifuged at 
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3000 g. Plasma was frozen at -80°C until assay. Copeptin concentrations were determined by using a 
sandwich immunoluminometric assay (LUMITEST CT-pro AVP, BRAHMS AG, Germany).
Coronary CTA
Coronary CTA was performed, without disclosure of the results to the treating physician, either 
on a dual-source 128-slice (Siemens Deﬁnition Flash, Forchheim, Germany) or a single-source 
128-slice (Siemens Deﬁnition AS+, Forchheim, Germany), depending on availability. The following 
scan parameters were used: 100–120 kV tube voltage, 320–370 or 160–188 mAs tube current-
time product depending on patient size, detector row width 0.6 mm, rotation times 280 and 300 
ms, temporal resolutions 75 and 150 ms, respectively. Followed by a 45 ml saline bolus chaser, 
90–100 ml Iopromide (Ultravist 370 mgI/ml, Bayer Schering Pharma, Berlin, Germany) was injected 
at 5.0–5.5 ml/s. Coronary branches were evaluated on axial images, multiplanar reformations and 
maximum intensity projections. The presence of coronary atherosclerotic plaque and the degree 
of stenosis was determined using a 16-segment American Heart Association (AHA) classiﬁcation by 
two experienced readers in a joint reading [12]. Stenosis grade was quantiﬁed either as no stenosis, 
less than 20%, 20–50%, 50–70%, >70% stenosis or occluded on a per-patient level. Non-evaluable 
segments were classiﬁed as obstructive CAD using the intention-to-treat principle.
Clinical Diagnosis of ACS
Patient data and hospital records were reviewed independently by two cardiologists to establish 
the presence of ACS. Both were blinded for the results of copeptin and coronary CTA. In case of 
disagreement, consensus was reached by a joint reading. ACS was deﬁned as either myocardial 
infarction or unstable angina pectoris. Myocardial infarction was diagnosed when there was 
evidence of myocardial necrosis in a clinical setting consistent with myocardial ischaemia (rising 
and/or falling pattern of troponin T, with at least one value >99th percentile). Unstable angina was 
diagnosed when there was chest pain with altered frequency or character, suspicious for ACS with 
documented ischaemia on the ECG, stress testing or invasive angiography [13,14].
Statistical Analysis
Continuous variables are presented as means (±SD) or medians (with IQR), categorical variables 
as proportions. Differences between groups were compared using the analysis of variance test 
(ANOVA) or Kruskal-Wallis one-way ANOVA test as appropriate. Parameters of diagnostic accuracy 
in terms of sensitivity and speciﬁcity were calculated with their corresponding 95% CIs using an 
optimal Receiver Operating Characteristics (ROC) curve cut-off value. The optimal ROC curve cut-off 
value was selected with the intention to optimise sensitivity and restrict false negative results. All 
probability values refer to 2-tailed tests of signiﬁcance; a value <0.05 was considered signiﬁcant. 
Statistical analyses were performed using SPSS software (V.17.0, SPSS Inc, Chicago, Illinois, USA) and 
STATA software (V.12.0, StataCorp, College Station, Texas, USA).
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Results
Patient Characteristics
The study population consisted of 65 patients with a mean age of 56±10 years and 45 (69%) men. 
Baseline characteristics are shown in table 1. According to the TIMI risk score, 53 (82%) patients 
had low, 11 (17%) intermediate, and 1 (2%) high risk. The ﬁnal diagnosis of ACS was established in 
10 (15%) patients, 6 patients with myocardial infarctions and 4 with unstable angina pectoris. The 
sensitivity and speciﬁcity of using an obstructive lesion (>50% stenosis) on coronary CTA to detect 
ACS was 100% (95% CI 65% to 100%) and 82% (69% to 90%) (Table 2).
Table 1 | Baseline characteristics.
Characteristic All patients (n=65)
Age (years) 56±10
Male gender 45 (69)
Smoking 31 (48)
Hypertension 36 (55)
Diabetes mellitus 13 (20)
Statin use 16 (25)
Family history 22 (34)
Peripheral artery disease 10 (15)
Heart rate (beats/min) 74±11
Systolic blood pressure (mmHg) 146±26
Diastolic blood pressure (mmHg) 82±18
Glucose (mmol/L) 6.2 (5.7–7.6)
Kreatinine (μmol/L) 75±14
CRP (mg/l) 1.5 (1.0–4.0)
TIMI score *
Low
Intermediate
High
5 (5–8)
53 (82)
11 (17)
1 (2)
Between time of onset (hrs) † 3.0 (1.5–12)
Coronary CTA‡
≤20% stenosis 
20–50% stenosis
50–70% stenosis
>70% stenosis
31 (48) 
14 (22)
11 (17)
9 (14)
Acute coronary syndrome
Myocardial infarction
Unstable angina pectoris
10 (15)
6 (9)
4 (6)
Data are presented as numbers (%), mean ±standard deviation or median (interquartile range). * Risk of in hospital death, myocardial 
infarction or urgent revascularisation, median (inter-quartile range). † Time between onset of symptoms and blood sampling. ‡ 
Maximal obstruction on coronary CTA on a per-patient level.
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Table 2 | Acute coronary syndrome detection with coronary CT angiography.
Coronary CT angiography
Obstructive CAD (n=20) No obstructive CAD (n=45)
Acute coronary syndrome (n=10) 10 0
No acute coronary syndrome (n=55) 10 45
Copeptin in ACS
Copeptin concentrations were higher in patients with ACS (median 7.42 pmol/l (IQR 3.71–18.72)) 
as compared with patients with no ACS (3.40 (1.13–6.27) pmol/l in those without (p=0.02, Figure 1). 
By using an ROC-derived optimal cut-off value of 3.27 pmol/l, we found a sensitivity of 90% (95% CI 
54% to 99%) and speciﬁcity of 49% (36% to 63%) for the detection of ACS.
Obstructive CAD on CTA
Coronary CTA revealed no or minimal (<20%) stenosis in 31 (48%) patients, 20–50% stenosis in 
one or more vessels in 14 (22%), 50–70% stenosis in 11 (17%) and >70% stenosis in 9 (14%) (Table 
1). Patients with obstructive CAD (>50% stenosis) had a median copeptin concentration of 4.87 
(IQR 2.90–8.51), and those with no obstructive CAD 3.60 (1.21–6.23) (p=0.20, Figure 2).
Figure 1 | Copeptin concentrations in patients with 
ACS (median 7.42 pmol/L [IQR 3.71–18.72]) vs. no ACS 
(3.40 [1.13–6.27]) (p=0.02).
Figure 2 | Copeptin concentrations in patients 
with obstructive CAD on coronary CTA (me-
dian 4.87 [IQR 2.90–8.51] vs. no obstructive CAD (3.60 
[1.21–6.23]). 
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Discussion
In this prospective study of patients with acute chest pain, we report the following ﬁndings: (1) 
serum copeptin concentrations at arrival were higher in patients with ACS; (2) in this population, 
no signiﬁcant correlation between copeptin and obstructive CAD on coronary CTA could be 
demonstrated.
 Since its introduction, copeptin has been studied in different populations as a potential clinical 
maker of haemodynamic stress [15]. Reichlin et al. [9] as well as Keller et al. demonstrated that 
copeptin allowed identiﬁcation of patients with acute myocardial infarction, with incremental value 
to troponin T. However, more recent observations by Karakas et al suggested that the diagnostic 
performance of copeptin might be less in patients with low risk ACS [17]. Our results conﬁrm 
previous larger studies and suggest rapid release of copeptin in patients with ACS.
 While the role of copeptin in suspected ACS appears to be limited in light of the rapidly expanded 
implementation of high-sensitivity troponins, which also identify myocardial injury within 3–6 h 
[18,19] ongoing research suggests diagnostic performance may still be improved with addition of 
copeptin to these new-generation troponin essays [20,21].
Copeptin and Coronary CTA
Coronary CTA is increasingly employed in patients with suspected ACS, to allow safe and early 
discharge of those without CAD [22,23]. In our population, we could not detect an association 
between copeptin and the presence of obstructive CAD on CTA. Given the small sample size, a 
truly existing difference might be concealed due to lack of statistical power. However, our results 
are in agreement with earlier observations [17]. Coronary CTA has modest positive predictive 
value, that is, the exact severity of stenosis and degree of ischaemia cannot be assessed [24]. In 
patients with modest obstructive lesions on CTA (50–70% stenosis), copeptin could complement 
imaging by identifying patients with haemodynamic stress resulting from myocardial ischaemia. 
With increasing use of imaging as well as cardiac biomarkers, there is a demand for research with 
prespeciﬁed protocols combining new biomarkers with imaging modalities, like coronary CTA, to 
guide future clinical practice.
Study Limitations
There are several limitations that need to be acknowledged. First of all, this is a single-centre study, 
and is based on a population of modest size. Conclusions should be made with caution and are not 
necessarily generalizable to other populations. Nevertheless, the results of this explorative study 
indicate a discriminative role for copeptin in patients suspected of ACS. Second, the use of a data-
derived ROC curve threshold in this study will overestimate diagnostic accuracy. Finally, the study 
was conducted in a selected population, because all patients also had to undergo coronary CTA. 
Those with an impaired renal function, previous coronary revascularization, arrhythmias, history 
of allergy to iodine, presence of contra-indication to β-blocker administration or clinical instability 
were excluded.
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Abstract
Background: It is uncertain whether a diagnostic strategy supplemented by early coronary 
computed tomography angiography (CCTA) is superior to contemporary standard optimal care 
(SOC) encompassing high-sensitivity troponin assays (hs-troponins) for patients suspected of acute 
coronary syndrome (ACS) in the emergency department (ED).
Objectives: This study assessed whether a diagnostic strategy supplemented by early CCTA improves 
clinical effectiveness compared with contemporary SOC.
Methods: In a prospective, open-label, multicenter, randomized trial, we enrolled patients presenting 
with symptoms suggestive of an ACS at the ED of 5 community and 2 university hospitals in the 
Netherlands. Exclusion criteria included the need for urgent cardiac catheterization and history of 
ACS or coronary revascularization. The primary endpoint was the number of patients identiﬁed with 
signiﬁcant coronary artery disease requiring revascularization within 30 days.
Results: The study population consisted of 500 patients, of whom 236 (47%) were women (mean 
age 5410 years). There was no difference in the primary endpoint (22 [9%] patients underwent 
coronary revascularization within 30 days in the CCTA group and 17 [7%] in the SOC group [p=0.40]). 
Discharge from the ED was not more frequent after CCTA (65% vs. 59%, p=0.16), and length of 
stay was similar (6.3 h in both groups; p=0.80). The CCTA group had lower direct medical costs 
(€337 vs. €511, p<0.01) and less outpatient testing after the index ED visit (10 [4%] vs. 26 [10%], 
p<0.01). There was no difference in incidence of undetected ACS.
Conclusions: CCTA, applied early in the work-up of suspected ACS, is safe and associated with less 
outpatient testing and lower costs. However, in the era of hs-troponins, CCTA does not identify 
more patients with signiﬁcant CAD requiring coronary revascularization, shorten hospital stay, or 
allow for more direct discharge from the ED. (Better Evaluation of Acute Chest Pain with Computed 
Tomography Angiography [BEACON]; NCT01413282) 
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Acute chest pain can herald severe cardiovascular conditions, such as an acute coronary syndrome 
(ACS) [1]. However, the differential diagnosis of acute chest pain is broad, and the consequences 
of misdiagnosis can be detrimental [2-4]. Physicians confront this diagnostic dilemma daily. 
Coronary computed tomography angiography (CCTA) allows noninvasive visualization of the 
coronary arteries [5]. Because of its high accuracy in ruling out coronary artery disease (CAD), 
CCTA has been proposed for better decision making in the emergency department (ED), allowing 
for rapid discharge of patients without important CAD and, possibly, more appropriate referral for 
coronary revascularization [6,7]. Early CCTA as a diagnostic strategy in low- to intermediate-risk 
patients suspected of ACS is considered safe and may provide logistic and economic beneﬁts [8-10]. 
Meanwhile, high-sensitivity troponin assays (hs-troponins) have become standard practice in many 
institutions, allowing for more accurate and faster rule-out of ACS [11,12]. Whether hs-troponins will 
erode the potential clinical, logistic, and economic beneﬁts of CCTA has not yet been investigated. 
The BEACON (Better Evaluation of Acute Chest Pain with Coronary Computed Tomography 
Angiography) trial is a European randomized trial comparing a diagnostic strategy supplemented by 
early CCTA with standard optimal care (SOC) for patients suspected of ACS in the era of hs-troponins.
Methods
Study Design 
The BEACON study is a prospective, open-label, multicenter, randomized trial. Patients were enrolled 
at 2 university and 5 community hospitals in the Netherlands. Enrollment was performed during 
working hours, except at the Erasmus Medical Center University Medical Centre, where patients were 
included around the clock. The study complied with the CONSORT 2010 Statement and Declaration 
of Helsinki, and was approved by the institutional ethics committees of each participating center. All 
patients provided written informed consent.
Participants
Patients with acute chest pain or symptoms suggestive of ACS warranting further diagnostic 
evaluation, as determined by the treating physician, were eligible for inclusion. We included patients 
30 years of age and older, with a maximum age of 75 years for men and 80 years for women. Patients 
were excluded if symptoms were clearly of noncardiac origin or a coexisting condition already 
necessitated hospital admission. Exclusion criteria also included a history of known CAD, clinical 
need for urgent invasive coronary angiography (ICA), clinical instability, serum troponin levels above 
3 times the upper limit of the 99th percentile of the local assay, impaired renal function (estimated 
glomerular ﬁltration rate <60% of age-corrected normal values), pregnancy, known allergy to an 
iodinated contrast agent, severe arrhythmias, and body mass index >40 kg/m2.
Randomization
Trial participants were randomly assigned to a CCTA-based diagnostic strategy or SOC (1:1). For 
allocation, a computer-generated block randomization sequence was used, stratiﬁed by participating 
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center. An independent physician at the coordinating center extracted the randomization schedule 
from an electronic randomization tool and codes were sent in sealed, sequentially numbered, 
opaque envelopes to the participating centers.
Procedures
The initial standard clinical work-up at the ED included a 12-lead electrocardiogram (ECG) and blood 
analysis. If the initial clinical work-up did not reveal either an evident ACS or an evident noncardiac 
cause, eligible and consenting patients were randomized between a CCTA-guided strategy and SOC. 
In the intervention group, CCTA was performed after the initial clinical work-up at the ED. In both 
groups, hs-troponins were available (Supplemental Table 1). Image acquisition was performed on 
64-slice or a more advanced computed tomography (CT) system, using ECG-synchronized axial or 
spiral scan protocols combined with radiation minimizing measures, depending on local practices, 
available technology, and patient characteristics. Results of CCTA were reported by certiﬁed 
radiologists with a minimum of 2 years of experience reading CCTA. Treating physicians were informed 
directly at the point of care regarding the result of CCTA and imaging-based recommendations were 
issued. Final medical management decisions were, however, left to the treating physicians (Figure 
1). In the SOC group, the attending physicians made clinical decisions regarding further testing, 
including repeated cardiac marker assessment, hospital admission, noninvasive tests, and referral 
to ICA, according to current guidelines [13,14]. Participants from both groups who were discharged 
from the ED, without prolonged observation (<8 h) were asked to return to the outpatient clinic after 
48 to 72 hours for repeated measurement of cardiac biomarkers and a 12-lead ECG. All participants 
were followed-up at the outpatient clinic or contacted by telephone after 30 days.
Outcome Measures
The pre-deﬁned primary endpoint of the study was the number of patients identiﬁed with 
signiﬁcant CAD requiring coronary revascularization, as interpreted by the clinical operators, within 
the follow-up period of 30 days. This outcome parameter was chosen on the basis of the hypothesis 
that a CCTA-driven strategy would identify more clinically important CAD, as suggested by the 
results of our single-center pilot study, which could effectuate a prognostic beneﬁt [15]. The use 
of fractional ﬂow reserve for ischemia-proven coronary revascularization was encouraged, but not 
mandatory. This study was set up as a pragmatic clinical trial focusing on initial ED management 
without protocol-mandated medical management during the remaining clinical course. Secondary 
endpoints included expedited discharge rate from the ED, length of hospital stay, undetected ACS, 
cumulative radiation exposure, direct medical costs, and repeat visits to the ED or re-hospitalization 
for recurrent chest pain within 30 days of follow-up. We deﬁned expedited discharge as discharge 
within 8 h from the ED, and length of stay as the time from presentation in the ED until hospital 
discharge. The treating physician made the decision to discharge. ACS was deﬁned as either unstable 
angina pectoris or myocardial infarction, according to current guidelines [16]. The diagnosis of ACS 
was not on the basis of the CCTA results. The occurrence of undetected ACS was assessed at both 
the safety follow-up within 72 hours and the general follow-up at 30 days. Cumulative radiation 
exposure was expressed in millisieverts (mSv) and deﬁned as radiation exposure from all tests and
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interventions undergone within the ﬁrst 30 days, including CCTA, single-photon emission computed 
tomography (SPECT) myocardial perfusion imaging, and ICA. Effective radiation dose was derived by 
multiplying the dose-length product by a conversion factor of 0.014 for CCTA, 0.0085 mSv/mBq for 
SPECT and 0.22 mSv/Gycm2 for ICA. To estimate the radiation dose of procedures without reported 
exposure data, the median radiation dose per procedure was used. Direct medical costs during the 
index visit and within the follow-up period of 30 days were assessed using reports from the Erasmus 
MC University Medical Centre cost-accounting system in 2013 in Euros (additional information in the 
Supplemental Appendix). Finally, we compared the occurrence of total major adverse cardiac events 
within 30 days, deﬁned as death, ACS, and coronary revascularization. Information on clinical events, 
repeat visits to the ED, re-hospitalization for recurrent chest pain, diagnostic testing, or interventions 
was veriﬁed by medical records. An adjudication committee consisting of 2 certiﬁed, independent 
cardiologists reviewed medical records of patients with clinically relevant events and a random 10% 
sample of patients without a diagnosis of cardiac disease.
Statistical Analysis
Statistical analyses were performed on the basis of an intention-to-treat analysis. Continuous data 
are presented as mean SD or medians with interquartile ranges. Independent samples Student 
t test or Mann-Whitney U test were used for between-group comparisons for continuous variables, 
and chi-square or Fisher exact test was used for categorical variables. A 2-sided p value <0.05 was 
considered to indicate statistical signiﬁcance. For statistical analyses, we used SPSS version 20.0.
 On the basis of our previous observational data, we anticipated an absolute 9% increase 
in the number of coronary revascularizations if the results of CCTA were to be incorporated [15]. 
Considering an α=0.05 and β=0.8 with an intervention versus control group enrollment ratio of 1:1, 
and allowing a loss to follow-up of approximately 10%, we would require 500 participants to detect 
a difference in the number of patients requiring revascularization of relevant CAD.
Results
Between July 11, 2011, and January 30, 2014, 573 eligible patients were approached for the study; 73 
(13%) declined to participate (Figure 2). In total, 7 patients in the CCTA group did not have a CT scan, 
and 6 patients in the SOC group eventually under-went a CT examination to exclude either CAD 
or other vascular conditions. At 30 days, 5 patients in each group had withdrawn from the study, 
resulting in complete follow-up in 490 (98%) patients.
Study Population
Table 1 shows patient demographics, clinical characteristics, and medical treatment at baseline. 
The mean age of the study population was 54±10 years and 236 (47%) participants were women. 
Baseline characteristics and clinical status were similar between the 2 groups. In the intervention 
group, CCTA identiﬁed 106 (42%) patients with no detectable CAD. Among the patients with CAD 
on CCTA, 71 (28%) had atherosclerotic plaque with <50% luminal narrowing, 35 (14%) had 50% to 
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70% luminal narrowing in 1 or more coronary arteries, and 13 (5%) had >70% luminal narrowing in 
1 or more coronary arteries. The scan was considered non-diagnostic in 18 patients (7%). The mean 
radiation dose in the CCTA group was 7.3±6.6 mSv versus 2.6±6.5 mSv in the SOC group.
Table 1 | Baseline Characteristics.
CCTA (n=250) SOC (n=250) p value
Age, yrs* 55±10 53±9 0.07
Sex, female 123 (49) 113 (45) 0.37
Medication
Statin 65 (26) 51 (20) 0.14
Aspirin 48 (19) 35 (14) 0.12
Beta-blocker 41 (16) 40 (16) 0.90
ACE inhibitor 29 (12) 29 (12) 1.00
Angiotensin-receptor blocker 18 (7) 17 (7) 0.86
Calcium-channel blocker 18 (7) 19 (8) 0.86
Diuretic agent 36 (14) 23 (9) 0.07
Oral antidiabetic agent 22 (9) 24 (10) 0.76
Insulin 6 (2) 3 (1) 0.31
Cardiovascular risk factors
Diabetes mellitus 31 (12) 33 (13) 0.79
Hypertension 0.95
>150 mm Hg systolic or >90 mm Hg diastolic 43 (17) 43 (17)
Treated 66 (26) 69 (28)
Hypercholesterolemia 0.31
Total cholesterol >5 mmol/l 25 (10) 35 (14)
Treated 65 (26) 52 (21)
Smoking 0.26
Current 93 (37) 78 (31)
Stopped >1 yr 25 (10) 22 (9)
History of cardiovascular disease 0.95
Peripheral artery disease 8 (3) 7 (3)
TIA/CVA 16 (7) 17 (7)
Family history 112 (45) 98 (39) 0.21
Blood pressure (mm Hg)
Systolic* 140±19 141±20 0.67
Diastolic* 82±12 82±11 0.63
Heart rate* (beats/min) 72±14 72±13 0.86
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Table 1 | Baseline Characteristics (Continued).
CCTA (n=250) SOC (n=250) p value
TIMI risk score (39)†
0
1
≥2
1 (0-2)
74
84
92
1 (0-2)
83
91
76
0.31
Grace risk score (40)† 85 (70–100) 81 (67–98) 0.28
Low 211 (84) 208 (83) 0.20
Intermediate 31 (12) 39 (16)
High 8 (3) 3 (1)
Ischemic ECG abnormalities 60 (24) 44 (18) 0.08
Baseline troponins
Elevated‡ 11 (4) 13 (5) 0.67
Unless otherwise specified, data are numbers of patients, with percentages in parentheses. *Data are means±SD. †Data are medians, 
with interquartile ranges in parentheses. Diabetes mellitus is defined as plasma glucose >11.0 mmol/l or treated with either diet reg-
ulation or medication. Ischemic ECG abnormalities defined as Q-wave or ST-T-segment alterations suggestive of ischemia. ‡Elevated 
within 3 times the upper limit of the 99th percentile. CCTA = coronary computed tomography angiography; CVA = cerebrovascular 
accident; SOC = standard optimal care; TIA = transient ischemic attack; TIMI = Thrombosis in Myocardial Infarction. 
Figure 2 | Enrollment, Randomization, and Follow-up of Study Participants. CT = computed tomography; 
ACS = acute coronary syndrome; CAD = coronary artery disease; CCTA = coronary computed tomography 
angiography; ICA = invasive coronary angiography.
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Primary Outcome and Clinical Endpoints
For the primary outcome, the number of patients requiring revascularization within 30 days, no 
difference was observed between the CCTA group and SOC, that is, 22 (9%) versus 17 (7%) (p=0.40) 
(Table 2). Also, the total number of ICAs performed within 30 days was similar. At hospital discharge, 
22 (9%) patients in the CCTA group and 17 (7%) in the SOC group were diagnosed with ACS (p=0.40). 
Repeat visits to the ED occurred in 13 (5%) patients in the CCTA group, compared with 19 (8%) in the 
SOC group (p=0.27). At 30 days, a similar incidence of total major adverse cardiac events, that is, 25 
(10%) in the CCTA group and 21 (9%) in the SOC group was observed (p=0.54).
Table 2 | Primary outcome and clinical endpoints within 30 days after index visit
CCTA SOC p value
Invasive coronary angiography* 41 (17) 31 (13) 0.20
Invasive coronary angiography at index visit 34 (14) 25 (10) 0.21
Coronary revascularization* 22 (9) 17 (7) 0.40
Percutaneous coronary intervention 22 (9) 13 (5)
Coronary artery bypass graft surgery 0 4 (2)
Acute coronary syndrome at discharge
Unstable angina
Myocardial infarction
22 (9)
8 (3)
14 (6)
17 (7)
3 (1)
14 (6)
0.40
0.64
Repeat emergency department visit 13 (5) 19 (8) 0.27
Repeat hospital admission 7 (3) 14 (6) 0.12
Undetected acute coronary syndrome 1 (0) 3 (1) 0.62
Major adverse cardiac event 25 (10) 21 (9) 0.54
All-cause mortality 1 (0) 0 1.0
Unless otherwise specified, data are numbers, with percentages in parentheses. Major cardiac adverse event includes all-cause 
mortality, myocardial infarction and coronary revascularization. CCTA = coronary computed tomography angiography; CVA = 
cerebrovascular accident; SOC = standard optimal care; TIA = transient ischemic attack; TIMI = Thrombosis in Myocardial Infarction. 
*Includes procedures at index visit.
Safety Endpoints
Undetected ACS occurred once (0.5%) in the CCTA group and 3 times (1%) in the SOC group within 
the 30-day follow-up period (p=0.62). In the CCTA group, 1 patient had recurrent chest pain with ECG 
changes suggestive of myocardial ischemia at his safety visit. In the SOC group, 1 patient returned 
with recurrent complaints, and underwent coronary revascularization following an abnormal 
exercise electrocardiography (ExECG) result. Another patient reported intermittent chest pain at 
his safety visit within 72 hours and his laboratory tests showed elevated cardiac biomarkers. The 
third patient returned after 5 days with recurrent complaints and elevated cardiac biomarkers. One 
patient in the CCTA group died of a hemorrhagic stroke following emergency thrombolysis for 
occlusive peripheral artery disease 11 days after the index ED visit.
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Nine CCTA examinations (4%) had minor com-plications: 3 patients had self-limiting, transient 
increases in their creatinine levels, 4 patients experienced contrast medium extravasation without 
clinical consequences, and 2 had mild, medically treated allergic skin reactions. In the SOC group, 1 
patient who was discharged early had a transient increase in the creatinine level at his safety visit.
Diagnostic testing and Resource Utilization
More patients were discharged immediately from the ED after CCTA (159 [65%] vs. 144 [59%]), 
although this difference did not reach statistical signiﬁcance (p=0.16) (Table 3). The median length of 
stay was similar in both groups. ExECG was the most commonly performed alternative noninvasive 
diagnostic test. In the CCTA group, 32 (13%) patients underwent ExECG within 30 days: 3 (9%) were 
suspected of ischemia and 10 (31%) were non-diagnostic. In the SOC group, 143 (58%) patients 
underwent ExECG within 30 days: 9 (6%) were suspected of ischemia and 39 (27%) were non-
diagnostic (Supplemental Table 2). Outpatient testing was less frequently performed in the CCTA 
group (10 [4%] vs. 26 [11%]; p<0.01), and direct medical costs after 30 days were lower (€337 [€337 
to €932] vs. €511 [€309 to €916]; p<0.01).
Table 3 | Diagnostic Testing and Resource Utilization.
CCTA SOC p value
Length of stay (h)* 6.3 (4.8–11.1) 6.3 (4.5–25.5) 0.80
Discharge status 0.16
Discharge from emergency department 159 (65) 144 (59)
Admitted to hospital 86 (35) 101 (41)
ExECG at index visit 23 (9) 130 (53) <0.01
ExECG<30 days 32 (13) 143 (58) <0.01
SPECT at index visit 2 (1) 7 (3) 0.18
SPECT <30 days 2 (1) 16 (7) <0.01
CMR at index 1 (0) 1 (0) 1.0
CMR <30 days 1 (0) 3 (1) 0.62
CCTA after index visit 1 (0) 2 (1) 1.0
Outpatient diagnostic testing <30 days† 10 (4) 26 (11) <0.01
Cost (€)* 337 (337–932) 511 (309–916) <0.01
Unless otherwise specified, data are numbers of patients, with percentages in parentheses. *Data are medians, with interquartile 
ranges in parentheses. †Total of ExECG, SPECT, CMR, and CCTA in an outpatient setting after index ED visit. CMR = cardiac magnetic 
resonance imaging; ExECG = exercise electrocardiography; SPECT = single-photon emission computed tomography myocardial 
perfusion imaging. CCTA = coronary computed tomography angiography; CVA = cerebrovascular accident; SOC = standard optimal 
care; TIA = transient ischemic attack; TIMI = Thrombosis in Myocardial Infarction.
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Discussion
In this prospective, open-label, multicenter, randomized trial, we compared a diagnostic strategy 
supplemented by early CCTA with contemporary SOC encompassing hs-troponins. In a European 
setting, early CCTA was safe, less expensive, with less sub-sequent outpatient testing than SOC 
alone. However, a diagnostic strategy supplemented by early CCTA did not identify more patients 
with signiﬁcant CAD requiring coronary revascularization, reduce the length of stay, or allow more 
expedited discharge from the ED (Central Illustration).
CCTA in the ED
Initial observational studies showed that CCTA was feasible and could safely be performed in the 
ED [19,20]. The ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) 
study, where 50% of patients with acute chest pain were free from any CAD, demonstrated high 
negative predictive value and underlined the potential of CCTA in this setting [6]. Because CCTA 
identiﬁes the presence of nonobstructive coronary atherosclerotic plaque, it also may provide the 
basis for preventive therapeutic medical measures, as opposed to SPECT or ExECG, which detect 
the presence of existing myocardial ischemia [21]. In the current study, non-obstructive coronary 
atherosclerosis was found in 28% of patients, warranting preventive management, which would be 
overlooked with SOC.
 Shortly after these initial studies, randomized controlled trials were initiated to examine whether 
a CCTA-based strategy would be more clinically effective than current practice. The CT-STAT trial 
compared CCTA with nuclear myocardial perfusion imaging as initial tests in the management of 
patients with acute chest pain [10]. Investigators reported a 54% reduction in time to diagnosis and 
38% lower costs of ED care with CCTA. In the ACRIN-PA (American College of Radiology Imaging 
Network-Pennsylvania) trial, investigators left decisions to perform diagnostic tests in the SOC group 
to the discretion of the treating physicians [9]. The study demonstrated that low-risk patients could 
be safely discharged with early CCTA twice as often, and CAD was more likely to be diagnosed with 
CCTA. The ROMICAT-2 trial also included a cost analysis, demonstrating a reduction of the median 
length of hospital stay from 26.7 to 8.6 hours with early CCTA and a 4-fold higher discharge rate from 
the ED (47% vs. 12%) without increasing medical expenditure [8].
 Since these trials were completed, the introduction of hs-troponin has changed SOC considerably. 
These new assays are more sensitive and reach negative predictive values of >97% for myocardial 
infarction within 3 h [11,12]. Early observations indicated that hs-troponins would allow fast and 
accurate exclusion of ACS in a substantial proportion of low- to intermediate-risk patients, obviating 
the need for prolonged observation and in-hospital diagnostic testing in the absence of elevated 
high-sensitivity cardiac biomarkers or precarious ECG abnormalities [22-24].
Current Results in Perspective
The BEACON trial was designed to compare the clinical effectiveness of a diagnostic strategy 
supplemented by early CCTA with contemporary SOC encompassing hs-troponins. The current 
study included a population with a higher prevalence of obstructive CAD on CCTA (19%) compared 
with previous randomized trials. The majority of patients were referred by a general practitioner, 
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deferring very low-risk patients or those with non-cardiac conditions from the ED. Furthermore, as 
mandated by the study protocol, only patients with acute chest pain or symptoms suggestive of an 
ACS warranting further diagnostic evaluation, as determined by the treating physician, were eligible 
for inclusion. Finally, the inclusion of patients with mildly elevated troponins probably led to an 
increased prevalence of CAD.
 A diagnostic strategy supplemented by early CCTA was inclined to detect more patients with 
signiﬁcant CAD requiring coronary revascularization in our study; however, this was not of statistical 
signiﬁcance. The results of our logistic endpoints differ from previous trials, as early performance 
of CCTA did not shorten the length of stay, nor reduce the number of hospital admissions in our 
study. The length of stay with early CCTA in this study is com-parable or even lower than previously 
reported (Figure 3). However, the length of stay in our SOC group was substantially lower (median 
6.3 hours), underlining the vigorous improvement of SOC after the introduction of hs-troponins, and 
also making it harder to achieve an improvement with early CCTA.
Figure 3 | CCTA for Triage of Suspected Acute Coronary Syndrome: Outcomes and Length of Stay. (A) 
Primary and secondary outcomes in the early CCTA group and SOC group. B. Length of stay and proportion of 
patients discharged. angiography. ACS = acute coronary syndrome; CCTA = coronary computed tomography 
angiography; ED = emergency department; ICA = invasive coronary angiography; SOC = standard optimal 
care.
99CT Angiography for Triage of Suspected ACS | 
6
Figure 4 | Length of Stay and Discharge Rate From the Emergency Department in the ACRIN-PA, ROMI-
CAT-2, and BEACON trials. Reported data are medians. ACS = acute coronary syndrome; CCTA = coronary 
computed tomography angiography; ED = emergency department; ICA = invasive coronary angiography; 
SOC = standard optimal care.
Similarly, as many as 59% of patients in the SOC group could be discharged from the ED, a 
proportion 2 to 4 times higher than reported in previous randomized trials with physician-directed 
standard care as a comparator. Differences in the Netherlands and U.S. health care systems may be 
responsible, to some extent, for the contrast between our observations and those from previously 
published studies from the United States. In the Netherlands, primary care physicians, who are 
easily accessible and fully covered by medical insurance, have an important gatekeeper role and 
can defer patients at very low risk or with probable non-cardiac etiology from the ED, which avoids 
overcrowding and likely increased the overall coronary disease prevalence in our population [25,26]. 
Furthermore, coverage by Dutch insurance companies is comparable for elective and emergency 
care, and ﬁnancial incentives that stimulate outpatient work-up and testing are in place [27,28]. In 
the United States, delays in access to care, social differences, and insurance coverage problems in-
crease the number of patients seeking care in the ED [29,30]. In addition, although guidelines allow 
for outpatient testing in 48 to 72 hours after discharge from the ED, U.S. physicians are more inclined 
to achieve a conclusive work-up for the presence of CAD before discharge because of the availability 
of the testing, poor follow-up, and vulnerability to litigation [31-34]. Testing is typically available 
only during working hours, leading to prolonged hospital stays. Nonetheless, we believe that the 
contrasting ﬁndings are largely explained by the profound effect of the introduction of hs-troponins 
in the work-up of suspected ACS [11,12,35].
 An attractive consequence of early CCTA in our study was the reduced number of subsequent 
outpatient testing and lower medical costs at 30 days. Outpatient testing was mostly driven by 
the preference of the treating physician to assess the presence of CAD as the cause of symptoms, 
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which was no longer necessary if CCTA had been performed at ﬁrst presentation. Although direct 
comparison of absolute costs between studies is difﬁcult, the shorter length of stay, more frequent 
use of exercise testing instead of nuclear imaging, and relatively lower cost of CCTA likely reduced 
general medical expenditure in this study [36]. When comparing costs between the 2 groups in our 
study, some important aspects should be taken into account. According to the applied hospital 
cost-accounting system, CCTA was only slightly more expensive than ExECG. Nuclear myocardial 
imaging, which is substantially more costly than either CCTA or ExECG in the Netherlands, was more 
frequently performed in the SOC group. Finally, the higher costs in the SOC group can likely be 
attributed to the higher proportion of admitted patients. The median cost per patient in the SOC 
group was not affected by the unbalanced coronary artery bypass graft distribution. 
Clinical Implications
There is growing evidence that patients with hs-troponin values below the 99th percentile of the 
upper reference limit have a very low likelihood of ACS. These patients have a very good prognosis 
and very often have a normal functional or CCTA test [37-39]. However, those with levels above the 
99th percentile might beneﬁt from additional testing (i.e., CCTA or a functional test) where (especially 
in those with low clinical risk proﬁle) a negative test would make the occurrence of cardiovascular 
events in the short term very unlikely and the need for immediate further testing unnecessary. In 
this light, it would be of interest for future studies to assess the value of a tiered approach, where 
application and timing of CCTA or test of choice is directly guided by risk proﬁles and biomarker 
results.
Study Limitations
The majority of patients were enrolled during ofﬁce hours, and round-the-clock implementation 
of CCTA in the ED poses practical challenges. In real-world clinical practice, SOC might prove more 
efﬁcient than CCTA for 24-hours use. Extrapolation of our results may be affected by differences 
in CT technology, imaging expertise, local practices, and cost-accounting systems. The overall 
observed incidence of the primary endpoint was lower than anticipated on the basis of experiences 
from our observational study. Although speculative, we believe that the exceptional sensitivity of 
hs-troponins, allowing early and precise detection of ACS, reduced the incidence of the primary 
endpoint in both groups, resulting in an underpowered sample size. Earlier troponin elevations and 
expedited catheterization procedures rendered a proportion of high-risk patients ineligible for study 
inclusion. In addition, a substantial proportion of patients (50%) with obstructive CAD on CCTA were 
ultimately not referred for catheterization. Without elevated troponins, these lesions were probably 
considered stable, which would justify optimal medical treatment on the basis of large coronary 
revascularization outcome trials [40]. Given the low incidence of undetected ACS, this strategy does 
not appear to have affected safety. Inherent to the nature of diagnostic trials, blinding of patients and 
treating physicians was not possible, although study participants were treated by physicians who 
aimed for optimal clinical care, and had no direct involvement in the design and realization of this 
study. The effect of an early CCTA strategy on long-term downstream testing, resource utilization, 
and clinical outcome has yet to be determined. Although the majority of patients were evaluated 
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with hs-troponins, 21% entered the study when these assays were not yet available at a number of 
centers. Finally, an important and noteworthy disadvantage of CCTA is the exposure of patients to 
radiation. However, use of more innovative CT technology and dose-saving protocols resulted in 
lower radiation exposure compared with earlier trials (7.3 vs. 14.3 mSv).
Conclusions
CCTA, applied early in the work-up of suspected ACS, is safe and associated with less outpatient 
testing and lower costs. However, in the era of hs-troponins, CCTA does not identify more patients 
with signiﬁcant CAD requiring coronary revascularization, nor does CCTA shorten hospital stay or 
allow for more immediate discharge from the ED.
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Supplemental Material
Direct medical costs
Based on the costs of the initial ED evaluation (including fee of physician, costs of laboratory tests and 
ECG), proportions of diagnostic tests, costs of hospital admission, and costs of repeat ED evaluation 
and readmission, an estimation of costs for the two arms can be compared for other settings and 
prices using the following formula: 
Average cost per patient in the CCTA group = [cost of initial ED evaluation] + [cost CCTA] + 0.13 * 
[cost XECG] + 0.01 * [cost SPECT] + 0.004 * [cost CMR] + 0.17 * [cost ICA] + 0.09 [cost PCI] + 0 * [cost 
CABG] + 0.05 [cost repeat ED evaluation] + 0.03 [repeat hospital admission] 
Average cost per patient in the SOC group = [cost of initial ED evaluation] + 0.58 * [cost XECG] + 0.07 
* [cost SPECT] + 0.01 * [cost CMR] + 0.13 * [cost ICA] + 0.05 [cost PCI] + 0.02 * [cost CABG] + 0.08 [cost 
repeat ED evaluation] + 0.06 [repeat hospital admission] 
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Abstract
A 25-year-old man with a ventricular septal defect resulting from a stab wound to his chest was 
admitted to our hospital. Because of extensive comorbidity and favorable location, transcatheter 
closure with an Amplatzer device was preferred over surgical repair. Ventricular septal defects are 
an uncommon complication of cardiac trauma, but when they do occur from this cause, they often 
have more dramatic consequences. Transcatheter closure is an attractive, less invasive alternative in 
patients with increased surgical risk, multiple previous surgical interventions, or poorly accessible 
defects.
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Introduction
Ventricular septal defects (VSD) are a common presentation of congenital heart disease (30–40% at 
birth) and the majority will close spontaneously before patients reach adulthood [1]. A less common 
cause of VSD is cardiac trauma, but when they do occur from this cause, they often have more 
dramatic consequences and mortality rates of up to 80% have been reported [2]. Cardiac trauma 
can be divided in two groups; blunt and penetrating injury, according to the causing mechanism. 
Ventricular defects may arise from direct lacerations, cardiac contusion, or myocardial infarction as 
a result of a coronary artery tear [3]. Defects can arise at any part of the septum and can become 
apparent hours or days after the original injury.
Case
A 25-year-old man with no history of heart disease was brought to the emergency room of a 
community hospital after sustaining a stab wound to the chest. His clinical situation deteriorated 
quickly necessitating emergency thoracotomy performed by the local general surgeon. A left lung 
laceration was stapled and a perforation of the left ventricle was directly sutured. Echocardiography 
revealed a large VSD, and the patient was subsequently transported to the intensive care unit (ICU) 
of our hospital. Transesophageal echocardiography showed a VSD of approximately 1.1×1.3 cm 
(Figure 1). CT angiography confirmed the presence of the defect (diameter of 8×16 mm in diastole) 
(Figure 2). His stay on the ICU was complicated by recurrent intrathoracic hemorrhages requiring re-
thoracotomy on two occasions. In relation to the initial hemodynamic instability, the patient suffered 
multiple intracranial infarcts. During the intensive care treatment, a rectal canula resulted in bowel 
perforation, for which he underwent resection of his ileum and rectosigmoid. These complications 
delayed treatment of the VSD with a clinically impressive left to right shunt.
 Once the patient had reached a stable clinical situation, transcatheter closure was attempted 
under general anaesthesia and systemic heparization. Antibiotics were given periprocedurally. 
Vascular access for cardiac catheterization was attained through the right femoral artery and the 
jugular vein. The VSD was crossed with a JR catheter (Cordis, Miami, FL, USA) and an arteriovenous 
loop was created by snaring a wire from the right jugular vein (Figure 3). Because of uncertainty about 
the size of the slit-like defect, balloon sizing was performed with a 25-mm PTS balloon, measuring 
a VSD diameter of 16 mm. A long sheath (AGA Medical, Plymouth, MN, USA) was placed from the 
jugular vein through the VSD and a 20-mm Amplatzer post-myocardial infarction VSD occluder (St 
Jude Medical, St Paul, MN, USA) was positioned under continuous echocardiographic control. The 
position of the occluder was checked for 20 min and was found to be stable with minimal residual 
flow. A check 30 min after release showed a stable position of the device and the procedure was 
ended. An immediate remarkable rise in the systemic blood pressure was seen with an aortic 
pressure, from 80/55 mmHg before placement to 121/78 mmHg after. Clinical observation after 
treatment showed normalization of both respiratory and heart rate. The patient was transferred to a 
rehabilitation centre for further recovery. Four years later, the patient is still in a stable condition and 
has no cardiac complaints.
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Figure 1 | Transthoracic echocardiogram. (a) Four-
chamber view showing a midseptal ventricular 
defect; (b) colour Doppler recording with left to right 
shunting.
Figure 2 | Computed tomo-
graphy angiogram. (a) 
Multiplanar four chamber 
and (b) short axis views 
visualizing the midseptal 
ventricular defect; (c, d) 
volume-rendered images 
with anterior (c) and lateral 
orientation (d).
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Figure 3 | Transcatheter closure of the ventricular septal defect. (a) Angiographic image before closure. 
(b, c) The VSD was crossed by a JR catheter (Cordis, Miami, Florda) and an arteriovenous loop was created by 
snaring a wire from the right jugular vein. (d) Sizing with a 25-mm PTS balloon, measuring a diameter of 16 
mm. (e) A long sheath was placed from the jugular vein through the VSD and a 20-mm Amplatzer post-myo-
cardial infarction VSD occluder was positioned under continuous echocardiographic control (arrowheads). (f) 
A check 30 min after release showed a stable position of the device. (g, h) Control echocardiography shows 
placement of the occluder with minimal residual flow (asterisk). 
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Discussion
Mostly seen after myocardial infarction, VSD associated with cardiac trauma are uncommon but 
not rare with an estimated incidence of 5% [4,5]. Echocardiography is a reliable non-invasive tool 
to establish the presence of such a VSD and therefore first choice for diagnosis [6]. The technique 
can be performed rapidly allowing the examiner to identify pericardial effusion, recognize septal 
defects, evaluate cardiac wall motion and examine valvular integrity. Alternatively, CT angiography, 
not limited by acoustic angles, allows a detailed morphological appreciation of the defect with 
depiction of other intrathoracal structures [7].
 The timing of closure remains a subject of debate and while spontaneous closure of traumatic 
VSDs has been reported on several occasions, patients are often symptomatic necessitating 
closure [8,9]. Because of extensive experience in adult congenital disease, surgical repair has been 
the benchmark for treating acquired VSDs.10 More recently, transcatheter techniques have been 
introduced as a less-invasive alternative [11-13]. Patients with increased surgical risk, multiple 
previous surgical interventions or poorly accessible defects for surgical closure are suitable 
candidates for transcatheter closure [1,14]. In this patient, we preferred the transcatheter approach 
over surgery because of the extensive comorbidity and favorable location, distant from any valve. In 
addition, a lower risk of necrosis sur-rounding the defect was expected compared to post-myocardial 
infarction VSDs.
 The most commonly described technique in transcatheter closure is the creation of an 
arteriovenous loop by retrograde approach from the aorta and exteriorization of a wire tip through 
the femoral or the jugular vein. A possible complication with this technique is injury to all structures 
that are in direct contact with the wire loop, including the aorta, ventricles, and valves. Other 
techniques are the trans-septal approach or crossing the defect from the right ventricular side 
without the need to exteriorize [15]. With interventional closure, continuous echocardiographic 
monitoring is recommended to visualize any remaining defects or damage to surrounding 
structures. The reported success rates are high in adult congenital VSDs (>90% closure); however, 
there is limited experience in traumatic VSDs [13,16]. Complications have been reported in 1–3% 
of the cases, including device embolization, rhythm and conduction abnormalities, haemolysis, 
valve injury, cardiac tamponade, and endocarditis [15]. This case illustrates that in selected patients 
transcatheter repair of a traumatic VSD can be successful and may be preferred over surgery as a 
less-invasive type of treatment.
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Abstract
Background: Although conventional (CAG) and computed tomography angiography (CTA) are 
reliable diagnostic modalities for exclusion of obstructive coronary artery disease (CAD), they are 
costly and with considerable exposure to radiation and contrast media. We compared the accuracy 
of coronary calcium scanning (CCS) and exercise electrocardiography (X-ECG) as less expensive and 
non-invasive means to rule out obstructive CAD.
Methods: In a rapid-access chest pain clinic, 791 consecutive patients with stable chest pain 
were planned to undergo X-ECG and dual-source CTA with CCS. According to the Duke pre-test 
probability of CAD patients were classiﬁed as low (<30%), intermediate (30–70%) or high risk (>70%). 
Angiographic obstructive CAD (>50% stenosis by CAG or CTA) was found in 210/791 (27%) patients, 
CAG overruling any CTA results. 
Results: Obstructive CAD was found in 12/281 (4%) patients with no coronary calcium and in 73/319 
(23%) with a normal X-ECG (p<0.001). No coronary calcium was associated with a substantially lower 
likelihood ratio compared to X-ECG; 0.11, 0.13 and 0.13 vs. 0.93, 0.55 and 0.46 in the low, intermediate 
and high risk group. In low risk patients a negative calcium score reduced the likelihood of obstructive 
CAD to less than 5%, removing the need for further diagnostic work-up. CCS could be performed in 
754/756 (100%) patients, while X-ECG was diagnostic in 448/756 (59%) patients (p<0.001).
Conclusions: In real-world patients with stable chest pain CCS is a reliable initial test to rule out 
obstructive CAD and can be performed in virtually all patients.
121First-line Evaluation of Coronary Artery Disease with Coronary Calcium Scanning or Exercise Electrocardiography | 
8
Introduction
Angina pectoris is a common and disabling condition that affects millions of people worldwide. 
The diagnostic evaluation and subsequent management of patients suspected of coronary artery 
disease (CAD) is aimed at reducing complaints and improving prognosis. Although invasive coronary 
angiography (CAG) remains the gold standard for the diagnosis of obstructive CAD, coronary 
computed tomography (CTA) has emerged as a reliable non-invasive alternative, with an excellent 
accuracy for ruling out obstructive CAD [1-4]. However increasing concern about the costs, radiation 
exposure and contrast agents involved with either angiographic modalities justiﬁes exploration of 
alternative approaches [5-8].
 Exercise electrocardiography (X-ECG) is a widely available, well-established and cost-effective 
means to assess ischemic heart disease, despite its limited diagnostic accuracy and substantial rate 
of inconclusive test results [9]. Alternatively, coronary calcium scanning (CCS) is inexpensive, fast, 
operator-independent, associated with a much lower radiation exposure and without need for 
contrast media [10,11]. In this study we compared the ability of CCS and X-ECG as an initial test to 
rule out obstructive CAD in a large group of patients with stable angina from a rapid-access chest 
pain clinic. According to pre-test probabilities of obstructive CAD patients were assigned to low, 
intermediate and high risk groups.
Methods
Study Population
From September 2006 to April 2010 we evaluated 791 consecutive patients with stable chest 
complaints and no history of CAD at our rapid-access chest pain clinic. Patients were planned to 
undergo both dual-source CTA and X-ECG, in addition to a clinical examination and blood analysis. 
Referral to CAG was clinically driven. Using the Duke Clinical Score (DCS), based on the type of chest 
discomfort, age, gender and cardiovascular risk factors, patients were classiﬁed as having a low 
(<30%), intermediate (30–70%) or high (>70%) pre-test probability of obstructive CAD [12]. Chest 
pain was classiﬁed using the three categories by Diamond: typical angina pectoris, atypical angina 
pectoris and non-anginal chest pain [13].
 Angiographic obstructive CAD was found in 210/791 (27%) patients, deﬁned as the presence of 
>50% stenosis in ≥1 coronary branches by CAG or CTA (CAG overruling any CTA result). Obstructive 
CAD was absent in 546/791 (69%) patients, deﬁned as none or >50% coronary stenosis by CAG 
(overruling any CTA result) or CTA.
 In total 27/791 (3%) patients, without sufﬁcient cause for invasive angiography, did not 
undergo CTA, because of renal failure, contrast allergy, patient preference, Parkinson disease, 
patient willingness to cooperate, failed venous access and severe obesity. Because of premature 
scan initiation or movement during scan 8 (1%) scans were considered non-diagnostic. The mean 
age in the study population was 56±10 years, with signiﬁcantly more elderly patients in higher 
risk groups. Males were at higher risk for obstructive CAD, although overall the gender was evenly 
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divided (369/756=49% female) (Table 1). There were fewer smokers, diabetics and patients with 
dyslipidemia in the low risk group. There were more patients with hypertension and a history of 
vascular disease in the high risk group. The study complied with the Declaration of Helsinki and the 
ethical committee at our institution approved the study. Informed consent was obtained from all 
patients.
Table 1 | Baseline characteristics.
Overall
(n=756)
Lowa
(n=284)
Intermediatea
(n=270)
Higha
(n=202)
p valueb
 
Age (years) 56±10 52±9 56±9 62±9 <0.001
Women 369 (49%) 220 (78%) 122 (45%) 27 (13%) <0.001
Nicotine abuse 198 (26%) 49 (17%) 91 (34%) 58 (29%) <0.001
Hypertension 404 (53%) 141 (50%) 139 (52%) 124 (61%) 0.04
Diabetes mellitus 129 (17%) 27 (10%) 49 (18%) 53 (26%) <0.001
Dyslipidemia 451 (60%) 125 (44%) 187 (69%) 139 (69%) <0.001
Family history of cardiovascular disease 357 (47%) 146 (51%) 138 (51%) 73 (36%) 0.001
History of vascular disease 83 (11%) 22 (8%) 27 (10%) 34 (17%) 0.04
Body-mass index 28±5 28±5 27±5 28±5 0.63
CCS performed 754 (100%) 284 (100%) 268 (99%) 202 (100%) 0.25
CTA performed 753 (100%) 284 (100%) 268 (99%) 201 (100%) 0.39
X-ECG performed 675 (89%) 259 (91%) 241 (89%) 175 (87%) 0.22
Inconclusive X-ECG 227 (30%) 72 (25%) 90 (33%) 65 (32%) 0.06
Catheter angiography 180 (24%) 24 (9%) 69 (26%) 87 (43%) <0.001
Revascularisation 112 (15%) 11 (4%) 32 (12%) 69 (34%) <0.001
PCI 87 (12%) 10 (4%) 26 (10%) 51 (25%) <0.001
CABG 25 (3%) 1 (<1%) 6 (2%) 18 (9%) <0.001
CCS = coronary calcium scanning, CTA = computed tomography angiography, X-ECG = exercise electrocardiography, PCI = percu-
taneous coronary intervention, CABG = coronary artery bypass graft surgery. a Duke clinical score: pre-test probability of significant 
CAD. Low: ≤30%; intermediate: 30–70%; high: >70%. b ANOVA or nonparametric test.
 
Non-enhanced Coronary Calcium Scan
The calcium scan was performed using an ECG-triggered sequential scan mode, with 120-kV tube 
voltage, 78±26-mAs tube current and 3-mm slice thickness. Quantiﬁcation was performed by the 
Agatston method with a standard 130-HU attenuation threshold. The absence of detectable calcium 
was considered as a negative CCS result. Patients with detectable coronary calcium were divided in 
two groups: moderate (1–400) and severe (>400 Agatston units) [14,15].
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Contrast-enhanced CT Angiography
Computed tomography angiography was performed in the absence of the following 
contraindications: pregnancy, renal dysfunction or known allergy to iodine contrast media.
 Image acquisition was conducted using a dual-source CT: Siemens Deﬁnition (Forchheim, 
Germany) from September 2006 to April 2009 and Siemens Flash from April 2009 to April 2010. 
Technical details regarding image acquisition are summarized in Table 2. Before the scan patients 
received a sublingual dose of nitroglycerine but no additional beta-blockers. Effective radiation doses 
for CCS and CTA were 0.8±0.2 mSv (range 0.4 to 1.6) and 8.5±3.4 mSv (range 0.5 to 17.8). Readers 
were blinded for patients’ symptoms or exercise test results. Data was sent to an ofﬂine workstation 
for image analysis. All coronary segments were evaluated on axial images, multiplanar reformations, 
and maximum intensity projections according to readers’ preferences. In a joint session, two readers 
evaluated the coronary anatomy, and vessels were qualitatively scored as normal, not signiﬁcantly 
stenosed (<50% stenosis) or signiﬁcantly stenosed (>50% stenosis).
Table 2 | Scan parameters.
64-slice DSCT a 128-slice DSCT b
Patients (n) 527 234
Conventional spiral mode (n) 527 35
Sequential mode (n) 0 169
High pitch spiral mode (n) 0 30
Collimation (mm) c 64 (32x2) 128 (64x2)
Gantry rotation time (ms) 0.33 0.28
Effective temporal resolution (ms) d 83 75
Pitch (conventional spiral mode) 0.2–0.53 0.2–3
Tube voltage (kV) 120 100–120
Tube current (ma) e 370–412 320–412
Scan parameters of patients undergone CTA (761/791) using dual source computed tomography (DSCT): Siemens Definitiona and 
Flashb, Forchheim, Germany; cby alternating focal spot (Z-sharp®), dusing a single-segmental reconstruction algorithm, edepending 
on patient size.
Exercise Electrocardiography
Bicycle X-ECG was performed by standardized protocol, with established criteria for performance 
and exercise discontinuation. Criteria for myocardial ischemia included horizontal or down sloping 
ST-segment depression or elevation ≥0.1 mV during or after exercise or typical, increasing angina 
during exercise. In case of established contra-indications patients did not perform an X-ECG [16]. 
A non-diagnostic result was deﬁned by discontinuation without evidence of myocardial ischemia 
before reaching 85% of the target heart rate.
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Coronary Angiography
Clinically indicated quantitative coronary angiography (QCA) was performed using standard 
techniques, with assessment of the most severe obstruction from ≥2 orthogonal projections using 
quantitative software (CAAS, Pie Medical, Maastricht, The Netherlands).
Statistical Analysis
Statistical analyses were performed using SPSS software (version 15.0, SPSS Inc, Chicago, Ill). 
Categorical variables are presented as proportions. Continuous variables are expressed as mean 
(±SD) or median (±IQR) as appropriate. All probability values refer to 2-tailed tests of signiﬁcance; 
a probability value <0.05 was considered signiﬁcant. Differences between groups were compared 
using 2-sided unpaired t test, chi-square test, or analysis of variance, as appropriate. Diagnostic 
performance parameters in terms of sensitivity and speciﬁcity were calculated with 95% conﬁdence 
intervals. Post-test probabilities were calculated for low, intermediate and high risk patients using 
likelihood ratios.
 Because of the known high number of not performed or inconclusive tests, we also analyzed 
X-ECG results using an intention-to-diagnose approach, considering inconclusive tests as positive 
tests.
 Additionally, we hypothesized that a calcium threshold slightly above the conventional zero 
calcium would reduce the false positive results without signiﬁcant sacriﬁce on the negative predictive 
value. A ROC analysis was performed to ﬁnd calcium scores optimally discriminating angiographic 
obstructive CAD in our study population.
Results
Coronary Calcium Scanning
In two patients CCS was not performed because of patient preference or severe obesity. There was 
no detectable coronary calcium in 281/756 (37%) patients, 152 (54%) in the low, 99 (37%) in the 
intermediate and 30 (15%) in the high risk group (Figure 1). Angiographic obstructive CAD was 
found in 10/281 (4%) patients with no calcium, 2/152 (1%) with low risk, 4/99 (4%) with intermediate 
risk and 4/30 (13%) with high risk. In comparison, these patients did not differ in age (55 vs. 56 
years, p=0.67), gender (30 vs. 49%, p=0.21), smoking (30 vs. 26% p=0.75), hypertension (50 vs. 54% 
p=0.82), dyslipidemia (60 vs. 59% p=0.94), family history (60 vs. 47% p=0.41) or BMI (27 vs. 28 p=0.66). 
However, none had a prior history of vascular disease or diabetes mellitus. A ROC analysis with 
consideration for pre-test probability of CAD revealed calcium thresholds of 2, 2.5 and 15 Agatston 
units in low, intermediate and high risk group, respectively, to optimally differentiate patients with 
or without obstructive CAD (Figure 2).
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Figure 1 | Distribution of groups with no detectable 
calcium, intermediate calcium scores and high cal-
cium scores considering pre-test probability of CAD.
Figure  2 | ROC-curve of coronary calcium scores 
predicting obstructive coronary disease considering 
pre-test probabilities.
Exercise Electrocardiography
In 81 (11%) patients X-ECG could not be performed because of inability to cycle, resting ECG 
abnormalities, pulmonary disease and combined or unspeciﬁed reasons. In 227 (30%) patients X-ECG 
did not yield a diagnostic result, mostly because the target heart rate was not reached. A normal 
X-ECG was found in 319/756 (42%) patients, 157 (49%) in the low, 109 (34%) in the intermediate and 
53 (17%) in the high risk group (Figure 3). A normal X-ECG was found in 55/319 (17%) patients with 
angiographic obstructive CAD, 15/157 (10%) with low risk, 17/109 (16%) with intermediate risk and 
23/53 (43%) with high risk.
Figure 3 | Distribution of exercise electrocardiography 
results considering pre-test probability of CAD.
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Coronary Angiography
Invasive coronary angiography was performed in 180 patients (24%), with subsequent need for 
coronary revascularization in 112 (15%) patients: 87 (12%) percutaneous coronary intervention, 25 
(3%) coronary bypass surgery.
Comparison of Diagnostic Performance
Overall CCS showed signiﬁcantly higher negative predictive value compared to X-ECG, 96% (95% CI 
93–98) vs. 83% (95% CI 78–87), regardless of pre-test probability of disease. In patients with low and 
intermediate risk we found excellent negative predictive values of 99% (95–100) and 96% (89–99), 
respectively (Table 3). No detectable calcium was associated with a likelihood ratio of 0.11 (0.03–0.4), 
0.13 (0.05–0.3) and 0.13 (0.05–0.3) in the low, intermediate and high risk group. A normal XECG 
was associated with a likelihood ratio of 0.93 (0.7–1.2), 0.55 (0.4–0.8) and 0.46 (0.3–0.6) in the low, 
intermediate and high risk group, respectively.
 By increasing the calcium threshold to 2, 2.5 and 15 Agatston units, respectively, based on the 
previous ROC analysis, the speciﬁcity of CCS increased from 60% (53–66), 47% (40–54) and 29% 
(20–39) to 68% (62–74), 52% (45–59) and 46% (36–57) in the low, intermediate and high risk group, 
respectively (Table 3). Excluding non-diagnostic results, X-ECG was signiﬁcantly more speciﬁc: overall 
82% (77–86) vs. 50% (45–54), regardless of pre-test probabilities. However, using an intention-to 
diagnose approach, assuming non-diagnostic tests to be positive, the speciﬁcity decreased to a 
value comparable to CCS.
Discussion
From our results we concluded that the absence of calcium rules out angiographic obstructive 
CAD reliably in real-world patients, particularly in those with low to intermediate risk of CAD, out-
performing X-ECG in this setting. No calcium was found in 281/756 (37%) patients and 319/756 
(42%) patients had a normal X-ECG result. Patients without detectable calcium were substantially 
less likely to have obstructive CAD (Figure 4) in comparison to a normal X-ECG result: 10 (4%) vs. 55 
(17%) (pb0.001).
Clinical Implications
Recently a large US registry reported on the low yield of obstructive coronary artery disease by 
invasive coronary angiography, recommending a more effective non-invasive diagnostic workup 
[17]. While CCS has been used for exclusion of CAD in asymptomatic and symptomatic individuals 
for the past decade [15,18], its capacity to rule out obstructive CAD was recently questioned in a 
paper assessing patients referred for invasive catheterisation [19]. According to the Bayes’ theorem 
test performance is inﬂuenced by the pre-test probability of the population. Patients selectively 
referred for catheterization generally have a higher likelihood of obstructive CAD compared to our 
outpatient cohort presenting with stable chest pain. Our results demonstrate that the negative 
predictive value of the calcium scan is excellent in subgroups with low disease prevalence. In line 
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with the observations by Gottlieb et al., the rate of patients with obstructive CAD and no detectable 
calcium gradually increases concomitantly with their pre-test probability.
Table 3 | Operating characteristics.
Sensitivity % (95% CI) Specificity % (95% CI) LR+ (95% CI) LR– (95% CI)
Overall        
 CCS (>0) 95 (91–98) 50 (45–54) 1.9 (1.7–2.1) 0.1 (0.05–0.2)
 Optimal CCS 94 (89–96) 58 (54–63) 2.3 (2.0–2.5) 0.1 (0.06–0.2)
 X-ECG 56 (47–65) 82 (77–86) 3.1 (2.4–4.1) 0.5 (0.4–0.7)
 X-ECG-itd 70 (63–76) 54 (49–58) 1.5 (1.3–1.7) 0.6 (0.5–0.7)
Low
 CCS (>0) 94 (78–99) 60 (53–66) 2.3 (1.9–2.8) 0.1 (0.03–0.4)
 Optimal CCS 94 (78–99) 68 (62–74) 2.9 (2.4–3.6) 0.1 (0.02–0.3)
 X-ECG 21 (7–46) 85 (78–89) 1.4 (0.5–3.5) 0.9 (0.7–1.2)
 X-ECG-itd 44 (26–64) 61 (55–67) 1.1 (0.7–1.8) 0.9 (0.6–1.3)
Intermediate
 CCS (>0) 94 (84–98) 47 (40–54) 1.8 (1.5–2.0) 0.1 (0.05–0.3)
 Optimal CCS 94 (84–98) 52 (45–59) 2.0 (1.7–2.3) 0.1 (0.02–0.3))
 X-ECG 55 (38–71) 81 (73–88) 3.0 (1.8–4.8) 0.5 (0.4–0.8)
 X-ECG-itd 73 (60–83) 51 (44–59) 1.5 (1.2–1.9) 0.5 (0.4–0.8)
High
 CCS (>0) 96 (90–99) 29 (20–39) 1.3 (1.2–1.5) 0.1 (0.05–0.3)
 Optimal CCS 94 (87–97) 46 (36–57) 1.7 (1.4–2.1) 0.1 (0.06–0.3)
 X-ECG 67 (54–77) 73 (57–85) 2.5 (1.5–4.2) 0.5 (0.3–0.6)
 X-ECG-itd 76 (65–84) 37 (27–49) 1.2 (1.0–1.5) 0.7 (0.4–1.0)
CCS = coronary calcium scanning, Optimal CCS = ROC-based calcium thresholds, X-ECG = exercise electrocardiography, X-ECG-itd 
= exercise electrocardiography with an intention-to-diagnose approach, LR+ = positive likelihood ratio, LR− = negative likelihood 
ratio.
In low risk patients (0–30%) a negative calcium score reduced the likelihood of obstructive CAD <5% 
(Figure 5), removing the need for further diagnostic work-up in a substantial proportion of patients 
(19%). For intermediate risk patients (30–70%) the likelihood decreased to 5–25%, reducing the need 
for further testing, particularly in those with a post-test probability of <10%. In high risk patients 
(N70%) neither CCS nor X-ECG excluded angiographic obstructive CAD, although a negative X-ECG 
may be more helpful to exclude hemodynamically relevant lesions and guide patient management.
 Furthermore, we found that a cut-off value above the conventional zero calcium score reduced 
false positive results without sacriﬁce on the high negative predictive value in patients with a low to 
intermediate probability.
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Figure 4 | 52 year old female with typical angina pectoris, positive family history and recent cessation of 
smoking. A, B: There was no detectable calcium on the non-enhanced CT-scan. CTA curved MPR and volume 
rendering show a non-obstructive, non calcified plaque in the mid left anterior descending (LAD) coronary ar-
tery. C: CAG revealed no significant obstructions. D: Optical Coherence Tomography (OCT) (Lightlab Imagewire®, 
Lightlab Imaging, Westford, MA, USA) confirmed the presence of a non-obstructive, non calcified plaque in 
the LAD. The eccentric intimal thickening is visible from 12–6 o’clock. The 3-layered appearance of the vessel 
is well visible: the inner endoluminal yellow, bright layer corresponds with the intima, the dark middle layer 
corresponds with the media and the outer, bright layer corresponds with the adventitia. E: X-ECG was borderline 
positive with slight ST-deviation of ±1 mm in V4-V6.
Limitations
Because not all patients had a clinical indication for invasive angiography, a composite diagnostic 
endpoint including CT angiography was used. Given the well-established diagnostic accuracy of 
CTA, especially its negative predictive value, performing invasive CAG in every patients would be 
unethical [20]. However, limiting the study to patients with QCA would have resulted in loss of the 
real-world character of this study. In this study we focused on reliability of CCS or X-ECG to rule 
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out CAD. We believe that using a composite endpoint of CTA next to invasive angiography does 
not jeopardize our conclusions. Nevertheless to anticipate overestimation of CTA we performed 
a sensitivity analysis using a composite diagnostic endpoint of >50% coronary stenosis by CAG 
(overruling any CTA result) and >50% left main or three-vessel disease or >70% one or two-vessel 
stenosis by CTA. By excluding patients with intermediate coronary stenosis on one or two vessels, 
we obtained no signiﬁcantly different diagnostic performances of CCS and X-ECG.
 There was no comparison of CCS to more advanced functional imaging tests, nor was the 
hemodynamic signiﬁcance of the coronary lesions routinely determined. Assessment of myocardial 
ischemia has prognostic consequences and is important for clinical decision making. The incremental 
value of stress testing applies mostly to those with angiographic coronary disease, and less to 
patients in whom CAD has been excluded (by CTA or QCA), which involves the majority of patients 
presenting in a chest pain clinic. Recent work from Esteves et al. demonstrated that the absence of 
coronary calcium also excludes ischemia on functional testing [21]. In addition, patients with no 
detectable calcium show slow progression of CAD over time [22].
 Nevertheless, clinical outcome studies are needed to evaluate the value of CCS as a tool for 
exclusion of obstructive CAD, in comparison to functional tests.
Figure  5 | Post test probability of obstructive 
coronary artery disease (CAD) considering pre-
test probability. Conventional CCS = coronary cal-
cium scanning regarding zero calcium as negative 
result, exercise electrocardiography, optimal CCS = 
coronary calcium scanning with ROC analysis based 
thresholds, XECG = exercise electrocardiography, 
XECG-itd = exercise electrocardiography with an 
intention-to-diagnose approach.
Conclusions 
Coronary calcium scanning is a reliable initial test in real-world patients with stable chest pain 
to rule out obstructive CAD and it can be performed in virtually all patients. In low risk patients 
without detectable coronary calcium further diagnostic work-up seems redundant as the post-
test probability of obstructive CAD is less than 5% for these patients. In the group of patient with 
intermediate risk of obstructive CAD the likelihood decreased to 5–25% after a negative CCS, 
reducing the need for further testing, particularly in those with a post-test probability of <10%. High 
risk patients do not seem to beneﬁt from neither CCS nor X-ECG to exclude angiographic obstructive 
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CAD, although a normal X-ECG may be more helpful to exclude hemodynamically relevant lesions 
and guide management.
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Abstract
At present, traditional risk factors are used to guide cardiovascular management of asymptomatic 
subjects. Intensiﬁed surveillence may be warranted in those identiﬁed as high risk of developing 
cardiovascular disease (CVD). This study aims to determine the prognostic value of coronary 
computed tomography (CT) angiography (CCTA) next to the coronary artery calcium score (CACS) 
in patients at high CVD risk without symptoms suspect for coronary artery disease (CAD). A total 
of 665 patients at high risk (mean age 56±9 years, 417 men), having at least one important CVD 
risk factor (diabetes mellitus, familial hypercholesterolemia, peripheral artery disease, or severe 
hypertension) or a calculated European systematic coronary risk evaluation of >10% were included 
from outpatient clinics at 2 academic centers. Follow-up was performed for the occurrence of 
adverse events including all-cause mortality, nonfatal myocardial infarction, unstable angina, or 
coronary revascularization. During a median follow-up of 3.0 (interquartile range 1.3 to 4.1) years, 
adverse events occurred in 40 subjects (6.0%). By multivariate analysis, adjusted for age, gender, 
and CACS, obstructive CAD on CCTA (≥50% luminal stenosis) was a signiﬁcant predictor of adverse 
events (hazard ratio 5.9 [CI 1.3 to 26.1]). Addition of CCTA to age, gender, plus CACS, increased the 
C statistic from 0.81 to 0.84 and resulted in a total net reclassiﬁcation index of 0.19 (p<0.01). In 
conclusion, CCTA has incremental prognostic value and risk reclassiﬁcation beneﬁt beyond CACS in 
patients without CAD symptoms but with high risk of developing CVD.
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Introduction
In the general population, the annual incidence of sudden cardiac death is estimated from 50 to 
100 cases per 100,000 adults, both in Europe and North America, accounting for approximately 50% 
of all cardiac deaths [1,2]. In at least half of these cases, sudden cardiac death is the ﬁrst and only 
manifestation of cardiovascular disease (CVD) in an otherwise asymptomatic individual [3]. Autopsy 
data show that >80% of these subjects had anatomically important, subclinical coronary artery 
disease (CAD) [4]. At present, traditional risk factors are used to guide cardiovascular management 
of asymptomatic subjects [5]. Patients without symptoms or signs of CAD, but with diabetes mellitus 
(DM), familial hyper-cholesterolemia (FH), peripheral artery disease (PAD), severe hypertension, or 
a calculated European systematic coronary risk evaluation of >10% are considered at high risk of 
developing a cardiovascular event. Therefore, optimal primary prevention is required including 
preventive pharmacologic treatment and screening for organ damage [6]. Studies have shown that 
the coronary artery calcium score (CACS) is useful for reﬁned risk stratiﬁcation in these patients at 
high risk, in particular, in those with DM [7,8]. It has been postulated that asymptomatic patients at 
high risk might beneﬁt from increased medical surveillance [9]. Coronary computed tomography 
(CT) angiography (CCTA) offers a more detailed assessment of subclinical CAD and could be of 
incremental prognostic value, as previously demonstrated in symptomatic patients [10-12]. The aim 
of this observational multicentre study was to determine whether CCTA improves risk prediction 
beyond CACS in patients without symptoms of CAD but at high risk of developing CVD. 
Methods
Eligible patients (aged between 45 and 70 years) were clinically referred to the outpatient clinics 
of 2 academic hospitals by general practitioners or other physicians for optimized cardiovascular 
management and primary prevention according to current guidelines [5]. For this observational 
study, we collected patients prospectively and retrospectively, who were considered at high risk 
of developing CVD, because of the presence of a markedly elevated single cardiovascular risk 
factor, such as DM, FH, PAD, severe hypertension, or a calculated European systematic coronary risk 
evaluation of >10% [5]. 
 Diabetes mellitus was defined as fasting glucose levels >7.0 mmol/L or >11.1 mmol/L 2 hours 
after an oral glucose tolerance test [13]. FH was deﬁned as the presence of a documented low-
density lipoprotein receptor mutation or a low-density lipoprotein cholesterol level above the 
gender and age corrected 95th percentile in combination with typical clinical characteristics in the 
patient or a ﬁrst-degree relative [14]. Severe hypertension was deﬁned as a systolic blood pressure 
level >160 mm Hg or a diastolic blood pressure >100 mm Hg [5]. PAD was deﬁned as a history of 
targeted surgical, percutaneous, or medical treatment of atherosclerosis in a noncoronary artery.
 All patients were receiving intense lifestyle counseling and/or medical therapy at baseline, and 
strict compliance was ensured by regular outpatient clinic visits. Exclusion criteria included a history 
of CAD, renal dysfunction (serum creatinine >120 mmol/L), contrast allergy, irregular heart rhythm, 
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severe chronic obstructive pulmonary disease, or known pregnancy. The study complies with the 
Declaration of Helsinki, and the study protocol was approved by the institutional review boards. 
A waiver was obtained for the use of retrospective data. A proportion of patients was enrolled 
prospectively and provided written informed consent.
 Image acquisition was performed on multidetector row CT scanners with 64 rows. Detection 
of coronary artery calcium was performed using an electrocardiogram-triggered axial scan and 
measured using the Agatston method [15]. Patients were stratiﬁed in groups according to the 
extent of coronary artery calciﬁcation: 0, 1 to 100, 101 to 400, and >400 CACS. CCTA was performed 
during a single inspiration using an electrocardiogram-triggered axial scan with X-ray tube current 
modulation and tube voltage reduction when clinically feasible. A 17-segment coronary artery tree 
model (as recommended by the American Heart Association) was used to describe the presence, 
extent, and severity of CAD [16]. In the case of severe movement or inappropriate contrast delivery, 
resulting in non-diagnostic image quality of >1 coronary artery or important proximal segments, the 
entire scan was considered non-diagnostic.
 Stenosis grade was visually classified either as <29%, 30–49%, 50–69%, ≥70% luminal narrowing 
or occluded (100%). We used commonly applied methods of measuring extent of CAD [17]. First, 
subjects were categorized in groups by most severe CAD lesion: ‘obstructive CAD’ (≥1 plaques 
with ≥50% luminal stenosis), ‘non-obstructive CAD’ (<49% luminal stenosis), or ‘absence of CAD’. 
Secondly, patients were classified by the number of coronary arteries with obstructive CAD, into 
‘3-vessel or left main obstructive CAD’, ‘2-vessel obstructive CAD’, ‘single-vessel obstructive CAD’, 
‘non-obstructive CAD’ or ‘absence of CAD’. In addition, to determine the overall coronary artery 
plaque burden a segment stenosis score was calculated: <29% stenosis: score 0; 30–49%: score 
1; 50–69%: score 2; ≥70%: score 3. Finally, the number of segments with CAD ≥30% stenosis was 
determined.
 The primary outcome measure was a combination of adverse events including all-cause 
mortality, nonfatal myocardial infarction (MI), unstable angina, or coronary revascularization beyond 
90 days after the index CCTA. All-cause mortality was conﬁrmed using the Dutch National Mortality 
Registry. Information regarding clinical events was acquired through questionnaires, outpatient 
visits, or electronic patient records. Nonfatal MI and unstable angina were deﬁned according to 
current guidelines [18].
 Statistical analyses were performed using SPSS software (SPSS Inc, Chicago, Illinois) and SAS 
software (SAS Institute, Cary, North Carolina). Categorical variables are presented as proportions and 
continuous variables are expressed as mean (SD) or median (interquartile range), as appropriate. 
The cumulative incidence of adverse events over time was estimated according to the Kaplan-Meier 
method, whereas the log-rank test was applied to evaluate differences. Univariate Cox regression 
analysis was applied to assess associations between clinical characteristics or imaging results 
and incidence of adverse events. Cox regression models including CACS and CCTA, adjusted for 
age and gender, were used to determine adjusted hazard ratios with 95% CIs. Improvement in 
discriminative model performance and reclassiﬁcation was assessed by calculating C statistics and 
net reclassiﬁcation index (NRI) at 2.5 years. NRI is a measure of correctly reclassiﬁed patients penalized 
for those incorrectly classiﬁed [19]. Because no validated risk score is available to determine baseline 
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risk in this population, required for the calculation of NRI, we used a binary regression model with 
age and gender to substratify patients to low (<1%), intermediate (1% to 5%), or high baseline 
risk (>5%). Subsequently, CACS and CCTA information was added to calculate NRI. In addition, we 
examined the association between CCTA ﬁndings and incidence of adverse events in patients with 
zero, intermediate, and high CACS. All probability values refer to 2-tailed tests of signiﬁcance and a 
p value <0.05 was considered signiﬁcant.
Results
A total of 665 subjects were included between September 2006 and March 2013. The mean age was 
56±9 years and 417 (63%) were male (Table 1). Most patients received medical therapy, and statins 
(492 [74%] patients) were the most frequently prescribed medication. No coronary artery calcium 
was detected in 174 (27%) patients, while 127 (19%) patients had an Agatston score >400. On CCTA, 
126 (19%) patients had no detectable CAD, 337 (51%) had non-obstructive CAD and obstructive 
CAD was noted in 192 (29%) patients. We observed CAD on CCTA in 66 (38%) patients with zero 
CACS (Figure 1). The median radiation dose of the calcium scan was 1.0 [IQR 0.7–1.4] mSv and 5.3 
[3.4–8.4] mSv for CCTA using a conversion factor (k) of 0.014.
 Follow-up was obtained for 620 (95%) patients with an interpretable scan during a median 
follow-up period of 3.0 (1.3–4.1) years. All-cause mortality was checked for all patients. The composite 
outcome occurred in 40 (6.0%) patients with an estimated annual incidence of 2.0% after a median 
period of 3 years. All-cause mortality was recorded in 9, non-fatal MI in 3, unstable angina in 3 and 
late coronary revascularisation in 25 individuals. The annual incidence of adverse events in patients 
with zero CACS (0.4% [CI 0.1–1.3%]) was significantly lower compared to patients with CACS >400 
(6.8% [CI 4.8–9.4%]) (Figure 2). Patients with obstructive CAD on CCTA (6.0% [CI 4.4–8.0%]) had a 
significantly higher incidence of adverse events compared to patients without (0.5% [CI 0.2 – 1.9%]) 
or non-obstructive CAD (0.5% [CI 0.2–1.2%]) (Figure 3). 
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Table 1 | Patient baseline characteristics.
Variable All patients 
(n=665)
Age, mean ± SD 56±9
Men 417 (63%)
Cardiovascular risk factors 
Smoker 150 (23%)
Blood pressure >130/80 mmHg 333 (50%)
Dyslipidemia* 423 (64%)
Diabetes mellitus 378 (57%)
Positive family history of CAD 295 (44%)
Body Mass Index >30 kg/m2 173 (26%)
Medication 
Statin 492 (74%)
Oral antidiabetics 236 (35%)
Insulin 207 (31%)
ACE inhibitor 169 (25%)
Aspirin 162 (24%)
Beta-blocker 151 (23%)
AR-blocker 129 (19%)
Calcium channel blocker 78 (12%)
Coronary artery calcium score
0 174 (27%)
1-100 239 (37%)
100-400 115 (18%)
>400 127 (19%)
Coronary Computed Tomography Angiography
No Coronary Artery Disease 126 (19%)
Non-obstructive Coronary Artery Disease 337 (51%)
Obstructive Coronary Artery Disease (≥50% diameter stenosis) 192 (29%)
1 103 (15%)
2 59 (9%)
3 or left main disease 30 (5%)
Segment stenosis score, median (IQR) 6 (2–12)
Segment involvement score, median (IQR) 4 (1–7)
CT data were not available in 10 patients. * Dyslipidemia was defined as either known familial hypercholesterolemia, on statin treat-
ment or measured serum LDL-C levels >190 mg/dL. AR = angiotensin receptor.
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Figure 1 | Distribution of coronary artery disease 
(CAD) detected by coronary CT angiography 
across different coronary artery calcium score 
(CACS) groups. Non-obs CAD = non-obstructive 
coronary artery disease (1-49% luminal stenosis) 
in ≥1coronary vessels. 1vd = presence of 1-vessel 
obstructive (≥50% luminal stenosis) disease. 2vd 
= presence of 2-vessel obstructive disease. 3vd 
= presence of 3-vessel obstructive disease. LM = 
presence of left main obstructive disease. 
Figure 2 | Unadjusted survival for different 
coronary artery calcium score (CACS) groups. 
Log-rank p<0.001 for any difference.
Univariable Cox regression analysis identified age, male gender, and DM as significant predictors 
of the composite outcome (Table 2). There was a positive correlation between the occurrence of 
adverse events and CACS. Also, patients with obstructive CAD on CCTA had a higher incidence of 
adverse events compared to patients without obstructive CAD. The semi-quantitative measures of 
plaque burden, segment stenosis score or number of segments with CAD were significant predictors 
of adverse events. In multivariable Cox regression analysis, accounting for age, gender and CACS, 
obstructive CAD on CCTA remained a significant predictor of adverse events (Figure 4). 
 Most adverse events, that is, 32 (8.5%) in 378 patients, was observed in patients with DM, where 
the incidence of CAD detected with CCTA was also higher compared with patients without diabetes 
(Supplementary Material). The prognostic performance of both CCTA and CACS in these patients 
was equally well compared to the total study population.
 The addition of CACS to a model with age and gender increased the C statistic to 0.81; subsequent 
addition of obstructive CAD increased the C statistic to 0.84 (Table 3). With the addition of CACS, we 
observed an NRI of 0.35 (p<0.01). There was an additional reclassiﬁcation observed with the addition 
of CCTA to age, gender plus CACS with an NRI of 0.19 (p<0.01).
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Table 2 | Univariable Cox regression analysis.
Variable Hazard ratio 
(95% Confidence Interval)
p value
Age, per year 1.05 (1.01–1.09) 0.01
Man 2.83 (1.25–6.40) 0.01
Cardiovascular risk factors 
Smoker 1.84 (0.95–3.59) 0.07
Blood pressure >130/80 mmHg 1.80 (0.95–3.43) 0.07
Dyslipidemia* 0.83 (0.43–1.57) 0.56
Diabetes mellitus 4.49 (2.05–9.81) <0.001
Positive family history of CAD 0.77 (0.41–1.44) 0.41
Body Mass Index >30 kg/m2 1.18 (0.59–2.36) 0.65
Coronary artery calcium score 
0
1-100
101-400
>400
Reference
1.84 (0.36–9.50)
5.55 (1.18–26.17)
17.56 (4.16–74.20)
NA
0.47
0.03
<0.001
Coronary Computed Tomography Angiography 
No Coronary Artery Disease Reference NA
Non-obstructive Coronary Artery Disease 0.87 (0.17–4.46) 0.86
Obstructive Coronary Artery Disease (≥50% diameter stenosis) 11.23 (2.69–46.80) 0.001
Number of coronary arteries with ≥50% diameter stenosis 
None Reference NA
1 5.09 (1.10–23.65) 0.04
2 14.54 (3.25–65.06) <0.001
3 26.12 (5.82–117.22) <0.001
Segment stenosis score (per point) 1.13 (1.09–1.18) <0.001
Segment involvement score (per point) 1.21 (1.13–1.30) <0.001
* Dyslipidemia was defined as either known familial hypercholesterolemia, on statin treatment or measured serum LDL-C levels 
>190 mg/dL.
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Figure 3 | Unadjusted survival for obstructive coro-
nary artery disease (≥50% luminal stenosis) versus 
none and non-obstructive coronary artery disease 
on coronary CT angiography (CCTA). Log-rank 
p<0.001 for any difference.
Figure 4 | Risk-adjusted survival for obstructive coro-
nary artery disease (≥50% luminal stenosis) versus 
none and non-obstructive coronary artery disease, 
corrected for age, gender and coronary artery calcium 
scores. CCTA = coronary CT angiography. CI = Confi-
dence interval.
Table 3 | Model discriminative performance and reclassification index. 
Model C Statistic
(95% Confidence 
Interval)
Total NRI Proportion of 
non- events correctly 
reclassified
Proportion of events 
correctly reclassified
Model I: Age and gender
Model II: Model I + CACS
Model III: Model II + CCTA
0.66 (0.58–0.75)
0.81 (0.74–0.87)
0.84 (0.78–0.90)
0.35* 
0.19*
0.32*
0.16*
0.02
0.02 
CACS = Coronary artery calcium score. CCTA = Coronary computed tomography angiography, classified as either presence or ab-
sence of obstructive coronary artery disease (≥50% luminal stenosis). NRI = Net Reclassification Index. * = (p<0.01)
There were 2 patients (1%) with zero CACS who had an adverse event during follow-up. In 1 patient, 
who was free from any CAD on CCTA as well, the cause of death was unknown; the other patient, 
with a <29% stenosis on CCTA, underwent late coronary revascularization (Table 4). Obstructive CAD 
in the absence of coronary artery calcium was rare (3%), and none of these patients experienced an 
adverse event. In patients with CACS 1 to 100, the event rate was higher in those with obstructive 
CAD compared with those with non-obstructive CAD. In contrast, in patients with CACS 100 to 400, 
there were no differences in event rates between obstructive or non-obstructive CAD. Finally, in 
patients with CACS >400, none with non-obstructive CAD had an adverse event as opposed to 25 
patients with obstructive CAD (p=0.002).
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Table 4 | Distribution of adverse events across different coronary artery calcium score groups in relation to 
the presence of non-obstructive or obstructive coronary artery disease on coronary computed tomography 
angiography.
Coronary Computed Tomography Angiography Coronary artery calcium score
0 1–100 100–400 >400
Non-obstructive Coronary Artery Disease Adverse event- 156 (96%) 193 (87%) 56 (50%) 26 (21%)
Adverse event+ 2 (1%) 1 (0.5%) 4 (4%) 0
Obstructive Coronary Artery Disease 
(≥50% diameter stenosis)
Adverse event- 5 (3%) 24 (11%) 47 (42%) 73 (59%)
Adverse event+ 0 4 (2%) 4 (4%) 25 (20%)
Discussion
The main ﬁndings of this observational multicenter CT imaging study of patients at high risk for 
developing CVD, but without CAD symptoms, can be summarized as follows. First, the incidence of 
adverse events during a median follow-up period of 3 years was low, annually 2.0%. Second, both 
CACS and CCTA independently predicted adverse events. Third, CCTA had incremental prognostic 
value over baseline clinical risk factors and CACS as demonstrated by an improved risk reclassiﬁcation, 
mainly through correctly shifting patients without any CAD from the substratiﬁed high-risk group to 
a lower risk group. Finally, patients with zero CACS were found to have an excellent prognosis, and 
these patients may not require further imaging with CCTA, whereas in patients with a positive CACS, 
CCTA is useful to discriminate patients who are likely to experience an adverse event.
 The prognostic value of CACS has been clearly demonstrated in large prospectively enrolled, 
unselected asymptomatic cohorts [20-22], where increasing CACS were associated with increasing 
incidence of all-cause mortality. Current guidelines consider CACS an acceptable option (class IIa) 
for primary screening of patients at intermediate risk [5]. Although CACS is a good reﬂection of the 
extent of CAD, it does not equate with the evaluation of CAD by CCTA, which provides more detailed 
information about atherosclerotic plaque and stenosis severity. In our study, CCTA identiﬁed CAD in 
38% of patients with zero CACS.
 The question whether CCTA has incremental value next to CACS in asymptomatic subjects 
was addressed in the Coronary CT Angiography Evaluation For Clinical Out-comes International 
Multicenter (CONFIRM) registry, including a mix of 7,590 subjects at low to high-risk without CAD 
symptoms who were followed for a median period of 24 months [23]. This study demonstrated that 
both CACS and CCTA were predictors of all-cause mortality and a composite end point of all-cause 
mortality and nonfatal MI. However, CCTA did not improve risk stratiﬁcation beyond CACS. The 
CONFIRM registry then presented results from a subanalysis, focusing on 400 asymptomatic patients 
with diabetes only, where addition of CCTA did have incremental value next to CACS, improving 
the C statistic of a model with age, gender, and CACS from 0.64 to 0.77 [24]. Likewise, when 3,217 
asymptomatic patients from the same registry were stratiﬁed according to the magnitude of their 
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CACS, CCTA did provide incremental value in patients with a CACS >100 [25]. In line with these 
observations, our study demonstrates that CCTA has additional risk reclassiﬁcation beneﬁt next to 
CACS in a prespeciﬁed high-risk population.
 In the present study, we enrolled a prespeciﬁed high-risk population, where CAD was found 
to have a high prevalence (81% of patients with any CAD on CCTA). However, we encountered 
an unexpectedly low rate of adverse events. Although speculative, the low incidence of adverse 
events may be the consequence of a stringent primary prevention program, including intensive 
pharmacologic therapy. This low event rate is in line with other large scale follow-up studies [20-22]. 
The rate of cardiac death or nonfatal MI in subjects studied to assess the predictive value of CACS 
including the Multi-Ethnic Study of Atherosclerosis, Heinz Nixdorf Recall, and the Rotterdam studies 
ranged from 0.4% to 0.7% per year. The annual rate of cardiac death or nonfatal MI in the Detection 
of Ischemia in Asymptomatic Diabetics study was 0.6%. This study included 1,123 asymptomatic 
patients with DM with a follow-up of 4.8 years [26]. In the previously mentioned CONFIRM registry, 
all-cause mortality was 1.2% per year in 7,590 patients without CAD symptoms [23]. This reported 
low incidence of adverse events makes it difﬁcult to accurately establish the predictive value of 
clinical scores, biomarkers, or imaging techniques. In the randomized, multicenter Screening For 
Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using 
CT Angiography Following Core 64 (FACTOR-64) trial, investigators aimed to assess whether 
incorporation of CCTA ﬁndings into management of asymptomatic patients at high risk would 
improve patient outcome. This study included 900 asymptomatic patients with diabetes, who were 
followed for a mean follow-up time of 4 years and showed that CCTA-guided management was 
not better than standard care intervention in terms of pre-venting mortality, MI, or unstable angina 
requiring hospitalization [27]. The investigators of the FACTOR-64 trial stated that the rate of adverse 
events was also unexpectedly low, which may have obscured a potential beneﬁt of CCTA.
 CCTA has relevant drawbacks that must be taken into account. In our study, CCTA was associated 
with a ﬁvefold higher radiation dose compared with CACS. Using contemporary CT technology and 
radiation hygienic Coronary Artery Disease/Primary Screening with Cardiac CT 5 protocols, the CCTA 
dose can be reduced to <1 mSv in selected patients, whereas with the most recent technology this 
may be even as low as 0.21 mSv [28]. However, the need for iodinated contrast medium remains and 
the impact of incidental ﬁndings on downstream testing should not be overlooked.
 The main purpose of our study was to examine whether CCTA has incremental value next to 
CACS to justify its use in screening a high-risk asymptomatic population. However, patients with 
zero CACS are known to be have an excellent prognosis [29], and another approach would be to 
exclude them from further imaging with CCTA, thereby obviating the additional exposure with 
ionizing radiation and the use of iodinated contrast medium in a substantial number of patients. 
Also in our study, zero CACS is associated with an excellent prognosis and addition of CCTA was 
not helpful in this particular group. This is in contrast to the group of patients with CACS 1 to 100, 
where CCTA could discriminate between patients who experienced adverse events. Patients with 
high CACS (>400) experienced the highest incidence of adverse events and those with additional 
obstructive CAD on CCTA had the worst prognosis. Therefore, in patients with a positive CACS, CCTA 
is useful to discriminate patients who are likely to experience an adverse event.
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Several limitations of the present study deserve attention. First, the rather low adverse event rate 
requires caution to the interpretation of the predictive power of CCTA. Larger study populations 
and/or longer follow-up times, expecting to yield higher incidences of adverse events, should 
provide more robust outcomes. The incorporation of late coronary revascularization in addition 
to all-cause mortality and nonfatal MI may be a limitation as late revascularization is a less hard 
outcome. However, by incorporating late coronary revascularization as part of our composite 
outcome, we attempted to investigate whether CCTA ﬁndings are associated with CAD that is prone 
to progress, causing symptoms and eventually the need for coronary revascularization. Also, late 
coronary revascularization was incorporated into our composite outcome, as is it is often included 
as an outcome of other comparable imaging studies focused on prognosis.
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Supplementary Files
Table 1 | Supplemental material. Baseline characteristics of patients with diabetes mellitus.
Variable Diabetes Mellitus 
(n=378)
Age, mean±SD 56±9
Men 221 (59%)
Cardiovascular risk factors
Smoker 84 (22%)
Blood pressure >130/80 mmHg 225 (60%)
Dyslipidemia* 224 (59%)
Positive family history of CAD 137 (36%)
Body Mass Index >30 kg/m2 129 (34%)
Coronary artery calcium score
0 101 (27%)
1-100 130 (34%)
100-400 66 (18%)
>400 79 (21%)
Coronary Computed Tomography Angiography 
No Coronary Artery Disease 86 (23%)
Non-obstructive Coronary Artery Disease 168 (44%)
Obstructive Coronary Artery Disease (≥50% diameter stenosis) 124 (33%)
Number of coronary arteries with ≥50% diameter stenosis
1 62 (16%)
2 36 (10%)
3 or left main disease 26 (7%)
Segment stenosis score, median (IQR) 6 (2–11)
Segment involvement score, median (IQR) 4 (1–7)
SD = Standard deviation, IQR = interquartile range. * Dyslipidemia was defined as either known familial hypercholesterolemia, on 
statin treatment or measured serum LDL-C levels >190 mg/dL.
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Table 2 | Supplemental material. Univariable and multivariable Cox regression analysis in patients with 
diabetes mellitus.
Variable  Univariable  Multivariable
Hazard ratio 
(95% CI)
p value Hazard ratio 
(95% CI)
p value
Age, per year 1.05 (1.00–1.09) 0.04
Man 3.30 (1.35–8.04) 0.01
Cardiovascular risk factors
Smoker 2.40 (1.15–5.00) 0.02
Blood pressure >130/80 mmHg 1.28 (0.62–2.68) 0.51
Dyslipidemia* 0.99 (0.48–2.04) 0.98
Positive family history of CAD 0.85 (0.41–1.75) 0.66
Body Mass Index >30 kg/m2 0.75 (0.35–1.63) 0.47
Coronary artery calcium score
0
1-100
101-400
>400
Reference
3.86 (0.45–33.14)
10.67 (1.31–86.96)
27.34 (3.65–205.03)
NA
0.22
0.03
0.001
Coronary Computed Tomography Angiography 
No Coronary Artery Disease Reference NA Reference NA
Non-obstructive Coronary Artery Disease 2.01 (0.23–18.03) 0.53 0.95 (0.78–11.72) 0.97
Obstructive Coronary Artery Disease 
(≥50% diameter stenosis)
22.07 (2.98–162.83) 0.002 9.46 (0.86–104.23) 0.07
Number of coronary arteries with ≥50% diameter 
stenosis 
None Reference NA Reference NA
1 8.64 (2.89–25.86) <0.001 6.74 (2.16–21.03) 0.001
2 19.79 (6.67–58.72) <0.001 14.74 (4.72–46.01) <0.001
3 or left main disease 16.01 (5.17–50.11) <0.001 11.95 (3.65–3916) <0.001
Segment stenosis score (per point) 1.14 (1.09–1.19) <0.001 1.13 (1.07–1.18) <0.001
Segment involvement score (per point) 1.28 (1.13–1.33) <0.001 1.19 (1.09–1.30) <0.001
* Dyslipidemia was defined as either known familial hypercholesterolemia, on statin treatment or measured serum LDL-C levels 
>190 mg/dL.
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Abstract
Purpose: To determine and compare the prognostic value of cardiac computed tomographic (CT) 
angiography, coronary calcium scoring, and exercise electrocardiography (ECG) in patients with 
chest pain who are suspected of having coronary artery disease (CAD).
Materials and Methods: This study complied with the Declaration of Helsinki, and the local ethics 
committee approved the study. Patients (n=471) without known CAD underwent exercise ECG 
and dual-source CT at a rapid assessment outpatient chest pain clinic. Coronary calciﬁcation and 
the presence of 50% or greater coronary stenosis (in one or more vessels) were assessed with CT. 
Exercise ECG results were classiﬁed as normal, ischemic, or non-diagnostic. The primary outcome 
was a major adverse cardiac event (MACE), deﬁned as cardiac death, nonfatal myocardial infarction, 
or unstable angina requiring hospitalization and revascularization beyond 6 months. Univariable 
and multivariable Cox regression analysis was used to determine the prognostic values, while 
clinical impact was assessed with the net reclassiﬁcation improvement metric.
Results: Follow-up was completed for 424 (90%) patients; the mean duration of follow-up was 2.6 
years. A total of 44 MACEs occurred in 30 patients. Four of the MACEs were cardiac deaths and six 
were nonfatal myocardial infarctions. The presence of coronary calciﬁcation (hazard ratio [HR], 8.22 
[95% conﬁdence interval {CI}: 1.96, 34.51]), obstructive CAD (HR, 6.22 [95% CI: 2.77, 13.99]), and non-
diagnostic stress test results (HR, 3.00 [95% CI: 1.26, 7.14]) were univariable predictors of MACEs. In 
the multivariable model , CT angiography ﬁndings (HR, 5.0 [95% CI: 1.7, 14.5]) and non-diagnostic 
exercise ECG results (HR, 2.9 [95% CI: 1.2, 7.0]) remained independent predictors of MACEs. CT 
angiography ﬁndings showed incremental value beyond clinical predictors and stress testing 
(global χ2, 37.7 vs 13.7; p<.001), whereas coronary calcium scores did not have further incremental 
value (global χ2 , 38.2 vs 37.7; p=.40).
Conclusion: CT angiography ﬁndings are a strong predictor of future adverse events, showing 
incremental value over clinical predictors, stress testing, and coronary calcium scores.
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Introduction
Over the past decade, cardiac computed tomographic (CT) angiography has emerged as a valuable 
diagnostic tool to evaluate coronary artery disease (CAD) and has found use as an anatomic alternative 
to functional testing and a noninvasive alternative to conventional (catheter-based) coronary 
angiography [1,2]. Functional assessment of CAD severity with exercise electrocardiography (ECG) 
is well established, and its prognostic value has been studied extensively [3,4]. Although evidence 
regarding the prognostic value of CT angiography ﬁndings is emerging [5-7], the question remains 
if this angiographic modality holds incremental prognostic value beyond functional evaluation 
with exercise ECG. In this study, in a prospectively enrolled population, we sought to determine 
and compare the prognostic value of cardiac CT angiography, coronary calcium scoring (CCS), and 
exercise ECG in patients with chest pain who were suspected of having CAD.
Materials and Methods
From September 2006 to December 2008, 471 consecutive patients without a history of CAD were 
evaluated at our rapid assessment outpatient chest pain clinic (mean age, 56 years ± 10 [standard 
deviation]; age range, 18–84 years; 244 men) [8]. They had been referred by their general practitioner 
because of chronic complaints of chest pain potentially caused by CAD to undergo additional 
testing with exercise ECG, CT angiography, and CCS. Information on risk factors was prospectively 
acquired, and clinical risk estimators – that is, the Systematic Coronary Risk Evaluation (SCORE) 
[9] and Diamond and Forrester metrics [10] – were calculated from these data. According to the 
SCORE, 291 patients had a 10-year risk of less than 5% of developing fatal cardiovascular disease, 130 
patients had a risk of 5%–10%, and 50 patients had a risk of greater than 10%.
 The study complied with the Declaration of Helsinki, and the local ethics committee approved 
the study.
CCS Protocol
Calcium detection was performed with an ECG-triggered step-and-shoot acquisition mode, 
by using a 120-kV tube voltage, a mean tube current of 78 mAs ± 26, and a section thickness of 
3 mm. The coronary calcium score was assessed by using dedicated software (Syngo CaScore; 
Siemens, Forchheim, Germany) and was quantiﬁed with the Agatston method with a standard 
130-HU attenuation threshold [11]. To account for the skewed distribution, all calcium scores were 
transformed by taking the natural logarithm of the calcium score +1.
CT Angiographic Parameters
Contrast material-enhanced dual-source multisection CT (Deﬁnition; Siemens) was performed by 
using the following parameters: number of detector rows, 32; section thickness, 0.6 mm; 64-channel 
acquisition by z-axis focal spot alternation; rotation time, 330 msec; temporal resolution, 83 msec; 
spiral acquisition mode with prospectively ECG-triggered tube modulation depending on the heart 
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rate regularity; tube volt-age, 120 kV; tube current, 380–412 mAs depending on patient size; and 
variable pitch depending on the heart rate. Iopromide 70–100 mL (Ultravist, 370 milligrams of iodine 
per milliliter; Schering, Berlin, Germany), followed by a 40-mL saline bolus chaser, was peripherally 
injected at 5.0–5.5 mL/sec. Patients received sublingual nitroglycerin before the examination but 
no additional β-blockers. Effective radiation doses for CCS and CT angiography were 0.8 mSv ± 0.2 
(range, 0.4–1.6 mSv) and 11.0 mSv ± 3.5 (range, 4.7–17.8 mSv), respectively.
 The coronary arteries were evaluated on axial images, multiplanar reconstructions, and 
maximum intensity projections according to readers’ preferences. Readers (including A.M., with 
5 years of experience), who were assisted by research fellows with a minimum of 1 year of experience 
in coronary imaging, were blinded to patients’ symptoms and exercise ECG results. Vessels were 
qualitatively scored as signiﬁcantly stenosed (≥50% diameter narrowing) or less than signiﬁcantly 
stenosed (<50%) or free from plaque. To assess the prognostic value of CT angiography, we 
constructed a model comparing obstructive plaque to non-obstructive plaque. In a second model, 
we assessed the prognostic value of obstructive and non-obstructive plaque versus no plaque.
Exercise ECG
Patients underwent stress testing on a bicycle ergometer by using a standardized protocol. Use 
of any β-blockers was ceased 72 hours before stress testing, if possible. During continuous ECG 
registration and 12-lead printing at 1-minute intervals, the workload was increased from 40 W in 
20-W increments at 1-minute intervals. Blood pressure was measured every 2 minutes. In cases of 
established contraindications, patients did not undergo exercise ECG [12]. Criteria for myocardial 
ischemia included horizontal or downsloping ST-segment depression or elevation of 0.1 mV or 
greater during or after exercise or typical, increasing angina during exercise. A non-diagnostic test 
was deﬁned as when there was an inability to perform the test or the test was discontinued without 
evidence of myocardial ischemia before reaching 85% of the predicted maximum heart rate [12]. 
Additionally, for every patient, we approximated the Duke Treadmill Score by using a standardized 
formula as follows: DE − (5 · STD) − (4 · TAI), where DE is duration of exercise in minutes, STD is 
maximum net ST-segment deviation during or after exercise in millimeters, and TAI is treadmill 
angina index (where a score of 0 = no complaints, a score of 1 = non-limiting angina, and a score of 
2 = angina requiring discontinuation) [3].
Follow-up
Follow-up data were obtained by consulting the national death registry for the occurrence of 
mortality and through standardized telephone interviews, questionnaires, or hospital visits. All events 
were conﬁrmed with death records, hospital records, or correspondence with treating physicians 
and hospitals. If patients experienced multiple events during follow-up, only the ﬁrst event counted. 
Patients lost to follow-up were censored. All events were reviewed by an independent cardiologist 
(K.N., with 3 years of post-residency experience as a Cardiology Department staff member) who was 
blinded to both CT angiography and exercise ECG results. 
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Outcome Measures
The primary outcome measure was a composite of cardiac death, nonfatal myocardial infarction, 
unstable angina requiring hospitalization, and coronary revascularization (percutaneous coronary 
intervention or coronary artery bypass graft surgery). Cardiac death was deﬁned as death caused 
by acute myocardial infarction, ventricular arrhythmia, refractory heart failure, or cardiogenic shock. 
Nonfatal myocardial infarction was deﬁned as ischemia resulting in abnormal cardiac biomarkers 
(>99th percentile of the upper limits of normal). Unstable angina was deﬁned as chest pain with 
altered frequency or character that was suspicious for acute coronary syndrome; a diagnosis of 
unstable angina also required ischemic ECG changes or signiﬁcantly obstructive CAD at invasive 
conventional angiography [13]. Coronary revascularizations initiated as a result of the initial 
diagnostic work-up and performed within 6 months were not considered as an end point.
Statistical Analysis
Statistical analyses were performed by using SPSS (version 15.0; SPSS, Chicago, Ill) and STATA (version 
11.1; Stata, College Station, Tex). All probability values refer to two-tailed tests of signiﬁcance; p<.05 
was considered to indicate a signiﬁcant difference. Categoric variables are presented as proportions. 
Continuous variables are expressed as means±standard deviations or as medians±interquartile 
ranges (IQRs) as appropriate. Clinical patient characteristics are summarized by the SCORE 10-year 
cardiovascular mortality risk [9].
 Univariable Cox regression analyses of each potential clinical predictor, as well as coronary 
calciﬁcation, CT angiography results, and exercise ECG results, were performed to evaluate their 
effect in predicting major adverse cardiac events (MACEs) during follow-up.
 Cumulative event rates as a function over time were estimated according to the Kaplan-Meier 
method. Unadjusted comparison of survival between groups deﬁned by the two CT angiography 
results, coronary calcium categories, and exercise ECG results was performed by using the log-rank 
test. Annual event rates were calculated by dividing the cumulative event rates by the median 
number of follow-up years.
 A multivariable Cox proportional hazards model was used to assess the independent prognostic 
value of exercise ECG, CT angiography, and CCS. Risk adjustment for clinical characteristics was 
performed by using patients’ SCORE results. To assess the incremental value of exercise ECG, CT 
angiography, and CCS, the global χ2 values were compared between models with and those without 
the addition of each incrementally. Using logistic regression, receiver operating characteristic curves 
with estimates of the area under the receiver operating characteristic curve (AUC, or the C-statistic) 
were obtained to compare the discriminative performance of the different models.
 To quantify the clinical impact of adding exercise ECG, CT angiography, and CCS to the model 
predicting MACE, we calculated the net reclassiﬁcation improvement (NRI), which is a measure 
of correctly reclassiﬁed subjects that is penalized for those incorrectly classiﬁed. In this context, 
clinically relevant cutoff values for the risk of a MACE (ie, the thresholds of risk where reclassiﬁcation 
to another category would inﬂuence clinical management) are absent. Thus, we used an extension 
of the traditional NRI that was recently introduced by Pencina et al. [14]. The so-called continuous 
NRI (or category-free NRI) does not depend on the existence of risk categories and allows NRI 
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estimation in the context of survival data. The continuous NRI is the weighted sum of the observed 
event rate increase among the individuals for whom the predicted risk goes up and observed event 
rate de-crease among those for whom the predicted risk goes down.
Results
Coronary CT could not be performed in 16 (3%) patients because of renal failure (n=2), known 
allergy to contrast material (n=1), patient preferences (n=8), Parkinson disease (n=1), patient 
noncooperation (n=1), lack of venous access (n=1), and severe obesity (n=2). Two examinations 
(0.4%) failed because of patient movement or premature scanning initiation. Three patients (0.6%) 
had mild to moderate allergic reactions.
 Exercise ECG could not be performed in 48 (10%) patients because of orthopedic restraints (n=13), 
neurologic restraints (n=8), severe obesity (n=3), abnormalities at resting ECG (n=8), pulmonary 
disease (n=2), in-ability to bicycle (n=3), and a combination of these factors or an unspeciﬁed factor 
(n=11). Results were considered inconclusive in 140 (30%) patients, mostly because the target heart 
rate was not reached. These patients together (n=188) were considered to have had non-diagnostic 
tests in the survival analysis (Figure 1).
Figure 1 | Flowchart of patients included in the 
survival analysis. *Included in multivariable analysis. 
CTA = CT angiography, X-ECG = exercise ECG.
Follow-up
Follow-up data were obtained for 424 (90%) patients. Forty-four adverse cardiac events occurred 
in 30 patients. These events consisted of four cardiac deaths, six acute myocardial infarctions, 23 
coronary revascularizations, and 11 instances of unstable angina pectoris. The occurrence of 
mortality was obtained for all patients, and, according to the national bureau of statistics, another 
four patients died of a non-cardiac cause – that is, respiratory failure, stroke, or malignancy (n=2). 
The median follow -up time was 2.6 years (IQR, 2.1–3.2 years). The overall rate of events was 3.2% 
per year.
 Patients without follow-up were younger (p<.001) and more often smokers (p=.02). Lower 
coronary calcium scores and fewer abnormal CT angiography and exercise ECG results were 
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observed for patients without follow-up, although this did not reach statistically signiﬁcance. There 
was no signiﬁcant difference in Duke Treadmill Score between the patients with and those without 
follow-up (median score, 5 [IQR, 1–7] vs 5 [IQR, 0.5–7]). Only six patients were classiﬁed as having 
high risk, and they all completed follow-up. 
Descriptive Analysis
Coronary calcium score | Patients with no coronary calcium had excellent prognoses. No cardiac deaths 
and no nonfatal myocardial infarctions were observed (Table 1). However, three hospitalizations for 
unstable angina occurred, and one late revascularization was performed.
Coronary CT | In the group of patients with obstructive CAD, 22 (17%) events occurred, consisting 
of three cardiac deaths (2%) and four myocardial infarctions (3%). Patients without obstructive CAD 
experienced signiﬁcantly fewer total events (eight patients [3%]; p<.001), one cardiac death (0.4%), 
and two (0.7%) myocardial infarctions (Table 1). Patients who did not undergo CT angiography or in 
whom the study was non-diagnostic did not experience a MACE.
Exercise ECG | Patients with a normal exercise ECG result experienced seven (4%) events during 
follow-up, of which one (0.6%) was a myocardial infarction. An abnormal exercise ECG result was 
associated with the occurrence of four (5%) events, of which one (1%) was a myocardial infarction. 
We observed 19 (11%) events in the group of patients who were unable to perform the test or 
who had an inconclusive test; of these events, four (2%) were cardiac deaths and four (2%) were 
myocardial infarctions (Table 1).
Univariable Analysis
The clinical risk estimators SCORE and Diamond and Forrester score were both signiﬁcant predictors 
of MACE (Table 2). Of the traditional risk factors, only sex was a statistically signiﬁcant predictor. A 
typical angina presentation was associated with an HR of 3.86 (95% CI: 0.88, 16.87) compared with 
non-anginal complaints, while atypical presentation was associated with an HR of 1.91 (95% CI: 0.43, 
8.47).
 Detectable coronary calcium was a signiﬁcant predictor of MACE (HR, 8.22 [95% CI: 1.96, 34.51]; 
p=.004), along with nondiagnostic exercise ECG results (HR, 3.00 [95% CI: 1.26, 7.14]; p=.01). Regarding 
CT angiography results, in the ﬁrst model, obstructive CAD was associated with a signiﬁcantly higher 
hazard (HR, 6.22 [95% CI: 2.77, 13.99]; p<.001). In the second model, the presence of non-obstructive 
plaque was also associated with a higher hazard (HR, 5.03 [95% CI: 0.62, 40.85]), although this did 
not reach statistical signiﬁcance (p=.13), while obstructive CAD remained a signiﬁcant predictor (HR, 
20.80 [95% CI: 2.80, 154.33]; p=.003).
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Table 1 | Baseline characteristics.
Follow–up 
(n=424)
No follow–up 
(n=47)
p value
Age (yrs) 56 (10) 50 (11) <0.001
Male sex (%) 219 (52) 25 (53) 0.88
Smoking (%) 116 (27) 22 (47) 0.01
Hypertension (%) 213 (50) 21 (45) 0.54
Diabetes (%) 58 (14) 10 (21) 0.19
Dyslipidemia (%) 251 (59) 29 (62) 0.88
Family history of CAD (%) 191 (45) 23 (49) 0.65
History of vascular disease (%) 30 (7) 1 (2) 0.35
Body mass index 26.8 (24.2–30.0) 26.9 (24.5–30.5) 0.58
Non-anginal chest pain (%)
Atypical chest pain (%)
Typical chest pain (%)
66 (16)
222 (52)
136 (32)
8 (17)
29 (62)
10 (21)
0.31
SCORE 3 (1–7) 1 (1–5) 0.02
Diamond & Forrester 54(32–79) 46 (13–59) 0.02
Calcium score 
0 (%)
0-10
10-100
100-400
>400
18(0–158)
151 (34)
45 (11)
92 (22)
66 (16)
63 (15)
0 (0–93)
24 (52)
3 (7)
9 (20)
8 (17)
2 (4)
0.06
0.04
CT Angiography (%)
Non-obstructive CAD (%)
Obstructive CAD (%)
453 (96%)
277 (68)
132 (32)
35 (80)
9 (20)
0.12
Exercise ECG (%)
Normal (%)
Ischemic (%)
Non-diagnostic (%)
471 (100%)
172 (41)
85 (20)
167 (39)
18 (38)
8 (17)
21 (45)
0.76
Duke treadmill score
Low risk (%)
Intermediate risk (%)
High risk (%)
5 (1–7)
190 (51)
181 (48)
6 (2)
5 (0.5–7)
24 (55)
20 (45)
0
0.95
CAD = coronary artery disease, SCORE 10-year cardiovascular disease mortality risk [9], Diamond&Forrester [10].
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Table 2 | Events sorted by test.
N MACE Cardiac 
death
AMI Late 
revascularization
UAP Annual event 
rate
CCS=0 151 2 (1%) 0 (0%) 0 (0%) 1 (0.7%) 3 (2%) 0.5%
CCS>0 266 28 (11%) 4 (2%) 6 (2%) 22 (8%) 8 (3%) 4.2%
CTA <50% 277 8 (3%) 1 (0.4%) 2 (0.7%) 3 (1%) 3 (1%) 1.2%
CTA >50% 132 22 (17%) 3 (2%) 4 (3%) 20 (15%) 8 (6%) 6.8%
Normal X-ECG 172 7 (4%) 0 (0%) 1 (0.6%) 6 (4%) 3 (2%) 1.6%
Ischemic X-ECG 85 4 (5%) 0 (0%) 1 (1%) 5 (6%) 1 (1%) 1.9%
Nondiagn X-ECG 167 19 (11%) 4 (2%) 4 (2%) 12 (7%) 7 (4%) 4.6%
MACE = Major adverse cardiac event, AMI = acute myocardial infarction, UAP = unstable angina pectoris requiring hospitalizations, 
CCS = coronary calcium score, CTA = cardiac computed tomography angiography, X-ECG = exercise electrocardiography (Nondiagn 
= non-diagnostic result) 
Survival Analysis
Unadjusted comparison between patients with and those without coronary calcium showed 
signiﬁcantly higher event-free survival in the group with no calcium (Figure 2a ) (p=.001). The annual 
event rate in patients without calcium was 0.5%.
 Absence of obstructive CAD at CT angiography was associated with a signiﬁcantly lower event 
rate than the presence of obstructive CAD at CT angiography (Figure 2b ) (P<.001). The annual event 
rates were 6.8% versus 1.2% for obstructive versus non-obstructive CAD (Table 1).
 Non-diagnostic exercise ECG results were associated with signiﬁcantly higher event rates than 
normal or ischemic exercise ECG results (Figure 2c) (P=.016). The observed annual event rate for 
patients with non-diagnostic results compared with that for patients with normal or ischemic results 
was substantially higher (4.6% vs 1.6% and 1.9%, respectively).
Figure 2a | Graphs show Kaplan-Meier estimates of 
survival as compared between (a) patients with and 
those without visible coronary calcium (CCS), (b) 
patients with and those without obstructive CAD 
at CT angiography, and (c) patients with normal, 
those with ischemic, and those with non-diagnostic 
exercise ECG results.
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Figure 2b | Graphs show Kaplan-Meier estimates 
of survival as compared between (a) patients with 
and those without visible coronary calcium (CCS), 
(b) patients with and those without obstructive 
CAD at CT angiography, and (c) patients with 
normal, those with ischemic, and those with non-
diagnostic exercise ECG results.
Figure 2c | Graphs show Kaplan-Meier estimates 
of survival as compared between (a) patients with 
and those without visible coronary calcium (CCS), 
(b) patients with and those without obstructive 
CAD at CT angiography, and (c) patients with 
normal, those with ischemic, and those with non-
diagnostic exercise ECG results.
Multivariable Risk-adjusted Analysis
In the multivariable Cox regression analysis, after adjusting for SCORE, the presence of obstructive 
CAD (HR, 6.61 [95% CI: 2.83, 15.43]) and non-diagnostic exercise ECG result (HR, 2.93 [95% CI: 
1.23, 6.99]) remained independent predictors of MACE (Table 3). The addition of CCS led to a slight 
decrease in the HRs of CT angiography (HR, 5.00 [95% CI: 1.72, 14.52]) and exercise ECG (HR, 2.80 [95% 
CI: 1.17, 6.73]), whereas CCS itself was not an independent predictor (HR, 1.09 [95% CI; 0.89, 1.33]). 
 A statistically signiﬁcant increase in the global χ2 value was seen after adding CT angiography 
results to a risk-adjusted model with exercise ECG (global χ2 value, 37.7 vs. 13.7; p<.001) but not with 
the subsequent addition of CCS (global χ2 value, 38.2 vs 37.7; p=.40).
 Detectable calcium was an independent predictor in a risk-adjusted model with exercise ECG 
alone (HR, 1.33 [95% CI: 1.13, 1.56]). Subsequent addition of CT angiography improved model 
performance signiﬁcantly (global χ2 value, 38.2 vs. 26.3; p=.002).
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Table 3 | Cox univariable analysis.
MACE  
(n=30)
No MACE  
(n=392)
Hazard ratio  
(95% CI)
p value
Age (yrs) 58±8 56±10 1.02 (0.99–1.06) 0.21
Male sex (%) 22 (73) 195 (50) 2.68 (1.19–6.02) 0.02
Smoking (%) 9 (30) 107 (27) 1.15 (0.53–2.52) 0.72
Hypertension (%) 20 (67) 193 (49) 1.99 (0.93–4.25) 0.08
Diabetes (%) 7 (23) 51 (13) 1.92 (0.82–4.47) 0.13
Dyslipidemia (%) 20 (67) 229 (58) 1.29 (0.60–2.76) 0.52
Family history of CAD (%) 16 (53) 173 (44) 1.39 (0.68–2.85) 0.37
History of vascular disease (%) 2 (7) 28 (7) 0.94 (0.22–3.94) 0.93
Body mass index 26.9 26.8 1.01 (0.94–1.08) 0.86
Non-anginal chest pain (%)
Atypical chest pain (%)
Typical chest pain (%)
2 (7)
13 (43)
15 (50)
64 (16)
207 (53)
121 (31)
1
1.91 (0.43–8.47)
3.86 (0.88–16.87)
0.39
0.07
SCORE 6 (2.75–8.25) 3 (1–6) 1.06 (1.01–1.12) 0.03
Diamond & Forrester 
Low (<22)
Interm(22–78)
High (>78)
67 (53–92) 54 (28–79)
1.02 (1.01–1.04)
1
2.83 (0.64–12.47)
5.16 (1.17–22.70)
0.003
0.17
0.03
Calcium score (%)
0
0–10
10–100
100–400
>400
>0
2 (7)
2 (7)
10 (33)
7 (23)
9 (30)
28 (93)
149 (39)
43 (11)
82 (21)
59 (15)
54 (14)
238 (62)
1
3.19 (0.45–22.65)
8.45 (1.85–38.58)
8.50 (1.77–40.793)
11.66 (2.52–54.01)
8.22 (1.96–34.51)
0.25
0.006
0.008
0.002
0.004
CT Angiography model 1
Non-obstructive CAD (%)
Obstructive CAD (%)
8 (27)
22 (73)
269 (71)
108 (29)
6.22 (2.77–13.99) <0.001
CT Angiography model 2
No plaque (%)
Non-obstructive plaque (%)
Obstructive plaque (%)
1 (3)
7 (23)
22 (73)
114 (30)
155 (41)
110 (29)
1
5.03 (0.62 – 40.85)
20.80 (2.80–154.33)
0.13
0.003
Exercise ECG
Normal (%)
Ischemic (%)
Non-diagnostic (%)
7 (23)
4 (13)
19 (63)
164 (42)
80 (20)
148 (38)
1
1.19 (0.35–4.08)
3.00 (1.26–7.14)
0.78
0.01
CAD = coronary artery disease, SCORE 10-year cardiovascular disease mortality risk(9), Diamond&Forrester(10), 95% CI = 95% 
confidence interval
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Receiver Operating Characteristics
The obtained curves and their AUC estimates demonstrated that the combination of clinical 
characteristics and exercise ECG ﬁndings resulted in an AUC of 0.71 (95% CI: 0.63, 0.79) (Figure 3). 
A risk-adjusted model with CT angiography resulted in an AUC of 0.75 (95% CI: 0.67, 0.83), while 
clinical characteristics and CCS produced an AUC of 0.73 (95% CI: 0.65, 0.81).
 When clinical characteristics, exercise ECG ﬁndings, and CT angiography ﬁndings were combined 
in a model, we found an AUC of 0.80 (95% CI: 0.72, 0.88). Insertion of CCS into this model did not 
improve its predictive value consider-ably (AUC, 0.81 [95% CI: 0.73, 0.88]).
Figure 3a | Graphs show receiver operating 
characteristics curves of multivariable mod-
els of (a) exercise ECG (XECG), CCS, and CT 
angiography (CTA) and (b) incremental value 
of CT angiography and CCS beyond exercise 
ECG. The models are risk adjusted with the 
SCORE 10-year cardiovascular disease mor-
tality risk metric [9].
Figure 3b | Graphs show receiver operating 
characteristics curves of multivariable mod-
els of (a) exercise ECG (XECG), CCS, and CT 
angiography (CTA) and (b) incremental value 
of CT angiography and CCS beyond exercise 
ECG. The models are risk adjusted with the 
SCORE 10-year cardiovascular disease mor-
tality risk metric [9].
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NRI Results
The NRI was 54% (number of patients classiﬁed upward: 160; downward: 249) when exercise ECG 
was added to the clinical Cox proportional hazards model using only the SCORE. The addition of CT 
angiography to the model with both SCORE and exercise ECG resulted in a NRI of 80% (number of 
patients classiﬁed upward: 132; downward: 277). Finally, the full model that included CCS resulted in 
an NRI of 47% (number of patients classiﬁed upward: 182; down-ward: 227) (Table 3).
Table 4 | Cox multivariable analysis.
Hazard ratio  
(95% CI)
p value Global  
chi-square
Model comparison  
p value
AUC
(95% CI)
Continuous  
NRI (%)
SCORE 1.06 (1.01–1.12) 0.03 5.1 0.66 (0.57–0.75) reference
SCORE
X-ECG-
X-ECG+
X-ECG≠
1.07 (1.01–1.12)
1
1.02 (0.29–3.52)
2.96 (1.24–7.04)
0.02
0.98
0.01
13.7 0.01 0.71 (0.63–0.79) 54
SCORE
X-ECG-
X-ECG+
X-ECG≠
CTA
1.02 (0.96–1.09)
1
0.69 (0.20–2.41)
2.93 (1.23–6.99)
6.61 (2.83–15.43)
0.54
0.57
0.02
<0.001
37.7 <0.001 0.80 (0.72–0.88) 80
SCORE
X-ECG-
X-ECG+
X-ECG≠
CTA
CCS
1.02 (0.95–1.08)
1
0.69 (0.20–2.39)
2.80 (1.17–6.73)
5.00 (1.72–14.52)
1.09 (0.89–1.33)
0.67
0.56
0.02
0.003
0.41
38.2 0.40 0.81 (0.73–0.88) 47
SCORE 10-year cardiovascular disease mortality risk(9), X-ECG = exercise electrocardiography, CTA = cardiac computed tomography 
angiography (- normal, + ischemic and ≠ non-diagnostic), CCS = natural logarithm of the calcium score +1, AUC = area under the 
curve, 95% CI = 95% confidence interval, NRI = net reclassification improvement(14)
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Table 5 | Cox multivariable analysis.
Hazard ratio  
(95% CI)
p value Global  
chi-square
Model comparison 
p value
AUC 
(95% CI)
Continuous 
NRI (%)
SCORE 1.06 (1.01–1.12) 0.03 5.1 0.66 (0.57–0.75) reference
SCORE
X-ECG-
X-ECG+
X-ECG≠
1.07 (1.01–1.12)
1
1.02 (0.29–3.52)
2.96 (1.24–7.04)
0.02
0.98
0.01
13.7 0.01 0.71 (0.63–0.79) 54
SCORE
X-ECG-
X-ECG+
X-ECG≠
CCS
1.02 (0.96–1.09)
1
0.79 (0.23–2.75)
2.40 (1.00–5.79)
1.33 (1.13–1.56)
0.57
0.71
0.05
0.001
26.3 <0.001 0.77 (0.70–0.85) 72
SCORE
X-ECG-
X-ECG+
X-ECG≠
CCS
CTA
1.02 (0.95–1.08)
1
0.69 (0.20–2.39)
2.80 (1.17–6.73)
1.09 (0.89–1.33)
5.00 (1.72–14.52)
0.67
0.56
0.02
0.41
0.003
38.2 0.002 0.81 (0.73–0.88) 15
SCORE 10-year cardiovascular disease mortality risk(9), X-ECG = exercise electrocardiography, CTA = cardiac computed tomography 
angiography (- normal, + ischemic and ≠ non-diagnostic), CCS = natural logarithm of the calcium score +1, AUC = area under the 
curve, 95% CI = 95% confidence interval, NRI = net reclassification improvement(14)
Discussion
Our results show that the presence of obstructive CAD at CT angiography, the degree of exercise 
tolerance, and the extent of coronary calciﬁcation predict future adverse events in patients with 
stable symptoms of chest pain. After adjustment for clinical characteristics, CT angiography showed 
incremental value beyond exercise testing, whereas the additive prognostic value of CCS was limited 
compared with CT angiography.
 For the past decades, exercise testing has been the diagnostic cornerstone for the evaluation 
of ischemic heart disease and can help identify patients at increased risk for adverse events [3,4]. 
Exercise tolerance is a powerful predictor of prognosis [15,16], which is conﬁrmed in our study by the 
fact that inability to perform and complete exercise ECG predicted unfavorable outcome. Exercise 
capacity is an important predictor of adverse outcome, representing contractile left ventricular 
function as well as overall physical health. Most non-diagnostic exercise tests were the result of a 
low exercise capacity and consequent inability to reach the target heart rate.
 Remarkably, ischemic ECG changes were not associated with increased event rates. Presumably, 
patients with these changes were treated more aggressively, explaining their better event-free 
survival. Second, patients developing ischemic ECG changes during exercise, but straining 
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themselves outstandingly, apparently tolerate ischemia well and may be in good general shape. 
The fact that only a minority of the study population was categorized as having high-risk disease 
according to the Duke Tread-mill Score supports this hypothesis.
 Nonenhanced CT imaging can be used to help detect and quantify calciﬁed CAD, and its ﬁndings 
have independent prognostic value in both symptomatic and asymptomatic individuals [17–21]. 
Also in our study, the presence of coronary calcium was associated with an adverse outcome. In 
particular, our results conﬁrm the idea that patients with no detectable calcium have an excellent 
outcome (annual event rate, 0.5%).
 More recently, CT coronary angiography has emerged as a noninvasive alternative for direct 
assessment of CAD. Evidence of its prognostic value is emerging [5–7], although results from some 
studies were affected by work-up bias, selected populations, and short follow-up periods [22-24]. In 
our consecutive population we can conﬁrm the good predictive value of CT angiography for future 
adverse events.
 Because of the nature of our diagnostic work-up, we could directly compare the prognostic value 
of the different diagnostic modalities in patients with stable chest pain and a low-to-intermediate 
probability of CAD. To the best of our knowledge, ours is the ﬁrst study to evaluate the incremental 
predictive value of CT angiography over exercise ECG in a consecutive patient population.
 In the risk-adjusted multivariable analysis, obstructive atherosclerosis at CT angiography and 
non-diagnostic exercise ECG results remained independent predictors of late cardiac adverse 
events, whereas coronary calcium did not remain a signiﬁcant predictor. This ﬁnding is conﬁrmed 
by a recent study [25] that reported no additive prognostic value of CCS next to CT angiography. It 
appears that the information obtained with calcium scanning largely overlaps with the information 
obtained with CT angiography, while the latter also provides such additional characteristics as total 
plaque burden and luminal obstruction. 
 The performance of the ﬁnal model with clinical predictors, exercise ECG, and CCS improved 
signiﬁcantly after the addition of CT angiography results. In addition, we assessed the potential 
clinical value of the considered predictors by calculating the continuous NRI, an extension of the 
traditional NRI that is independent of risk categories. Our results suggest that CT angiography is 
most effective in improving risk prediction, since the NRI was substantial. For CCS, the NRI was 
47%, although the addition of CCS did not improve model performance in terms of the χ2 value or 
AUC. This ﬁnding is explained by the fact that the continuous NRI does not take into account the 
magnitude of the increase (or decrease) in predicted risk. In other words, the predictions were not 
substantially inﬂuenced when CCS was added, but among patients with a higher predicted risk, the 
observed event rate increased compared with the overall mean. Similarly, for patients with a lower 
predicted risk, the observed event rate decreased compared with the overall mean. Finally, it should 
be noted that the continuous NRIs reported in the current study cannot be compared directly with 
the traditional NRIs that have been reported in other studies because of the differences in deﬁnition 
and calculation described earlier.
 Although our study population consisted of prospectively enrolled “all-comers” with stable 
angina complaints, the limitations associated with an observational single-center study were still 
present. Therefore our results may not necessarily reﬂect populations or practices elsewhere. Because 
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of the limited number of hard events, we used a composite end point of cardiac death, nonfatal 
myocardial infarction, unstable angina requiring hospitalization, and coronary revascularization. 
The use of coronary revascularization as an end point could lead to overestimation of the prognostic 
value as a result of a potential work-up bias. Revascularizations performed within 6 months from 
the initial work-up were excluded to minimize this effect. Even though an experienced cardiologist, 
blinded to the initial test reports, evaluated all events, unstable angina requiring hospitalization can 
be a subjective end point.
 Given the limited number of events, our analysis could be subject to overﬁtting. Current 
guidelines stating a minimum of 10 outcome events per predictor variable have been questioned 
[26]. In this view, our ﬁndings regarding the additive value of coronary calcium should be considered 
explanatory, and conclusions should be made with caution. To limit the number of variables in the 
multivariable analysis, we dichotomized CT angiography results.
 Incomplete follow-up may result in underreporting of adverse events. However, the follow-up 
rate was substantial (90%), and no deaths occurred in the group without follow-up, as conﬁrmed by 
the national death registry. Patients lost to follow-up appear to have been at lower risk, with fewer 
abnormal test results. Larger multicenter studies with longer follow-up, or meta-analyses of existing 
studies, are needed to fully comprehend the prognostic value of these modalities.
 In conclusion, both functional and anatomic assessment of CAD has prognostic value. Coronary 
CT angiography ﬁndings are strong predictors of future adverse events, with incremental value over 
clinical predictors, stress testing, and coronary calciﬁcation.
Advances in Knowledge
 • Coronary CT angiography has incremental prognostic value over exercise testing.
 • Coronary calcium scoring seems to have no additive prognostic value beyond coronary CT 
angiography.
 • Inability to perform a diagnostic exercise test is associated with unfavorable outcome.
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Abstract
Aims: Non-culprit plaques are responsible for a substantial number of future events in patients with 
acute coronary syndrome (ACS). In this study, we evaluated the prognostic implications of non-
culprit plaques seen on coronary computed tomography angiography (CTA) in patients with ACS.
Methods and results: Coronary CTA was performed in 169 patients (mean 59±11 years, 129 males) 
admitted with ACS. Data sets were assessed for the presence of obstructive non-culprit plaques 
(>50% luminal narrowing), segment involvement score, and quantitative measures of plaque burden, 
after censoring initial culprit plaques. Follow-up was performed for the occurrence of major adverse 
cardiovascular events (MACEs) unrelated to the initial culprit plaque; cardiac death, second ACS, or 
coronary revascularization after 90 days. After a median follow-up of 4.8 (IQR 2.6–6.6) years, MACE 
occurred in 36 (24%) patients: 6 cardiac deaths, 16 second ACS, and 14 coronary revascularizations. 
Dyslipidaemia (hazard ratio [HR] 3.1 [95% conﬁdence interval 1.5–6.6]) and diabetes mellitus (HR 4.8 
[2.3–10.3]) were univariable clinical predictors of MACE. Patients with remaining obstructive non-
culprit plaques (HR 3.66 [1.52–8.80]) and higher plaque burden index (HR 1.22 [1.01–1.48]) had a 
higher risk of MACE. In multivariate analysis, with diabetes, dyslipidaemia, and plaque burden index, 
obstructive non-culprit plaques (HR 3.76 [1.28–11.09]) remained an independent predictor of MACE.
Conclusion: Almost a quarter of the study population experienced a new event arising from a non-
culprit plaque during a follow-up of almost 5 years. ACS patients with remaining obstructive non-
culprit plaques or high plaque burden have an increased risk of future MACE.
11
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Introduction
Coronary computed tomography angiography (CTA) offers direct non-invasive assessment of 
atherosclerotic plaque throughout the entire coronary tree and has proved to be a reliable diagnostic 
tool in patients suspected of coronary artery disease with valuable prognostic information [1-5]. 
While several publications have evaluated the prognostic value of coronary CTA in patients with 
stable chest pain complaints [6-9], little is known about the prognostic implications of non-culprit 
plaques on coronary CTA in patients with acute coronary syndrome (ACS). Follow-up studies using 
intravascular imaging techniques in patients with ACS have shown that a substantial number of 
second events arise from these non-culprit plaques [10]. The aim of this study was to determine the 
prognostic implications of non-culprit plaques on coronary CTA in patients with ACS.
Methods
The study population consisted of patients admitted for ACS, including unstable angina pectoris, 
non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial 
infarction (STEMI) according to the deﬁnitions of the European Society of Cardiology in the period 
between August 2004 and March 2011 [11]. Patients from three separate diagnostic studies with 
consecutive enrolment were pooled for the current study population; patients requiring urgent 
invasive intervention underwent coronary CTA after coronary angiography(CAG) [12-14]. Treating 
physicians were not informed regarding the ﬁndings on CTA.
 Information on the presence of cardiac risk factors was prospectively collected. Hypertension 
was deﬁned as a blood pressure of ≥140/90 mmHg or undergoing treatment for hypertension. 
Dyslipidaemia was deﬁned as total cholesterol of >5.0 mmol/L or current statin treatment. Diabetes 
mellitus was deﬁned as treatment with oral anti-diabetic medication or use of insulin. Smoking 
was considered as a risk factor if patients were current smokers and family history of cardiovascular 
disease was considered as positive if a ﬁrst-degree relative (males <55 years or females <65 years) 
was diagnosed with cardiovascular disease [15,16]. The study complied with the Declaration of 
Helsinki and the institutional review board of Erasmus MC Rotterdam approved the study.
Image Acquisition
Image acquisition was performed using a multislice CT scanner (64-slice single source from August 
2004 to September 2006, 64-slice dual source from September 2006 to April 2009, and 128-slice 
dual source from April 2009 to March 2011; Siemens, Forchheim, Germany) using the following scan 
parameters: 100–120 kV tube voltage, 850–960 mAs (64-slice single source), 370–412 mAs (64-slice 
dual source), and 320–412 mAs (128-slice dual source) tube current with X-ray tube modulation 
depending on patient size and variable pitch depending on the heart rate. A bolus of 80–100 mL 
of contrast material was injected intravenously followed by a 45-mL saline bolus chaser at a ﬂow 
rate of 5.0–5.5 mL/s. A bolus-tracking technique was used to synchronize the arrival of contrast in 
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the coronary arteries. Patients received sublingual nitroglycerine before the scan and beta-blockers 
were administered in patients with high heart rates.
Follow-up
The national mortality registry was consulted for all patients. Questionnaires, standardized 
telephonic interviews, and information from hospital visits were additionally used to determine the 
occurrence and nature of potential events.
 To determine the nature of the second event, an independent cardiologist, blinded for CT 
information, interpreted all clinical information, including ECG, echocardiography, and CAG at 
the time of the new event. Based on the ECG and angiographic ﬁndings at the time of the second 
event, the same physician identiﬁed the coronary segment most likely associated with the new 
event. The outcome measure was major adverse cardiac event (MACE) unrelated to the index culprit 
plaque: cardiac death, second ACS, and coronary revascularization after 90 days. Cardiac death was 
deﬁned as death caused by acute myocardial infarction, ventricular arrhythmias, refractory heart 
failure, or cardiogenic shock. ACS was deﬁned as either myocardial reinfarction with a rise and fall 
of cardiac biomarkers (>99th percentile of the upper limit of normal) or unstable angina requiring 
revascularization [17,18].
Image Evaluation
Coronary arteries were evaluated on axial images, multiplanar reconstructions (MPRs), and maximum 
intensity projections according to readers’ preferences. All plaques deemed responsible for ACS at 
baseline were censored. The presence of coronary atherosclerotic plaque was determined using the 
16-segment AHA classiﬁcation by two experienced readers [19]. Stenosis grade was quantiﬁed as 
<20%, 20–50%, 50–70%, >70% stenosis or occluded. Segments of poor quality due to misalignment 
or movement artefacts and small segments (<1.5 mm) were excluded from analysis. After censoring 
for plaques causing ACS at baseline, we determined the segment involvement score: all lesions with 
a stenosis grade >20% [20]. Coronary atherosclerotic plaque was classiﬁed as non-calciﬁed, partially 
calciﬁed (≤50% calcium), or predominantly calciﬁed (>50% calcium). Interobserver disagreements 
were resolved by a joint reading. With the semi-automated software (QAngioCT Research Edition, 
Medis Medical Imaging Systems, Leiden, the Netherlands), we determined total plaque volume and 
plaque burden index, as described previously [13]. In short, planimetry of the inner lumen and outer 
vessel areas was performed following a stepwise approach throughout the vessel. Plaque burden 
index was calculated by dividing the total plaque volume by the length of the evaluated vessel. 
Segments with chronic total occlusions or accountable for baseline ACS were not taken into account.
Morphological Evaluation
Plaques causing a second presentation with ACS were evaluated for their morphological features 
and compared with those that remained clinically silent in age- and gender-matched patients. The 
following characteristics were analysed by a blinded independent reader: percent area stenosis, 
plaque volume, remodelling index, minimal attenuation values, and presence of spotty calciﬁcations.
11
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For the evaluation of percent area stenosis, remodelling index, and minimal attenuation values, 
curved MPRs were created with perpendicular cross-sectional views using the dedicated software 
(Syngo.via; Siemens). Percent area stenosis was calculated by dividing the lumen are a at the site of 
maximal narrowing by the vessel area at the same cross-sectional view.
 Remodelling index was calculated by dividing the cross-sectional vessel area at the site of 
maximal luminal narrowing by the cross-sectional vessel area in a reference segment. For reference 
we used segments without detectable plaque preferably proximal and as close as possible to the 
lesion. In the absence of a disease-free segment, the least diseased segment or a segment distally, 
before major bifurcations, and close to the investigated lesion was used. Minimal attenuation values 
were determined by placing a region of interest with a minimum size of 0.25 mm2 in a region with 
the lowest attenuation assessed visually. Regions with extensive calciﬁcation or motion artefacts 
were avoided and fully calciﬁed lesions were excluded. Spotty calciﬁcations were deﬁned as small 
calciﬁed material <3 mm in size on MPRs, embedded in non-calciﬁed material and one-sided on 
cross-sectional images.
Statistical Analysis
Statistical analyses were performed using the SPSS software (version 15.0, SPSS, Inc., Chicago, IL, 
USA) and STATA software (version 12.0, StataCorp, College Station, TX, USA). All probability values 
refer to two-tailed tests of signiﬁcance; a p value of <0.05 was considered signiﬁcant. Categorical 
variables are presented as proportions. Continuous variables are expressed as mean (±SD) or median 
(±IQR). Differences between independent groups were compared using the two-sided unpaired t 
test, χ2 test, Wilcoxon rank-sum test or Fisher’s exact test, as appropriate. Cox regression analysis 
was used to assess any associations between outcome and clinical characteristics or coronary CTA 
results. A second regression analysis was performed for the combined outcome cardiac death and 
ACS. Hazard ratios (HRs) were calculated with their corresponding 95% conﬁdence intervals. Risk-
adjusted models were corrected for signiﬁcant (p<0.05) univariable clinical variables and used to 
create adjusted survival curves. The global χ2 value was calculated to determine the incremental 
value of coronary CTA. Receiver operating characteristic (ROC) curves with estimates of the area 
under the curve (AUC) were obtained to compare discriminative model performances.
Results
The study population consisted of 169 ACS patients (mean age 59±11 years, 129 males) who 
underwent coronary CTA during their admission. Follow-up was obtained for 152 (90%) patients 
with a median follow-up time of 4.8 (2.7–6.6 years; Table 1). Diagnosis at the discharge of index 
hospitalization was unstable angina pectoris in 65 (43%) patients, NSTEMI in 59 (39%), and STEMI 
in 28 (18%) (Table 1). The composite endpoint MACE occurred in 36 (24%) patients, consisting of 6 
cardiac deaths, 16 second ACS, and 14 late revascularizations unrelated to the plaque causing ACS 
at baseline. Coronary revascularization was driven by recurrent symptoms in 11 patients and by 
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ischaemia on non-invasive testing in 3 patients. The overall annual event rate was 4.9%. In addition, 
seven patients had died of a non-cardiac cause (all-cause mortality = 13 [9%]).
Table 1 | Baseline characteristics.
Characteristic All  
(n=152)
MACE+  
(n=36) 
MACE-  
(n=116)
p value
Age, yearsa 58±10 58±10 59±10 0.56
Gender, male 116 (76) 30 (83) 86 (74) 0.26
Smoking 76 (50) 19 (53) 57 (49) 0.70
Hypertension 77 (51) 23 (64) 54 (47) 0.07
Dyslipidemia 81 (53) 27 (75) 54 (47) 0.003
Diabetes Mellitus 20 (13) 10 (28) 10 (9) 0.003
Positive Family History 74 (49) 18 (50) 56 (48) 0.86
Creatinin (µmol/L) a 84±14 86±16 84±14 0.33
Heart rate (/min) a 62±9 62±11 62±8 0.90
Index diagnosis
Unstable angina
NSTEMI
STEMI
65 (43)
59 (39)
28 (18)
14 (39)
17 (47)
5 (14)
45 (39)
48 (41)
23 (20)
0.69
Index management
Invasive angiography
PCI
CABG
143 (94)
126 (83)
8 (5)
35 (97)
34 (94)
0
108 (93)
92 (79)
8 (7)
0.36
0.04
0.68
Unless otherwise specified, data are numbers of patients, with percentages in parentheses. MACE = major adverse cardiac event 
(cardiac death, second ACS = and late coronary revascularization); NSTEMI = non-ST-segment elevation myocardial infarction; STEMI 
= ST-segment elevation myocardial infarction; PCI = percutaneous coronary intervention; CABG = coronary artery bypass grafting. 
aData are means±standard deviations.
Coronary CTA Results
A total of 2432 segments were evaluated; of which 87 (3.6%) were considered non-diagnostic, 317 
(13.0%) too small for evaluation (,1.5 mm in diameter), and 172 (7.0%) were censored because of index 
ACS treatment. On a per-patient level, obstructive non-culprit plaques (>50% luminal narrowing) 
were more often seen in patients with MACE than in those without (83 vs. 52%, p=0.001, Table 2). A 
total of 263 non-calciﬁed, 185 partially calciﬁed, and 274 predominantly calciﬁed plaques were seen 
in the whole group. Predominantly calciﬁed plaques were more frequently seen in patients with 
MACE than in those without, although the difference did not reach statistical signiﬁcance (p=0.08). 
Plaque burden index was signiﬁcantly higher in patients with MACE, respectively, 8.4 vs. 7.2 mm2 
(p=0.009).
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Table 2 | Coronary CTA findings in patients with and without MACE.
All  
(n=152)
MACE+  
(n=36) 
MACE-  
(n=116)
p value
Non-calcified plaques 1 (0-2) 1 (0-3) 1 (0-2) 0.37
Partially calcified plaques 1 (0-2) 1 (0-2) 1 (0-2) 0.87
Calcified plaques 1 (0-3) 2 (2-4) 1 (0-2) 0.08
SIS 6 (2–10) 10 (5–12) 5 (2–8) 0.002
Total plaque volume (mm3) 1762 (1386–2278) 1803 (1427–2551) 1722 (1372–2253) 0.32
Plaque burden index (mm2) 7.5 (6.1–8.7) 8.4 (6.8–9.2) 7.2 (5.6–8.6) 0.009
Obstructive non-culprit plaque (>50%)a 90 (59) 30 (83) 60 (52) 0.001
Unless otherwise specified, data are medians with interquartile ranges in parentheses. SIS = segment involvement score; MACE = 
major adverse cardiac event (cardiac death, second ACS, and late coronary revascularization). aData are numbers of patients, with 
percentages in parentheses.
Prediction of Clinical Outcome
Patients with dyslipidaemia and diabetes mellitus experienced MACE more often during follow-up 
(Table 3). Obstructive non-culprit plaques and plaque burden index were signiﬁcant predictors 
of MACE. For the combined outcome cardiac death and second ACS, both variables remained 
signiﬁcant predictors. In multivariable analysis,correcting for dyslipidaemia and diabetes mellitus, 
the presence of obstructive non-culprit plaques on CT remained an independent predictor (Figure 
1 and Table 4). Model discrimination performance increased with the addition of CTA to a clinical 
model consisting of dyslipidaemia and diabetes (Figure 2).
Figure 1 | Event-free survival in patients with 
or without obstructive (>50%) non-culprit 
plaque. Risk-adjusted, p=0.006 (controlling for 
dyslipidaemia and diabetes mellitus).
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Table 3 | Univariable Cox regression analysis.
Characteristic MACE HR (95% CI) p value Cardiac death and recurrent 
ACS HR (95% CI)
p value
Age, per year 1.01 (0.98–1.04) 0.61 1.01 (0.98–1.06) 0.46
Gender, male 2.00 (0.82–4.88) 0.13 1.82 (0.60–5.47) 0.29
Smoking 1.25 (0.65–2.40) 0.51 2.09 (0.89–4.95) 0.09
Hypertension 1.89 (0.94–3.81) 0.07 2.08 (0.85–5.10) 0.11
Dyslipidemia 3.10 (1.45–6.61) 0.003 3.49 (1.29–9.45) 0.01
Diabetes Mellitus 4.81 (2.25–10.27) <0.001 5.01 (2.00–12.52) 0.001
Coronary CT angiography
Non-calcified plaques
Partially calcified plaques
Calcified plaques 
1.09 (0.98–1.22)
1.11 (0.89–1.39)
1.11 (0.97–1.26)
0.11
0.35
0.15
1.07 (0.92–1.24)
0.97 (0.71–1.32)
1.14 (0.97–1.34) 
0.40
0.85
0.12
SIS
Plaque burden index
1.14 (1.06–1.23)
1.22 (1.01–1.48)
0.002
0.04
1.01 (1.00–1.21)
1.29 (1.01–1.65)
0.05
0.04
Obstructive non-culprit 
plaque (>50%)
3.66 (1.52–8.80) 0.004 4.11 (1.21–13.89) 0.02
MACE = major adverse cardiac event (cardiac death, second ACS, and late coronary revascularization); SIS = segment involvement 
score; ACS = acute coronary syndrome; CTA = computed tomography angiography; HR = hazard ratio.
Table 4 | Multivariable analysis.
Risk-adjusted HR (95% CI) p value
Model I
SIS 1.03 (0.94–1.13) 0.49
Obstructive non-culprit plaque (>50%) 3.22 (1.10–9.43) 0.03
Model II
Plaque burden index 1.16 (0.94–1.44) 0.19
Obstructive non-culprit plaque (>50%) 3.76 (1.28–11.09) 0.02
Risk-adjusted for dyslipidaemia and diabetes mellitus. SIS = segment involvement score.
Comparison with CAG
In this study, 143 patients underwent CAG with an obstructive non-culprit lesion visible in 24 cases. 
During the follow-up, 10 of these patients experienced MACE, while 26 patients who experienced 
MACE had no obstructive lesions on CAG after initial treatment.
 In a model with CAG, CT remained a signiﬁcant predictor (HR 3.60 [1.36–9.59], p=0.01 for MACE 
and HR 4.27 [1.24–14.71], p=0.02 for cardiac death and ACS).
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Figure  2 | ROC curves for clinical character-
istics alone, i.e. dyslipidaemia and diabetes 
mellitus (red line AUC 0.68 [0.58–0.78]) and 
with obstructive non-culprit plaque on CTA 
(blue line AUC 0.76 [0.66–0.85]).
Morphological comparison
Second ACS occurred in 16 patients; among whom, a culprit lesion could be identiﬁed in 13 cases. 
Percent area stenosis (0.81% [0.76–0.88] vs. 0.71% [0.63–0.78], p=0.02) was signiﬁcantly higher in 
plaques causing second ACS. Total volume of plaques causing second ACS was 175 mm3 (IQR 95–254) 
and 120 mm3 (IQR 101–151) of control plaques (p=0.22). No difference was found for remodelling 
index (1.11±0.42 in culprit plaques vs. 1.08 ± 0.16 in control plaques, p=0.83), minimal plaque 
attenuation (98 HU [65–147] vs. 104 HU [72–168], p=0.79), and presence of spotty calciﬁcation 
(5 vs. 3, p=0.67) types.
Discussion
During a follow-up of almost 5 years, almost a quarter of patients with ACS at baseline experienced a 
second event and patients with higher plaque burden or obstructive non-culprit plaques on CT had 
a signiﬁcantly higher risk of MACE.
 As a reliable gatekeeper for invasive angiography, coronary CTA has become a part of the 
diagnostic armamentarium for patients suspected of ACS [21-23]. Once patients have been diagnosed 
with ACS and treated accordingly, their risk of new cardiac events will determine future therapy. 
With intravascular imaging techniques, the natural history of coronary atherosclerosis in patients 
admitted with ACS has been evaluated thoroughly [10]. The investigators of the PROSPECT study 
detected high residual plaque burden even after the treatment of all angiographically signiﬁcant 
lesions. Non-culprit plaques were responsible for a substantial number of second events and patients 
with higher plaque burden had an increased risk of MACE [24]. More recently, investigators of the 
PRAMI trial showed that preventive percutaneous coronary intervention (PCI) of non-culprit lesions 
with major stenoses signiﬁcantly reduced the risk of adverse cardiovascular events in patients with 
STEMI and multivessel disease [25]. Although currently not recommended and without immediate 
suggestion in differentiation of post-ACS treatment, our intention was to perform an exploratory 
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study to understand the role of non-culprit lesions better. Looking beyond luminology, coronary 
CTA provides detailed information regarding total plaque burden, accounting for non-obstructive 
lesions as well, and speciﬁc plaque characteristics that might be important for understanding of the 
occurrence of second cardiac events in these patients. We found that remaining obstructive plaques 
and quantitatively measured higher plaque burden are associated with an increased risk of cardiac 
events. Also, CT remained an independent predictor of MACE next to CAG, suggesting that CT picks 
up lesions which do not look important on CAG, but over time do cause cardiac events, which might 
be due to the additional information provided by CT over sheer luminology.
 Extensively studied in populations with stable complaints, CT has shown to be a strong predictor 
of mortality and cardiac-speciﬁc adverse outcomes [26-28]. However, there is a paucity of data in 
the group patients with ACS. In a study by Kristensen et al. [29], there was a signiﬁcant correlation 
found between the total amount of non-obstructive plaque and adverse cardiac events in NSTEMI 
patients after 16 months. In the present study, we included all non-culprit plaques for quantitative 
measurement of plaque burden, conﬁrming this correlation for a more heterogeneous ACS 
population.
 Morphological plaque features are next to stenosis severity also determinates of plaque 
progression and rupture. Intravascular imaging techniques allow a more detailed assessment of 
plaques and can visualize speciﬁc characteristics like thin ﬁbrous caps or large necrotic cores [10]. 
It has been postulated that a thin ﬁbrous cap is a major determinant in discrimination between a 
vulnerable plaque and a stable plaque [30]. Limited by its spatial resolution, CT cannot detect thin-
cap ﬁberoatheromas, but there are speciﬁc CT plaque features, such as low-attenuation, positive 
remodelling, and spotty calciﬁcations (Figure 3), that are associated with a higher risk of future 
cardiac events [31-34]. In a sub-analysis, we examined morphological features of lesions causing ACS. 
Percent area stenosis was signiﬁcantly higher in lesions causing second ACS compared with those 
that remained silent. There was no signiﬁcant difference found for other morphological features, 
possibly because of the small sample size, limited observation time, or methods of measuring, and 
also due to the high-risk nature of the study population. All patients had already experienced ACS at 
baseline and high-risk features of interest might have been frequent in the control group as well.
Limitations
There are several limitations to the present study. First, this is a single-centre study of a retrospective 
nature. Therefore, our results may not necessarily reﬂect populations or practices elsewhere and 
may be subject to a selection bias. In this study, we reached considerable follow-up (90%); however, 
incomplete follow-up may result in underreporting of events. Allocation of deaths to cardiac or non-
cardiac was made by an independent cardiologist, blinded for CT in-formation, who reviewed clinical 
records and information provided by the general practitioners. Autopsy was either not performed or 
results were not available in many patients who had died during follow-up and we cannot exclude 
that baseline ACS or its complications inﬂuenced or were the direct cause of subsequent cardiac 
deaths during follow-up. By censoring initial culprit lesions, we tried to minimize misclassiﬁcation 
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of cardiac deaths. Most importantly, our goal was to exclude clear non-cardiac cases or those with 
clinical information suggesting a clear link between cause of death and index event. Considering 
the observational methodology and modest sized population, our results should be considered 
exploratory and we do not advocate regular use of CT in ACS patients. Finally, the sample size in the 
present study might lack power to detect existing associations between clinical characteristics, CT, 
and outcome.
Figure 3 | (A and B) Coronary CTA in a 67-year-old male presenting with NSTEMI showing a severe lesion 
in the mid-right coronary artery (white arrows) and a moderate lesion proximally (white arrowhead). 
Cross-sectional views magnified in the right lower corner (asterisks). (C) The severe lesion was confirmed 
on invasive angiography (white arrow) and the patient subsequently underwent PCI. (D) After 6 years, the 
patients returned with a NSTEMI. Invasive angiography showed a significant lesion in the proximal right 
coronary artery (white arrowheads), on CT previously described as a moderately narrowing plaque with 
spotty calcification (A and B; white arrowheads).
Conclusions
Almost a quarter of the study population experienced a second event caused by a non-culprit 
plaque during 5-year follow-up. ACS patients with obstructive non-culprit plaques or high plaque 
burden have an increased risk of future MACE.
180 | Chapter 11
References
1. Veltman CE, de Graaf FR, Schuijf JD, van Werkhoven JM, Jukema JW, Kaufmann PA et al. Prognostic value of 
coronary vessel dominance in relation to signiﬁcant coronary artery disease determined with non-invasive 
computed tomography coronary angiography. Eur Heart J 2012; 33:1367-77.
2. Meijboom WB, Meijs MF, Schuijf JD, Cramer MJ, Mollet NR, van Mieghem CA et al. Diagnostic accuracy of 64-slice 
computed tomography coronary angiography: a prospective, multicenter, multivendor study. J Am Coll Cardiol 
2008; 52:2135-44.
3. Hausleiter J, Meyer T, Hadamitzky M, Zankl M, Gerein P, Dorrler K et al. Non-invasive coronary computed 
tomographic angiography for patients with suspected coronary artery disease: the Coronary Angiography by 
Computed Tomography with the Use of a Submillimeter resolution (CACTUS) trial. Eur Heart J 2007; 28:3034-41.
4. Leber AW, Johnson T, Becker A, von Ziegler F, Tittus J, Nikolaou K et al. Diagnostic accuracy of dual-source multi-
slice CT-coronary angiography in patients with an intermediate pretest likelihood for coronary artery disease. 
Eur Heart J 2007; 28:2354-60.
5. Buechel RR, Pazhenkottil AP, Herzog BA, Brueckner M, Nkoulou R, Ghadri JR et al. Prognostic performance of 
low-dose coronary CT angiography with prospective ECG triggering. Heart 2011; 97:1385-90.
6. Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ et al. Age- and sex-related differences in all-cause 
mortality risk based on coronary computed tomography angiography ﬁndings results from the International 
Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter 
Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol 2011; 58:849-60.
7. Chow BJ, Wells GA, Chen L,Yam Y, Galiwango P, Abraham A et al. Prognostic value of 64-slice cardiac computed 
tomography severity of coronary artery disease, coronary atherosclerosis, and left ventricular ejection fraction. 
J AmCollCardiol 2010; 55:1017-28.
8. Andreini D, Pontone G, Mushtaq S, Bartorelli AL, Bertella E, Antonioli L et al. Along-term prognostic value of 
coronary CT angiography in suspected coronary artery disease. JACC Cardiovasc Imaging 2012; 5:690-701.
9. van Werkhoven JM, Schuijf JD, Gaemperli O, Jukema JW, Kroft LJ, Boersma E et al. Incremental prognostic value 
of multi-slice computed tomography coronary angiography over coronary artery calcium scoring in patients 
with suspected coronary artery disease. Eur Heart J 2009; 30:2622-9.
10. StoneGW,MaeharaA,LanskyAJ,deBruyneB,CristeaE,MintzGSetal.Aprospect-ive natural-history study of coronary 
atherosclerosis. N Engl J Med 2011; 364: 226-35.
11. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD et al. Third universal deﬁnition of myocardial 
infarction. Eur Heart J 2012; 33:2551-67.
12. Meijboom WB, Mollet NR, Van Mieghem CA, Weustink AC, Pugliese F, van Pelt N et al. 64-Slice CT coronary 
angiography in patients with non-ST elevation acute coronary syndrome. Heart 2007; 93:1386-92.
13. Papadopoulou SL, Neefjes LA, Garcia-Garcia HM, Flu WJ, Rossi A, Dharampal AS et al. Natural history of coronary 
atherosclerosis by multislice computed tomography. JACC Cardiovasc Imaging 2012; 5:S28-37.
14. Dedic A, TenKate GJ, Neefjes LA,Rossi A,Dharampal A, Rood PP et al. Coronary CT angiography outperforms 
calcium imaging in the triage of acute coronary syndrome. Int J Cardiol 2013; 167:1597-602.
15. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M et al. European guidelines on cardiovascular 
disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of 
Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by 
representatives of nine societies and by invited experts). Eur Heart J 2012; 33:1635-701.
16. Reiner Z, Catapano AL, DeBacker G, Graham I, Taskinen MR,Wiklund O et al. ESC/ EAS guidelines for the 
management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society 
of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32:1769-818.
17. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD et al. Third universal deﬁnition of myocardial 
infarction. J Am Coll Cardiol 2012; 60:1581-98.
18. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno Hetal. ESC guidelines for the management of 
acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for 
the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment 
elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32:2999-3054.
11
181Prognostic Implications of Non-culprit Plaques on Coronary CT Angiography | 
19. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Grifﬁth LSetal. Are porting system on patients evaluated 
for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on 
Cardiovascular Surgery, American Heart Association. Circulation 1975; 51:5-40.
20. Min JK, Shaw LJ, Devereux RB, Okin PM, Weinsaft JW, Russo DJ et al. Prognostic value of multidetector coronary 
computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol 2007; 50:1161-70.
21. Hoffmann U, Truong QA, Schoenfeld DA, Chou ET, Woodard PK, Nagurney J Tetal. Coronary CT angiography 
versus standard evaluation in acute chest pain. N Engl J Med 2012; 367:299-308.
22. Litt HI, Gatsonis C, Snyder B,Singh H, Miller CD, Entrikin DW et al. CT angiography for safe discharge of patients 
with possible acute coronary syndromes. N Engl J Med 2012; 366:1393-403.
23. Goldstein JA, Chinnaiyan KM, Abidov A, Achenbach S, Berman DS, Hayes SW et al. The CT-STAT (Coronary 
Computed Tomographic Angiography for Systematic Triage of Acute Chest Pain Patients to Treatment) trial. J 
Am Coll Cardiol 2011; 58:1414-22.
24. McPherson JA, Maehara A, Weisz G, Mintz GS, Cristea E, Mehran R et al. Residual plaque burden in patients with 
acute coronary syndromes after successful percutaneous coronary intervention. JACC Cardiovasc Imaging 2012; 
5:S76-85.
25. Wald DS, Morris JK, Wald NJ, Chase AJ, Edwards RJ, Hughes LO et al. Randomized trial of preventive angioplasty 
in myocardial infarction. N Engl J Med 2013; 369:1115-23.
26. Ostrom MP, Gopal A, Ahmadi N, Nasir K, Yang E, Kakadiaris I et al. Mortality incidence and the severity of coronary 
atherosclerosis assessed by computed tomography angiography. J Am Coll Cardiol 2008; 52:1335-43.
27. Bamberg F, Sommer WH, Hoffmann V, Achenbach S, Nikolaou K, Conen D et al. Meta-analysis and systematic 
review of the long-term predictive value of assessment of coronary atherosclerosis by contrast-enhanced 
coronary computed tomography angiography. J Am Coll Cardiol 2011; 57:2426-36.
28. Pundziute G, Schuijf JD, Jukema JW, Boersma E, de Roos A, van der Wall EE et al. Prognostic value of multislice 
computed tomography coronary angiography in patients with known or suspected coronary artery disease. J 
Am Coll Cardiol 2007; 49:62-70.
29. Kristensen TS, Kofoed KF, Kuhl JT, Nielsen WB, Nielsen MB, Kelbaek H. Prognostic implications of nonobstructive 
coronary plaques in patients with non-ST-segment elevation myocardial infarction: a multidetector computed 
tomography study. J Am Coll Cardiol 2011; 58:502-9.
30. Narula J, Nakano M, Virmani R, Kolodgie FD, Petersen R, Newcomb R et al. Histo-pathologic characteristics of 
atherosclerotic coronary disease and implications of the ﬁndings for the invasive and noninvasive detection of 
vulnerable plaques. J Am Coll Cardiol 2013; 61:1041-51.
31. Pﬂederer T, Marwan M, Schepis T, Ropers D, Seltmann M, Muschiol G etal. Characterization of culprit lesions in 
acute coronary syndromes using coronary dual-source CT angiography. Atherosclerosis 2010; 211:437-44.
32. Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T et al. Computed tomo-graphic angiography 
characteristics of atherosclerotic plaques subsequently result-ing in acute coronary syndrome. J Am Coll Cardiol 
2009; 54:49-57.
33. Maurovich-Horvat P, Schlett CL, Alkadhi H, Nakano M, Otsuka F, Stolzmann P et al. The napkin ring sign indicates 
advanced atherosclerotic lesions in coronary CT angiography. JACC Cardiovasc Imaging 2012; 5:1243-52.
34. Ferencik M, Schlett CL, Ghoshhajra BB, Kriegel MF, Joshi SB, Maurovich-Horvat P et al.A computed tomography-
based coronary lesion score to predict acute coronary syndrome among patients with acute chest pain and 
signiﬁcant coronary stenosis on coronary computed tomographic angiogram. Am J Cardiol 2012; 110:183-9.

Epilogue
Part 4

185Summary and General Discussion | 
Summary and General Discussion 
In this thesis, we explored new clinical applications of coronary CT angiography. Presently, considered 
an established diagnostic modality, coronary CT angiography has made tremendous progress since 
its first steps in the clinical field. Current guidelines by the European Society of Cardiology have 
adopted coronary CT angiography as a viable alternative non-invasive test in the diagnostic work-
up of patients with stable coronary artery disease. Because of an excellent negative predictive value, 
it is the most effective non-invasive test in those cases where ruling out of important coronary artery 
disease is imperative [1].
 In Chapter 2, we provide an in-depth description of the technical background of cardiac CT 
imaging, to understand how images are acquired, what determines image quality, and why the new 
generation scanners provide better diagnostic accuracy. In addition, an overview is presented of the 
diagnostic accuracy and clinical applications available today or under development.
Coronary CT angiography in suspected acute coronary syndrome
Patients presenting to the emergency department with symptoms suggestive of an acute coronary 
syndrome remain a diagnostic challenge. While physicians are understandably cautious not to miss 
an acute coronary syndrome or any other important condition, they strive to perform a clinical 
efficient work-up as these patients present in large numbers worldwide every year and many of 
them actually do not have any serious illness. 
Chapter 3
In this chapter, we present a systematic review of the diagnostic accuracy of currently used imaging 
techniques (echocardiography, radionuclide myocardial perfusion imaging and coronary CT 
angiography) in the diagnostic work-up of patients suspected of an acute coronary syndrome. A 
meta-analysis of the currently available literature showed no significant difference in diagnostic 
accuracy between the three modalities. Pooled sensitivities ranged from 86%–94% and pooled 
specificities ranged from 73%–82%, with coronary CT angiography at the top-end of both. Based on 
these results, we conclude that all three modalities are suitable for the diagnostic work-up of patients 
suspected of an acute coronary syndrome. Practical aspects such as local practice, expertise, medical 
facilities, and individual patient characteristics should determine which modality to choose for.
Chapter 4
In a prospective, blinded observational study, we determined the diagnostic value of coronary CT 
angiography and the coronary calcium scan in 111 low- to intermediate-risk patients presenting to 
the emergency department with symptoms suggestive of an acute coronary syndrome. Absence of 
coronary atherosclerotic plaque on coronary CT angiography excluded an acute coronary syndrome 
and was associated with a benign short-term prognosis. In terms of diagnostic accuracy, coronary 
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CT angiography performed better than the coronary calcium scan and had incremental value over 
the GRACE risk score, a commonly used clinical risk prediction algorithm. 
Chapter 5
Copeptin is a biomarker that is secreted very early during times of haemodynamic stress and can 
be measured in peripheral blood. In this study, we determined the diagnostic accuracy of copeptin 
in 65 suspected acute coronary syndrome patients, and examined the association between 
copeptin levels and coronary artery disease detected by coronary CT angiography. Patients that 
were eventually diagnosed with an acute coronary syndrome had higher copeptin levels, but no 
significant correlation between copeptin and obstructive coronary artery disease on coronary CT 
angiography could be found. 
Chapter 6 
In a prospective, open-label, multicentre, randomized trial, 500 patients presenting with symptoms 
suggestive of an acute coronary syndrome were enrolled at the emergency departments of five 
community and two university hospitals in the Netherlands. Patients were randomized to either 
a diagnostic strategy supplemented by early coronary CT angiography or standard optimal care. 
We found that a diagnostic strategy supplemented by early coronary CT angiography is safe, less 
expensive and averts outpatient testing. However, in the era of high-sensitivity troponins, coronary 
CT angiography does not identify more patients with requiring coronary revascularization, nor does 
it shorten hospital stay or allow for more direct discharge from the emergency department.
Risk stratification with coronary CT angiography
Gradually scientific evidence is accumulating to support the use of coronary CT angiography for 
prognostic purposes as well. The technique can discriminate between low- and high-risk patients 
providing more individually tailored clinical management. 
Chapter 8
We compared the ability of the coronary artery calcium score and exercise electrocardiography as 
less expensive and cumbering tests to rule out obstructive coronary artery disease in 791 patients 
with stable angina pectoris. In low risk patients with a coronary calcium score of 0, further diagnostic 
work-up seems redundant as the post-test probability of obstructive coronary artery disease 
was less than 5%. In the group of patient with intermediate risk, both modalities were not able 
to sufficiently rule out obstructive coronary artery disease. High-risk patients also do not seem to 
benefit from either, although a normal exercise electrocardiography may be more helpful to exclude 
haemodynamically relevant lesions and guide management.
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Chapter 9
At present, traditional risk factors guide cardiovascular management of asymptomatic individuals. 
High-risk asymptomatic patients may benefit from increased medical surveillance. In an observational 
multicentre study we aimed to determine whether the coronary artery calcium score and coronary 
CT angiography could be used for improved risk prediction. In this study 665 patients participated. 
During a follow-up period of 3 years, we found a generally low annual incidence of adverse events. 
Both modalities were found to be significant predictors of adverse cardiovascular events. Coronary 
CT angiography had incremental prognostic value over the coronary calcium scan. Importantly, in 
patients without detectable coronary calcium, which had an excellent prognosis, this incremental 
value was not seen.
Chapter 10
In this study, consisting of 471 consecutively enrolled patients with stable angina pectoris, we aimed 
to determine and compare the prognostic value of coronary CT angiography, the coronary artery 
calcium score, and exercise electrocardiography. We found that the extent of coronary calcification, 
the presence of obstructive coronary artery disease detected by coronary CT angiography, and the 
maximal exercise tolerance during exercise electrocardiography all predict future adverse events. 
Importantly, after adjustment for clinical characteristics and results of exercise electrocardiography, 
coronary CT angiography remained a predictor of future adverse events.
Chapter 11 
Non-culprit plaques are responsible for a substantial number of future events in patients with an 
acute coronary syndrome. In this study, we evaluated the prognostic implications of non-culprit 
plaques seen on coronary CT angiography in 169 patients with an acute coronary syndrome. During 
a follow-up of nearly 5 years, almost a quarter of the study population experienced a second event, 
either cardiac death, second acute coronary syndrome, or coronary revascularisation after 90 days. 
Patients with higher plaque burden or obstructive non-culprit plaques on coronary CT angiography 
had a significantly higher risk of adverse events.
Future Directions
The growth of coronary CT angiography as a diagnostic and prognostic modality is evident. 
Although we strived to answer several questions in these thesis, several issues remain unresolved 
and at the same time new questions arise. In the field of acute cardiac care, where the sensitivity of 
hs-troponins seems impeccable, an unavoidable decrease in specificity has been noted, resulting in 
a substantial number of patients with slightly elevated troponins who do not suffer from an acute 
coronary syndrome. It would be important to investigate whether coronary CT angiography can 
guide management in these patients and defer those without important coronary artery disease 
from invasive angiography. Also, while coronary CT angiography is suitable to identify patients at 
higher risk of future adverse events, as demonstrated in this thesis, it still remains to be proven that 
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subsequent interventions based on findings from coronary CT angiography will actually prevent 
future adverse events. 
In other fields, research groups are working relentlessly to answer outstanding issues and challenges. 
Much attention has been directed towards further improvement of the diagnostic accuracy, more 
precisely the specificity, which is still lagging behind to that of other non-invasive tests. This has partly 
already been accomplished because of the better temporal and spatial resolution of new generation 
scanners, increasing the specificity to 86% compared to 78% of the traditional 64-slice scanners [2]. 
However, two altogether new cardiac CT imaging techniques have emerged addressing this issue 
more directly: stress myocardial perfusion CT imaging and CT angiography derived fractional flow 
reserve. Initial experiences show that both improve specificity for functional significant stenosis 
substantially, bringing the dream of a one-stop-shop diagnostic modality very close [3]. 
 On the other side, efforts are undertaken to decrease radiation exposure and the quantity of 
iodinated contrast medium needed per scan. Using new reconstruction algorithms with lower kV 
acquisition settings and modified contrast delivery protocols, complete scans can be attained for 
radiation doses of less than 1 mSV and a 30% decrease in the amount of contrast medium [4,5]. 
Lastly, it is still unclear how coronary CT angiography compares to other diagnostic tests in terms 
of cost-effectiveness. Considering the increasing medical expenditure in our society, partially the 
result of an aging population, it would be valuable to examine for what indication and which group 
of patients CT is cost-effective. 
 The coming years will reveal how the here above mentioned developing areas have moved 
coronary CT angiography as a diagnostic modality forward and what place it will have earned within 
the clinical field of cardiology.
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Coronaire CT angiografie heeft zich in het afgelopen decennium ontwikkeld tot een volwaardige 
diagnostische test bij kransslagvat ziekte. Hoofdstuk 1 geldt als een algemene inleiding van dit 
proefschrift, waarin een historisch perspectief geschetst wordt van deze ontwikkeling. Daarnaast 
worden hierin het doel en de opzet van dit proefschrift beschreven. 
 In Hoofdstuk 2 worden de technologische aspecten van de cardiale beeldvorming met 
behulp van de CT beschreven, alsmede de mogelijke acquisitie protocollen en de bijbehorende 
stralingsbelasting. Tevens wordt een overzicht gepresenteerd van de huidige diagnostische 
nauwkeurigheid en de klinische toepassingen.
 In Hoofdstuk 3 wordt een overzicht gegeven van de bestaande literatuur over het gebruik van 
echocardiografie, nucleaire perfusie beeldvorming, en coronaire CT angiografie bij verdenking 
op een acuut coronair syndroom. In dit artikel hebben wij de diagnostische prestaties van deze 
beeldvormende technieken vergeleken door middel van een systematische zoektocht in de 
beschikbare medische literatuur. Hoewel een lichte positieve trend ten gunste van de coronaire CT 
angiografie naar voren kwam, was er geen statistisch significant verschil tussen de drie modaliteiten. 
Hieruit concludeerden wij dat gezien de afwezigheid van grote verschillen in diagnostische 
nauwkeurigheid, andere aspecten zoals de lokale praktijk, expertise, medische voorzieningen, en de 
individuele kenmerken van de patiënt de doorslag moeten geven in de keuze van de diagnostische 
modaliteit.
 In Hoofdstuk 4 wordt een prospectieve geblindeerde studie beschreven waarin de diagnostische 
nauwkeurigheid van de coronaire CT angiografie en de coronaire calcium score wordt vergeleken 
in 111 patiënten met symptomen verdacht voor een acuut coronair syndroom. De studie liet 
zien dat afwezigheid van kransslagvatziekte op de coronaire CT angiografie een acuut coronair 
syndroom volledig uitsloot en een zeer gunstige korte termijn prognose garandeerde. Daarnaast 
bleek dat coronaire CT angiografie superieur was aan de coronaire calcium score was op het vlak 
van de diagnostische nauwkeurigheid. Tenslotte had de coronaire CT angiografie toegevoegde 
waarde naast de GRACE-score, de meest gebruikte klinische algoritme voor risicoinschatting in deze 
patiëntengroep.
 In Hoofdstuk 5 wordt de diagnostische nauwkeurigheid van copeptin, een biomarker van 
cardiovasculaire stress, onderzocht en afgezet tegen de bevindingen bij coronaire CT angiografie. 
Deze studie omvatte 65 patiënten die verdacht worden van een acuut syndroom. Bij deze patiënten 
werd bij presentatie op de Spoedeisende Hulp copeptin bepaald. Daarnaast ondergingen zij een 
coronaire CT angiografie. Het bleek dat patiënten met een acuut coronair syndroom gemiddeld 
een hogere copeptin waarden hebben, maar dat er geen significante associatie was tussen 
copeptin waarden en de aanwezigheid van kransslagvatziekte op coronaire CT angiografie. 
 In Hoofdstuk 6 wordt een prospectieve, gerandomiseerde, multicenter studie van 500 patiënten 
beschreven. Deze patiënten, die zich presenteerden met klachten verdacht voor een acuut coronair 
syndroom, werden op basis van willekeur verdeeld in twee groepen met verschillende diagnostische 
strategieën. De helft van de patiënten onderging de standaard optimale diagnostische strategie, 
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gedicteerd door hun behandelde arts. De andere groep onderging een diagnostische strategie waarin 
een vroege coronaire CT angiografie centraal stond. De belangrijkste bevinding van deze studie 
was dat een diagnostische strategie met coronair CT angiografie in een vroeg stadium, praktisch en 
veilig is, met lagere kosten en minder poliklinische onderzoeken nadien. Maar een diagnostische 
strategie met coronair CT angiografie kon niet meer patiënten met ernstige kransslagvatziekte 
vinden, noch kon het ziekenhuisopnames verkorten of zorgen dat meer patiënten meteen vanaf de 
spoedeisende-hulpafdeling ontslagen konden worden.
 In Hoofdstuk 8 hebben we de nauwkeurigheid van de coronaire calcium score en de 
fietsergometrie als een eventuele goedkopere, niet-invasieve test voor het screenen van ernstige 
kransslagvatziekte vergeleken. Beide testen werden in 791 patiënten met klachten van pijn op de 
borst verricht, gevolgd door een hartcatheterisatie of een coronaire CT angiografie als verificatie. 
Deze studie liet zien dat bij patiënten met een laag risico op basis van het klinisch profiel en verder 
geen verkalkingen van de kransslagvaten verdere diagnostiek onnodig lijkt omdat zij een kans van 
minder dan 5% op belangrijke kransslagvatziekte hebben. In de groep patiënten met een gemiddeld 
risico waren beide modaliteiten niet in staat om ernstig kransslagvatziekte uit te sluiten. Bij hoog 
risico patiënten lijkt de fietsergometrie bruikbaar om de prognose in te schatten.
 In Hoofdstuk 9 wordt onderzocht of coronaire CT angiografie een betere risico inschatting 
voor toekomstige cardiovasculaire aandoeningen kan geven dan de coronaire calcium score in 
individuen zonder klachten maar wel een hoog cardiovasculair risicoprofiel. In twee academische 
centra participeerden 665 patiënten aan deze studie. Zij werden gemiddeld 3 jaar gevolgd. Hoewel 
de patiënten gekenmerkt werden door een zeer ongunstig risicoprofiel, bleken zij over het algemeen 
na 3 jaar een lage incidentie van cardiovasculaire aandoeningen te hebben. Afwezigheid van 
verkalkingen van de kransslagvaten was geassocieerd met een zeer gunstige prognose. In diegene 
met verkalkingen van de kransslagvaten bleek coronaire CT angiografie toegevoegde waarde te 
hebben voor het voorspellen van cardiovasculaire aandoeningen.
 In Hoofdstuk 10 worden de voorspellende waarden van fietsergometrie, de coronaire 
calcium score en coronaire CT angiografie voor het optreden van toekomstige cardiovasculaire 
aandoeningen vergeleken. Aan deze studie participeerden 471 patiënten met klachten van stabiele 
angina pectoris. Zij ondergingen allemaal alle drie de testen. Deze studie liet zien dat hogere 
calcium scores, de aanwezigheid van belangrijke kransslagvatziekte op coronaire CT angiografie 
en de maximale inspanningstolerantie tijdens fietsergometrie allen voorspellend waren voor het 
optreden van cardiovasculaire aandoeningen in de toekomst. Als de drie modaliteiten worden 
vergeleken, blijkt de uitslag van de coronaire CT angiografie het meeste toegevoegde waarde te 
hebben.
In Hoofdstuk 11 wordt een studie beschreven van patiënten die zich presenteren met een acuut 
coronair syndroom en ook coronaire CT angiografie ondergingen. Specifiek wordt gekeken naar 
de gevolgen van overig kransslagvatziekte, niet verantwoordelijk voor het huidige acuut coronair 
syndroom. In totaal ondergingen 169 patiënten coronaire CT angiografie en werden gevolgd in de 
tijd op het voorkomen van dood, een nieuw hartinfarct of een behandeling van de kransslagvaten. 
Gedurende 5 jaar bleek bijna een kwart van deze patiënten een van deze aandoening te hebben 
gehad. Patiënten met veel zogeheten overige kransslagvatziekte op coronair CT angiografie hadden 
een statistisch significant hoger risico op nieuwe cardiovasculaire aandoeningen in de toekomst.
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lieve ouders, moji dragi roditelji, bedankt voor alle kansen die jullie voor mij en Benji hebben gecreëerd 
en de motivatie om altijd het meeste uit ons leven te halen. Jullie hebben keihard gevochten, en ik 
weet hoe moeilijk het was, vooral voor mijn moeder, om ons een goed leven te geven. Last but 
not least, Sanneli, mijn schatje. Jij hebt misschien het meeste begrip en geduld moeten opbrengen 
voor de totstandkoming van dit proefschrift. Ik heb toch aardig wat uren moeten werken naast mijn 
reguliere taken in de kliniek om dit af te krijgen. Maar nooit heb ik je horen klagen en je hebt me 
altijd gesteund en verder geholpen in mijn ambities. 
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PhD Portfolio
Year Workload 
(ECTS)
PhD training
General Academic and Research Skills
NIHES Biostatistical Wintercourse 2010 5.7
COEUR PhD Day 2010 0.4
Seminar Clinical Decision Making 2010 0.4
OpenClinica Training 2012 0.6
In-depth Courses
ERCATHAN Functional Anatomy Masterclass 2010 0.3
COEUR Cardiovascular Imaging and Diagnostics 2010 1.5
COEUR Clinical Cardiovascular Epidemiology 2010 1.5
Molmed Imaging Workshop 2010 0.3
Course Radiation Protection level 5A/B 2010 0.6
Research Seminar Biomarkers for Risk prediction 2010 0.4
Seminar Detection of Early Atherosclerosis 2011 0.4
COEUR Intensive Care Research 2012 1.5
COEUR Pathophysiology of Ischemic Heart Disease 2012 1.5
COEUR Arrhythmia Research Methodology 2012 1.5
CVOI Cardiac Imaging 2012 0.3
Conferences and Symposia
AHA – Chicago 2010 2.1
ICNC – Amsterdam 2011 0.9
Cardiac MRI & CT – Cannes 2011 0.9
Hypertrophic Cardiomyopathy – Rotterdam 2011 0.3
RSNA – Chicago 2011 2.1
NVVC – Arnhem 2011 0.3
ESC – Parijs 2011 1.5
Simoons de Doelen – Rotterdam 2011 1.2
ESC Acute Cardiac Care – Istanbul 2012 1.5
ESC – Munchen 2012 1.5
RSNA – Chicago 2012 2.1
ACC – San Francisco 2013 0.5
ESC EuroEcho – Istanbul 2013 1.5
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Year Workload 
(ECTS)
Conferences and Symposia (Continued)
ESC – Amsterdam 2013 1.2
Winter Meeting ESC Imaging Nucleus 2014 0.9
National Cardiology Convention Macedonia 2014 0.9
ESC – Londen 2015 1.2
AHA – Orlando 2015 1.2
Teaching Activities
Supervising research of 2nd year medical students 2012 1.0
CT reading course 2012 0.6
CT reading course 2013 0.9
CT reading course 2014 0.3
CT reading course 2015 0.3
CT reading course 2016 0.3
Total ECTS 42.1
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Abbreviations
ACP = Acute Chest Pain
ACS = Acute Coronary Syndrome
AHA = American Heart Association
AMI = Acute Myocardial Infarction
ANOVA = Analysis of Variance
AUC = Area Under the Curve
AVP = Arginine Vasopressin
CABG = Coronary Artery Bypass Graft surgery
CACS = Coronary Artery Calcium Score
CAD = Coronary Artery Disease
CAG = coronary Angiography
CCS = Coronary Calcium Scanning
CCTA = Coronary Computed Tomography Angiography
CI = Confidence Interval
CK-MB = Creatine Kinase Myocardial Band
CT = Computed Tomography
CTA = Computed Tomography Angiography
CTA-FFR = Computed Tomography Angiography based Fractional Flow Reserve
CVD = Cardiovascular Disease
DCS = Duke Clinical Score
DM = Diabetes Mellitus
ED = Emergency Department
EBCT = Electron-beam Computed Tomography
ECG = Electrocardiography
ExECG = Exercise Electrocardiography
FH = Familial Hypercholesterolemia
GRACE = Global Registry of Acute Coronary Events
HR = Hazard Ratio
Hs-troponins = High-sensitivity Troponins
ICA = Invasive Coronary Angiography
ICU = Intensive Care Unit
IQR = Interquartile Range
LAD = Left Anterior descending
LCX = Left Circumflex 
LM = Left Main
LR = Likelihood Ratio
LV = Left Ventricle
MACE = Major Adverse Cardiac Event
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MBF = Myocardial Blood Flow
MI = Myocardial Infarction
MPI = Myocardial Perfusion Imaging
MPR = Multiplanar Reconstruction
MRI = Magnetic Resonance Imaging
mSv = MiliSievert
NPV = Negative Predictive Value
NRI = Net Recalssification Index
NSTEMI = Non ST-segment Elevation Myocardial Infarction
PAD = Peripheral Artery Disease
PCI = Percutaneous Coronary Intervention
PPV = Positive Predictive Value
QCA = Quantitative Coronary Angiography
RCA = Right Coronary Artery
ROC = Receiver Operating Characteristics
SD = Standard Deviation
SIS = Segment Involvement Score
SOC = Standard Optimal Care
SPECT = Single-Photon Emission Computed Tomography
SROC = Summary Receiver Operating Characteristics
STEMI = ST-segment Elevation Myocardial Infarction
TIMI = Thrombolysis in Myocardial Infarction
UAP = Unstable Angina Pectoris
VSD = Ventricular Septal Defect
WMA = Wall Motion Abnormalities
X-ECG = Exercise Electrocardiography
